TermID	Term	Enrichment	logP	Genes in Term	Target Genes in Term	Fraction of Targets in Term	Total Target Genes	Total Genes	Entrez Gene IDs	Gene Symbols
R-HSA-352230	Amino acid transport across the plasma membrane	1.19516503069192e-05	-11.3346411881244	31	9	0.0222772277227723	404	8202	6541,6533,6520,6509,23657,8140,54716,124935,117247	SLC7A1,SLC6A6,SLC3A2,SLC1A4,SLC7A11,SLC7A5,SLC6A20,SLC43A2,SLC16A10
R-HSA-194840	Rho GTPase cycle	0.000112946115421361	-9.0885997076615	124	17	0.0420792079207921	404	8202	64411,58504,1894,4983,84033,9743,115703,29,9901,84144,1123,23263,57522,101928168,9828,90627,50649	ARAP3,ARHGAP22,ECT2,OPHN1,OBSCN,ARHGAP32,ARHGAP33,ABR,SRGAP3,SYDE2,CHN1,MCF2L,SRGAP1,LOC101928168,ARHGEF17,STARD13,ARHGEF4
R-HSA-2022090	Assembly of collagen fibrils and other multimeric structures	0.000256262498996683	-8.26930825212877	54	10	0.0247524752475248	404	8202	4316,7092,1285,9313,1287,1288,1293,85301,7093,3914	MMP7,TLL1,COL4A3,MMP20,COL4A5,COL4A6,COL6A3,COL27A1,TLL2,LAMB3
R-HSA-1474290	Collagen formation	0.000270370645355218	-8.21571677976539	86	13	0.0321782178217822	404	8202	4316,7092,1285,9313,5352,1287,26577,1288,1303,1293,85301,7093,3914	MMP7,TLL1,COL4A3,MMP20,PLOD2,COL4A5,PCOLCE2,COL4A6,COL12A1,COL6A3,COL27A1,TLL2,LAMB3
R-HSA-1474244	Extracellular matrix organization	0.000657380242106444	-7.32724795178507	267	26	0.0643564356435644	404	8202	4052,7077,7092,1285,9313,3339,2247,3684,10319,1287,7042,85301,1293,1303,84467,3914,6696,4316,5352,3673,85007,26577,3687,1288,170690,7093	LTBP1,TIMP2,TLL1,COL4A3,MMP20,HSPG2,FGF2,ITGAM,LAMC3,COL4A5,TGFB2,COL27A1,COL6A3,COL12A1,FBN3,LAMB3,SPP1,MMP7,PLOD2,ITGA2,PHYKPL,PCOLCE2,ITGAX,COL4A6,ADAMTS16,TLL2
R-HSA-382551	Transmembrane transport of small molecules	0.000986648603649819	-6.92119660659352	586	46	0.113861386138614	404	8202	6536,10079,1831,10396,9914,2792,9197,90423,6507,7037,23200,23225,6509,23657,7439,261729,7220,57101,121601,53373,81929,10057,4645,285195,6520,10257,64116,27032,9194,5577,23250,481,1181,6541,6533,162514,22841,41,6575,8140,3099,54716,55356,483,124935,117247	SLC6A9,ATP9A,TSC22D3,ATP8A1,ATP2C2,GNGT1,SLC33A1,ATP6V1E2,SLC1A3,TFRC,ATP11B,NUP210,SLC1A4,SLC7A11,BEST1,STEAP2,TRPC1,ANO2,ANO4,TPCN1,SEH1L,ABCC5,MYO5B,SLC9A9,SLC3A2,ABCC4,SLC39A8,ATP2C1,SLC16A7,PRKAR2B,ATP11A,ATP1B1,CLCN2,SLC7A1,SLC6A6,TRPV3,RAB11FIP2,ASIC1,SLC20A2,SLC7A5,HK2,SLC6A20,SLC22A15,ATP1B3,SLC43A2,SLC16A10
R-HSA-1650814	Collagen biosynthesis and modifying enzymes	0.00104515053220364	-6.86359435398392	64	10	0.0247524752475248	404	8202	7092,1285,5352,1287,26577,1288,1303,1293,85301,7093	TLL1,COL4A3,PLOD2,COL4A5,PCOLCE2,COL4A6,COL12A1,COL6A3,COL27A1,TLL2
R-HSA-210991	Basigin interactions	0.00109520641717697	-6.81681242464181	25	6	0.0148514851485149	404	8202	857,483,6520,481,23657,8140	CAV1,ATP1B3,SLC3A2,ATP1B1,SLC7A11,SLC7A5
R-HSA-193648	NRAGE signals death through JNK	0.00139781337569279	-6.57284613786358	45	8	0.0198019801980198	404	8202	5599,23263,9500,1894,84033,9828,29,50649	MAPK8,MCF2L,MAGED1,ECT2,OBSCN,ARHGEF17,ABR,ARHGEF4
R-HSA-936837	Ion transport by P-type ATPases	0.00246262165710195	-6.00652878223909	49	8	0.0198019801980198	404	8202	23200,10079,10396,27032,9914,23250,481,483	ATP11B,ATP9A,ATP8A1,ATP2C1,ATP2C2,ATP11A,ATP1B1,ATP1B3
R-HSA-425393	Transport of inorganic cations/anions and amino acids/oligopeptides	0.00253370539525026	-5.97807246459564	96	12	0.0297029702970297	404	8202	285195,6541,6533,6520,6509,23657,6575,8140,54716,6507,124935,117247	SLC9A9,SLC7A1,SLC6A6,SLC3A2,SLC1A4,SLC7A11,SLC20A2,SLC7A5,SLC6A20,SLC1A3,SLC43A2,SLC16A10
R-HSA-422475	Axon guidance	0.00265675725383921	-5.93064897737203	516	40	0.099009900990099	404	8202	6712,200734,5922,2043,1950,9542,1287,5361,2047,9252,785,5217,9965,1293,6196,775,5062,1739,57522,7220,776,4233,8831,1285,2247,287,1852,5682,283455,7422,9901,8660,2534,3673,6478,23129,23114,90249,8829,409	SPTBN2,SPRED2,RASA2,EPHA4,EGF,NRG2,COL4A5,PLXNA1,EPHB1,RPS6KA5,CACNB4,PFN2,FGF19,COL6A3,RPS6KA2,CACNA1C,PAK2,DLG1,SRGAP1,TRPC1,CACNA1D,MET,SYNGAP1,COL4A3,FGF2,ANK2,DUSP9,PSMA1,KSR2,VEGFA,SRGAP3,IRS2,FYN,ITGA2,SIAH2,PLXND1,NFASC,UNC5A,NRP1,ARRB2
R-HSA-202733	Cell surface interactions at the vascular wall	0.00328370540009746	-5.71878279905982	99	12	0.0297029702970297	404	8202	2534,6520,23657,3684,8140,857,481,483,3687,5291,285,140885	FYN,SLC3A2,SLC7A11,ITGAM,SLC7A5,CAV1,ATP1B1,ATP1B3,ITGAX,PIK3CB,ANGPT2,SIRPA
R-HSA-3323169	Defects in biotin (Btn) metabolism	0.00357852291789386	-5.63280515647642	7	3	0.00742574257425743	404	8202	5096,5095,56922	PCCB,PCCA,MCCC1
R-HSA-3371599	Defective HLCS causes multiple carboxylase deficiency	0.00357852291789386	-5.63280515647642	7	3	0.00742574257425743	404	8202	5096,5095,56922	PCCB,PCCA,MCCC1
R-HSA-2214320	Anchoring fibril formation	0.00357852291789386	-5.63280515647642	7	3	0.00742574257425743	404	8202	7092,3914,7093	TLL1,LAMB3,TLL2
R-HSA-166520	Signalling by NGF	0.00402576200312875	-5.5150410684824	430	34	0.0841584158415842	404	8202	5599,6712,200734,5922,9500,1950,9542,9252,2309,9965,84894,5581,6196,23263,5584,9828,8831,2247,3164,4914,1894,1852,283455,84033,5682,5577,5291,29,8660,57761,2534,409,4208,50649	MAPK8,SPTBN2,SPRED2,RASA2,MAGED1,EGF,NRG2,RPS6KA5,FOXO3,FGF19,LINGO1,PRKCE,RPS6KA2,MCF2L,PRKCI,ARHGEF17,SYNGAP1,FGF2,NR4A1,NTRK1,ECT2,DUSP9,KSR2,OBSCN,PSMA1,PRKAR2B,PIK3CB,ABR,IRS2,TRIB3,FYN,ARRB2,MEF2C,ARHGEF4
R-HSA-1474228	Degradation of the extracellular matrix	0.00412596595811199	-5.49045511494588	89	11	0.0272277227722772	404	8202	6696,4316,7077,7092,9313,3339,85007,1303,170690,7093,3914	SPP1,MMP7,TIMP2,TLL1,MMP20,HSPG2,PHYKPL,COL12A1,ADAMTS16,TLL2,LAMB3
R-HSA-2990846	SUMOylation	0.00516116873454235	-5.26659222619336	79	10	0.0247524752475248	404	8202	23225,80012,10274,286053,22955,165918,7486,9656,205564,81929	NUP210,PHC3,STAG1,NSMCE2,SCMH1,RNF168,WRN,MDC1,SENP5,SEH1L
R-HSA-379716	Cytosolic tRNA aminoacylation	0.00552646812497681	-5.19820634289898	24	5	0.0123762376237624	404	8202	833,6301,51520,2617,16	CARS,SARS,LARS,GARS,AARS
R-HSA-399954	Sema3A PAK dependent Axon repulsion	0.00657925849631004	-5.02383323052536	16	4	0.0099009900990099	404	8202	2534,5361,8829,5062	FYN,PLXNA1,NRP1,PAK2
R-HSA-193704	p75 NTR receptor-mediated signalling	0.00672629745998094	-5.00173044125081	82	10	0.0247524752475248	404	8202	5599,23263,9500,1894,5584,84033,9828,29,84894,50649	MAPK8,MCF2L,MAGED1,ECT2,PRKCI,OBSCN,ARHGEF17,ABR,LINGO1,ARHGEF4
R-HSA-977347	Serine biosynthesis	0.00702408797338802	-4.95840989804267	3	2	0.00495049504950495	404	8202	29968,26227	PSAT1,PHGDH
R-HSA-983712	Ion channel transport	0.00871890886135371	-4.74226117946944	198	18	0.0445544554455446	404	8202	10079,1831,10396,27032,9914,90423,23250,481,1181,23200,162514,7439,41,7220,483,57101,121601,53373	ATP9A,TSC22D3,ATP8A1,ATP2C1,ATP2C2,ATP6V1E2,ATP11A,ATP1B1,CLCN2,ATP11B,TRPV3,BEST1,ASIC1,TRPC1,ATP1B3,ANO2,ANO4,TPCN1
R-HSA-419037	NCAM1 interactions	0.00873110342950657	-4.74086352198534	37	6	0.0148514851485149	404	8202	1287,776,1285,775,785,1293	COL4A5,CACNA1D,COL4A3,CACNA1C,CACNB4,COL6A3
R-HSA-381119	Unfolded Protein Response (UPR)	0.00935842450180108	-4.6714783251176	86	10	0.0247524752475248	404	8202	58477,440,29927,7095,2137,51726,467,22926,27230,1649	SRPRB,ASNS,SEC61A1,SEC62,EXTL3,DNAJB11,ATF3,ATF6,SERP1,DDIT3
R-HSA-204998	Cell death signalling via NRAGE, NRIF and NADE	0.00962936349466076	-4.64293815144577	61	8	0.0198019801980198	404	8202	5599,23263,9500,1894,84033,9828,29,50649	MAPK8,MCF2L,MAGED1,ECT2,OBSCN,ARHGEF17,ABR,ARHGEF4
R-HSA-3108232	SUMO E3 ligases SUMOylate target proteins	0.0100876636716251	-4.59644202032561	74	9	0.0222772277227723	404	8202	23225,80012,10274,286053,22955,165918,7486,9656,81929	NUP210,PHC3,STAG1,NSMCE2,SCMH1,RNF168,WRN,MDC1,SEH1L
R-HSA-3108214	SUMOylation of DNA damage response and repair proteins	0.0100876636716251	-4.59644202032561	74	9	0.0222772277227723	404	8202	23225,80012,10274,286053,22955,165918,7486,9656,81929	NUP210,PHC3,STAG1,NSMCE2,SCMH1,RNF168,WRN,MDC1,SEH1L
R-HSA-198203	PI3K/AKT activation	0.0106214150393476	-4.54488302916796	101	11	0.0272277227722772	404	8202	8660,57761,2534,2247,3164,4914,1950,9542,2309,9965,5291	IRS2,TRIB3,FYN,FGF2,NR4A1,NTRK1,EGF,NRG2,FOXO3,FGF19,PIK3CB
R-HSA-400253	Circadian Clock	0.011631845015264	-4.45400868227699	63	8	0.0198019801980198	404	8202	56938,79718,79365,406,4209,6907,9575,4208	ARNTL2,TBL1XR1,BHLHE41,ARNTL,MEF2D,TBL1X,CLOCK,MEF2C
R-HSA-2730905	Role of LAT2/NTAL/LAB on calcium mobilization	0.0130778560007198	-4.33683486070657	104	11	0.0272277227722772	404	8202	8660,57761,2534,2247,3164,1950,9542,2309,9965,5291,7462	IRS2,TRIB3,FYN,FGF2,NR4A1,EGF,NRG2,FOXO3,FGF19,PIK3CB,LAT2
R-HSA-196780	Biotin transport and metabolism	0.0145581790324738	-4.22960231048603	11	3	0.00742574257425743	404	8202	5096,5095,56922	PCCB,PCCA,MCCC1
R-HSA-109704	PI3K Cascade	0.0151578111665061	-4.18923929134861	79	9	0.0222772277227723	404	8202	8660,5563,57761,2247,1978,30849,5140,9965,5291	IRS2,PRKAA2,TRIB3,FGF2,EIF4EBP1,PIK3R4,PDE3B,FGF19,PIK3CB
R-HSA-379724	tRNA Aminoacylation	0.0160354199314524	-4.13295525775134	42	6	0.0148514851485149	404	8202	833,10667,6301,51520,2617,16	CARS,FARS2,SARS,LARS,GARS,AARS
R-HSA-1368108	BMAL1:CLOCK,NPAS2 activates circadian gene expression	0.0160354199314524	-4.13295525775134	42	6	0.0148514851485149	404	8202	56938,6907,9575,79718,79365,406	ARNTL2,TBL1X,CLOCK,TBL1XR1,BHLHE41,ARNTL
R-HSA-109582	Hemostasis	0.0202167245930979	-3.90124506698327	515	36	0.0891089108910891	404	8202	7273,3684,2792,1950,2625,8527,4842,7042,1795,140885,5581,10019,23657,2624,3687,11343,1608,285,4602,7277,6520,10257,5577,10335,857,481,7422,80005,5140,5291,50940,2534,3673,8140,483,409	TTN,ITGAM,GNGT1,EGF,GATA3,DGKD,NOS1,TGFB2,DOCK3,SIRPA,PRKCE,SH2B3,SLC7A11,GATA2,ITGAX,MGLL,DGKG,ANGPT2,MYB,TUBA4A,SLC3A2,ABCC4,PRKAR2B,MRVI1,CAV1,ATP1B1,VEGFA,DOCK5,PDE3B,PIK3CB,PDE11A,FYN,ITGA2,SLC7A5,ATP1B3,ARRB2
R-HSA-373753	Nephrin interactions	0.0209495801527175	-3.86563667325788	22	4	0.0099009900990099	404	8202	2534,4868,84063,5291	FYN,NPHS1,KIRREL2,PIK3CB
R-HSA-375165	NCAM signaling for neurite out-growth	0.0217922261106728	-3.826201973212	266	21	0.051980198019802	404	8202	6712,200734,8831,1285,2247,5922,1950,1852,5682,283455,9542,1287,9252,785,9965,1293,8660,2534,775,776,409	SPTBN2,SPRED2,SYNGAP1,COL4A3,FGF2,RASA2,EGF,DUSP9,PSMA1,KSR2,NRG2,COL4A5,RPS6KA5,CACNB4,FGF19,COL6A3,IRS2,FYN,CACNA1C,CACNA1D,ARRB2
R-HSA-74713	IRS activation	0.0219173861544377	-3.82047506879185	5	2	0.00495049504950495	404	8202	8660,2887	IRS2,GRB10
R-HSA-71032	Propionyl-CoA catabolism	0.0219173861544377	-3.82047506879185	5	2	0.00495049504950495	404	8202	5096,5095	PCCB,PCCA
R-HSA-203641	NOSTRIN mediated eNOS trafficking	0.0219173861544377	-3.82047506879185	5	2	0.00495049504950495	404	8202	115677,857	NOSTRIN,CAV1
R-HSA-1250342	PI3K events in ERBB4 signaling	0.0220383366929206	-3.81497176519858	98	10	0.0247524752475248	404	8202	8660,57761,2534,2247,3164,1950,9542,2309,9965,5291	IRS2,TRIB3,FYN,FGF2,NR4A1,EGF,NRG2,FOXO3,FGF19,PIK3CB
R-HSA-5654720	PI-3K cascade:FGFR4	0.0220383366929206	-3.81497176519858	98	10	0.0247524752475248	404	8202	8660,57761,2534,2247,3164,1950,9542,2309,9965,5291	IRS2,TRIB3,FYN,FGF2,NR4A1,EGF,NRG2,FOXO3,FGF19,PIK3CB
R-HSA-5654689	PI-3K cascade:FGFR1	0.0220383366929206	-3.81497176519858	98	10	0.0247524752475248	404	8202	8660,57761,2534,2247,3164,1950,9542,2309,9965,5291	IRS2,TRIB3,FYN,FGF2,NR4A1,EGF,NRG2,FOXO3,FGF19,PIK3CB
R-HSA-5654695	PI-3K cascade:FGFR2	0.0220383366929206	-3.81497176519858	98	10	0.0247524752475248	404	8202	8660,57761,2534,2247,3164,1950,9542,2309,9965,5291	IRS2,TRIB3,FYN,FGF2,NR4A1,EGF,NRG2,FOXO3,FGF19,PIK3CB
R-HSA-5654710	PI-3K cascade:FGFR3	0.0220383366929206	-3.81497176519858	98	10	0.0247524752475248	404	8202	8660,57761,2534,2247,3164,1950,9542,2309,9965,5291	IRS2,TRIB3,FYN,FGF2,NR4A1,EGF,NRG2,FOXO3,FGF19,PIK3CB
R-HSA-1257604	PIP3 activates AKT signaling	0.0220383366929206	-3.81497176519858	98	10	0.0247524752475248	404	8202	8660,57761,2534,2247,3164,1950,9542,2309,9965,5291	IRS2,TRIB3,FYN,FGF2,NR4A1,EGF,NRG2,FOXO3,FGF19,PIK3CB
R-HSA-1963642	PI3K events in ERBB2 signaling	0.0220383366929206	-3.81497176519858	98	10	0.0247524752475248	404	8202	8660,57761,2534,2247,3164,1950,9542,2309,9965,5291	IRS2,TRIB3,FYN,FGF2,NR4A1,EGF,NRG2,FOXO3,FGF19,PIK3CB
R-HSA-2219528	PI3K/AKT Signaling in Cancer	0.0234641764433802	-3.7522804275867	85	9	0.0222772277227723	404	8202	8660,2534,2247,3164,1950,9542,5291,9965,2309	IRS2,FYN,FGF2,NR4A1,EGF,NRG2,PIK3CB,FGF19,FOXO3
R-HSA-70614	Amino acid synthesis and interconversion (transamination)	0.024400873461897	-3.71313634970497	23	4	0.0099009900990099	404	8202	84706,440,29968,26227	GPT2,ASNS,PSAT1,PHGDH
R-HSA-3000157	Laminin interactions	0.024400873461897	-3.71313634970497	23	4	0.0099009900990099	404	8202	10319,3339,3673,3914	LAMC3,HSPG2,ITGA2,LAMB3
R-HSA-392154	Nitric oxide stimulates guanylate cyclase	0.0281757545294314	-3.56929343931084	24	4	0.0099009900990099	404	8202	10335,4842,5140,50940	MRVI1,NOS1,PDE3B,PDE11A
R-HSA-180292	GAB1 signalosome	0.028220890841395	-3.56769276532379	102	10	0.0247524752475248	404	8202	8660,57761,2534,2247,3164,1950,9542,2309,9965,5291	IRS2,TRIB3,FYN,FGF2,NR4A1,EGF,NRG2,FOXO3,FGF19,PIK3CB
R-HSA-399955	SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion	0.0287848869103582	-3.54790478963199	14	3	0.00742574257425743	404	8202	2534,5361,8829	FYN,PLXNA1,NRP1
R-HSA-2219530	Constitutive Signaling by Aberrant PI3K in Cancer	0.0294435106850085	-3.52528174341961	61	7	0.0173267326732673	404	8202	8660,9542,2534,2247,9965,5291,1950	IRS2,NRG2,FYN,FGF2,FGF19,PIK3CB,EGF
R-HSA-1266738	Developmental Biology	0.0315403417644278	-3.45648786160146	710	46	0.113861386138614	404	8202	6712,200734,5922,2043,1950,9542,1287,5361,2047,9252,785,5217,2309,9965,1293,6196,775,5062,1739,57522,7220,776,4233,8831,1285,2247,79718,57167,287,1852,5682,283455,4209,7422,9901,8660,2534,3673,6478,23129,6907,23114,90249,8829,409,4208	SPTBN2,SPRED2,RASA2,EPHA4,EGF,NRG2,COL4A5,PLXNA1,EPHB1,RPS6KA5,CACNB4,PFN2,FOXO3,FGF19,COL6A3,RPS6KA2,CACNA1C,PAK2,DLG1,SRGAP1,TRPC1,CACNA1D,MET,SYNGAP1,COL4A3,FGF2,TBL1XR1,SALL4,ANK2,DUSP9,PSMA1,KSR2,MEF2D,VEGFA,SRGAP3,IRS2,FYN,ITGA2,SIAH2,PLXND1,TBL1X,NFASC,UNC5A,NRP1,ARRB2,MEF2C
R-HSA-3304356	SMAD2/3 Phosphorylation Motif Mutants in Cancer	0.0318150104848682	-3.44781707274005	6	2	0.00495049504950495	404	8202	7048,9372	TGFBR2,ZFYVE9
R-HSA-380994	ATF4 activates genes	0.0322788918591312	-3.43334176519284	25	4	0.0099009900990099	404	8202	22926,467,440,1649	ATF6,ATF3,ASNS,DDIT3
R-HSA-5685938	HDR through Single Strand Annealing (SSA)	0.0336534411175204	-3.39163996608354	37	5	0.0123762376237624	404	8202	5984,545,7486,11073,3364	RFC4,ATR,WRN,TOPBP1,HUS1
R-HSA-380259	Loss of Nlp from mitotic centrosomes	0.0343686455186895	-3.37061059772181	63	7	0.0173267326732673	404	8202	5577,80254,80321,22981,7840,10806,7277	PRKAR2B,CEP63,CEP70,NINL,ALMS1,SDCCAG8,TUBA4A
R-HSA-380284	Loss of proteins required for interphase microtubule organizationfrom the centrosome	0.0343686455186895	-3.37061059772181	63	7	0.0173267326732673	404	8202	5577,80254,80321,22981,7840,10806,7277	PRKAR2B,CEP63,CEP70,NINL,ALMS1,SDCCAG8,TUBA4A
R-HSA-74751	Insulin receptor signalling cascade	0.0355709716089745	-3.33622537798931	280	21	0.051980198019802	404	8202	5563,6712,200734,8831,2247,5922,1950,30849,1852,5682,283455,9542,5140,5291,9965,8660,57761,2534,1978,2887,409	PRKAA2,SPTBN2,SPRED2,SYNGAP1,FGF2,RASA2,EGF,PIK3R4,DUSP9,PSMA1,KSR2,NRG2,PDE3B,PIK3CB,FGF19,IRS2,TRIB3,FYN,EIF4EBP1,GRB10,ARRB2
R-HSA-425407	SLC-mediated transmembrane transport	0.036223480835093	-3.31804772857422	264	20	0.0495049504950495	404	8202	285195,6520,6536,64116,9194,9197,6507,6541,6533,23225,23657,6509,6575,8140,3099,54716,55356,124935,81929,117247	SLC9A9,SLC3A2,SLC6A9,SLC39A8,SLC16A7,SLC33A1,SLC1A3,SLC7A1,SLC6A6,NUP210,SLC7A11,SLC1A4,SLC20A2,SLC7A5,HK2,SLC6A20,SLC22A15,SLC43A2,SEH1L,SLC16A10
R-HSA-2029485	Role of phospholipids in phagocytosis	0.0367134615234726	-3.30461179217122	26	4	0.0099009900990099	404	8202	5581,5337,8398,5291	PRKCE,PLD1,PLA2G6,PIK3CB
R-HSA-2428924	IGF1R signaling cascade	0.0367584985895125	-3.30338582592201	281	21	0.051980198019802	404	8202	5563,6712,200734,8831,2247,5922,1950,30849,1852,5682,283455,9542,5140,5291,9965,8660,57761,2534,3480,1978,409	PRKAA2,SPTBN2,SPRED2,SYNGAP1,FGF2,RASA2,EGF,PIK3R4,DUSP9,PSMA1,KSR2,NRG2,PDE3B,PIK3CB,FGF19,IRS2,TRIB3,FYN,IGF1R,EIF4EBP1,ARRB2
R-HSA-2428928	IRS-related events triggered by IGF1R	0.0367584985895125	-3.30338582592201	281	21	0.051980198019802	404	8202	5563,6712,200734,8831,2247,5922,1950,30849,1852,5682,283455,9542,5140,5291,9965,8660,57761,2534,3480,1978,409	PRKAA2,SPTBN2,SPRED2,SYNGAP1,FGF2,RASA2,EGF,PIK3R4,DUSP9,PSMA1,KSR2,NRG2,PDE3B,PIK3CB,FGF19,IRS2,TRIB3,FYN,IGF1R,EIF4EBP1,ARRB2
R-HSA-2404192	Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R)	0.0367584985895125	-3.30338582592201	281	21	0.051980198019802	404	8202	5563,6712,200734,8831,2247,5922,1950,30849,1852,5682,283455,9542,5140,5291,9965,8660,57761,2534,3480,1978,409	PRKAA2,SPTBN2,SPRED2,SYNGAP1,FGF2,RASA2,EGF,PIK3R4,DUSP9,PSMA1,KSR2,NRG2,PDE3B,PIK3CB,FGF19,IRS2,TRIB3,FYN,IGF1R,EIF4EBP1,ARRB2
R-HSA-913709	O-linked glycosylation of mucins	0.0370246857806581	-3.29617040554469	64	7	0.0173267326732673	404	8202	2591,146712,79623,374378,6480,10331,84002	GALNT3,B3GNTL1,GALNT14,GALNT18,ST6GAL1,B3GNT3,B3GNT5
R-HSA-5693616	Presynaptic phase of homologous DNA pairing and strand exchange	0.0410629659221676	-3.19264863614311	39	5	0.0123762376237624	404	8202	5984,545,7486,11073,3364	RFC4,ATR,WRN,TOPBP1,HUS1
R-HSA-399956	CRMPs in Sema3A signaling	0.041187366473839	-3.18962370863449	16	3	0.00742574257425743	404	8202	2534,5361,8829	FYN,PLXNA1,NRP1
R-HSA-114508	Effects of PIP2 hydrolysis	0.0414811993159369	-3.18251498292555	27	4	0.0099009900990099	404	8202	5581,8527,11343,1608	PRKCE,DGKD,MGLL,DGKG
R-HSA-1855204	Synthesis of IP3 and IP4 in the cytosol	0.0414811993159369	-3.18251498292555	27	4	0.0099009900990099	404	8202	5332,23007,23236,5330	PLCB4,PLCH1,PLCB1,PLCB2
R-HSA-1368082	RORA activates gene expression	0.0414811993159369	-3.18251498292555	27	4	0.0099009900990099	404	8202	6907,9575,79718,406	TBL1X,CLOCK,TBL1XR1,ARNTL
R-HSA-3656534	Loss of Function of TGFBR1 in Cancer	0.0431096055130751	-3.14400944097071	7	2	0.00495049504950495	404	8202	7048,9372	TGFBR2,ZFYVE9
R-HSA-3304349	Loss of Function of SMAD2/3 in Cancer	0.0431096055130751	-3.14400944097071	7	2	0.00495049504950495	404	8202	7048,9372	TGFBR2,ZFYVE9
R-HSA-199920	CREB phosphorylation	0.0431096055130751	-3.14400944097071	7	2	0.00495049504950495	404	8202	6196,9252	RPS6KA2,RPS6KA5
R-HSA-3315487	SMAD2/3 MH2 Domain Mutants in Cancer	0.0431096055130751	-3.14400944097071	7	2	0.00495049504950495	404	8202	7048,9372	TGFBR2,ZFYVE9
R-HSA-3656532	TGFBR1 KD Mutants in Cancer	0.0431096055130751	-3.14400944097071	7	2	0.00495049504950495	404	8202	7048,9372	TGFBR2,ZFYVE9
R-HSA-74752	Signaling by Insulin receptor	0.0447118263641967	-3.10751724044962	304	22	0.0544554455445545	404	8202	5563,6712,200734,8831,2247,5922,1950,30849,1852,5682,90423,283455,9542,5140,5291,9965,8660,57761,2534,1978,2887,409	PRKAA2,SPTBN2,SPRED2,SYNGAP1,FGF2,RASA2,EGF,PIK3R4,DUSP9,PSMA1,ATP6V1E2,KSR2,NRG2,PDE3B,PIK3CB,FGF19,IRS2,TRIB3,FYN,EIF4EBP1,GRB10,ARRB2
R-HSA-381038	XBP1(S) activates chaperone genes	0.0448067826119511	-3.10539575343246	53	6	0.0148514851485149	404	8202	58477,51726,29927,27230,7095,2137	SRPRB,DNAJB11,SEC61A1,SERP1,SEC62,EXTL3
R-HSA-381042	PERK regulates gene expression	0.0465824600511394	-3.06653120245682	28	4	0.0099009900990099	404	8202	22926,467,440,1649	ATF6,ATF3,ASNS,DDIT3
R-HSA-5693607	Processing of DNA double-strand break ends	0.048932317165069	-3.01731721806688	97	9	0.0222772277227723	404	8202	5984,9577,11073,51720,545,165918,7486,9656,3364	RFC4,BRE,TOPBP1,UIMC1,ATR,RNF168,WRN,MDC1,HUS1
R-HSA-140180	COX reactions	0.0492562789557215	-3.01071842800366	1	1	0.00247524752475248	404	8202	5742	PTGS1
R-HSA-597592	Post-translational protein modification	0.0497485146244663	-3.0007746726179	411	28	0.0693069306930693	404	8202	23145,83696,10274,6480,56648,22955,55757,7486,9656,79623,84002,23243,2591,10195,6184,80012,23225,149111,286053,165918,89978,146712,374378,4249,205564,81929,10331,170690	SSPO,TRAPPC9,STAG1,ST6GAL1,EIF5A2,SCMH1,UGGT2,WRN,MDC1,GALNT14,B3GNT5,ANKRD28,GALNT3,ALG3,RPN1,PHC3,NUP210,CNIH3,NSMCE2,RNF168,DPH6,B3GNTL1,GALNT18,MGAT5,SENP5,SEH1L,B3GNT3,ADAMTS16
R-HSA-2032785	YAP1- and WWTR1 (TAZ)-stimulated gene expression	0.0520162825455698	-2.95619848353804	29	4	0.0099009900990099	404	8202	6907,1490,79718,25937	TBL1X,CTGF,TBL1XR1,WWTR1
R-HSA-5339562	Uptake and actions of bacterial toxins	0.0520162825455698	-2.95619848353804	29	4	0.0099009900990099	404	8202	7296,118429,6857,84168	TXNRD1,ANTXR2,SYT1,ANTXR1
R-HSA-381070	IRE1alpha activates chaperones	0.0521826484980652	-2.95300524360371	55	6	0.0148514851485149	404	8202	58477,51726,29927,27230,7095,2137	SRPRB,DNAJB11,SEC61A1,SERP1,SEC62,EXTL3
R-HSA-3000171	Non-integrin membrane-ECM interactions	0.0538921971980419	-2.92076957596137	42	5	0.0123762376237624	404	8202	10319,3339,2247,3673,3914	LAMC3,HSPG2,FGF2,ITGA2,LAMB3
R-HSA-5693579	Homologous DNA Pairing and Strand Exchange	0.0538921971980419	-2.92076957596137	42	5	0.0123762376237624	404	8202	5984,545,7486,11073,3364	RFC4,ATR,WRN,TOPBP1,HUS1
R-HSA-111885	Opioid Signalling	0.0540781840668848	-2.91732442645608	84	8	0.0198019801980198	404	8202	5530,2781,2792,5332,5577,5144,5330,23236	PPP3CA,GNAZ,GNGT1,PLCB4,PRKAR2B,PDE4D,PLCB2,PLCB1
R-HSA-186797	Signaling by PDGF	0.0543553398325124	-2.91221242125277	345	24	0.0594059405940594	404	8202	6712,200734,8831,1285,2247,3164,5922,1950,1852,5682,283455,9542,1287,5577,2309,5291,9965,1293,5581,8660,57761,6696,2534,409	SPTBN2,SPRED2,SYNGAP1,COL4A3,FGF2,NR4A1,RASA2,EGF,DUSP9,PSMA1,KSR2,NRG2,COL4A5,PRKAR2B,FOXO3,PIK3CB,FGF19,COL6A3,PRKCE,IRS2,TRIB3,SPP1,FYN,ARRB2
R-HSA-2672351	Stimuli-sensing channels	0.0544689521116992	-2.91012442566954	99	9	0.0222772277227723	404	8202	162514,1831,41,7439,7220,57101,121601,1181,53373	TRPV3,TSC22D3,ASIC1,BEST1,TRPC1,ANO2,ANO4,CLCN2,TPCN1
R-HSA-112399	IRS-mediated signalling	0.0549281604295127	-2.90172912154734	277	20	0.0495049504950495	404	8202	5563,6712,200734,8831,2247,5922,1950,30849,1852,5682,283455,9542,5140,5291,9965,8660,57761,2534,1978,409	PRKAA2,SPTBN2,SPRED2,SYNGAP1,FGF2,RASA2,EGF,PIK3R4,DUSP9,PSMA1,KSR2,NRG2,PDE3B,PIK3CB,FGF19,IRS2,TRIB3,FYN,EIF4EBP1,ARRB2
R-HSA-164944	Nef and signal transduction	0.0556402431630066	-2.88884854164517	8	2	0.00495049504950495	404	8202	2534,5062	FYN,PAK2
R-HSA-400451	Free fatty acids regulate insulin secretion	0.0556402431630066	-2.88884854164517	8	2	0.00495049504950495	404	8202	23236,5330	PLCB1,PLCB2
R-HSA-434316	Fatty Acids bound to GPR40 (FFAR1) regulate insulin secretion	0.0556402431630066	-2.88884854164517	8	2	0.00495049504950495	404	8202	23236,5330	PLCB1,PLCB2
R-HSA-3304351	Signaling by TGF-beta Receptor Complex in Cancer	0.0556402431630066	-2.88884854164517	8	2	0.00495049504950495	404	8202	7048,9372	TGFBR2,ZFYVE9
R-HSA-418457	cGMP effects	0.0558416157854093	-2.88523588496153	18	3	0.00742574257425743	404	8202	10335,5140,50940	MRVI1,PDE3B,PDE11A
R-HSA-3296482	Defects in vitamin and cofactor metabolism	0.0558416157854093	-2.88523588496153	18	3	0.00742574257425743	404	8202	5096,5095,56922	PCCB,PCCA,MCCC1
R-HSA-450282	MAPK targets/ Nuclear events mediated by MAP kinases	0.0577804589851317	-2.85110464030769	30	4	0.0099009900990099	404	8202	5599,6196,9252,4208	MAPK8,RPS6KA2,RPS6KA5,MEF2C
R-HSA-442660	Na+/Cl- dependent neurotransmitter transporters	0.0639742959063665	-2.749273902759	19	3	0.00742574257425743	404	8202	54716,6533,6536	SLC6A20,SLC6A6,SLC6A9
R-HSA-3928664	Ephrin signaling	0.0639742959063665	-2.749273902759	19	3	0.00742574257425743	404	8202	2534,2047,5062	FYN,EPHB1,PAK2
R-HSA-888590	GABA synthesis, release, reuptake and degradation	0.0639742959063665	-2.749273902759	19	3	0.00742574257425743	404	8202	6857,2571,6812	SYT1,GAD1,STXBP1
R-HSA-5173105	O-linked glycosylation	0.0667266822051169	-2.70715037299223	103	9	0.0222772277227723	404	8202	23145,2591,6480,146712,79623,374378,170690,84002,10331	SSPO,GALNT3,ST6GAL1,B3GNTL1,GALNT14,GALNT18,ADAMTS16,B3GNT5,B3GNT3
R-HSA-380287	Centrosome maturation	0.0670428503887508	-2.7024233059802	73	7	0.0173267326732673	404	8202	5577,80254,80321,22981,7840,10806,7277	PRKAR2B,CEP63,CEP70,NINL,ALMS1,SDCCAG8,TUBA4A
R-HSA-380270	Recruitment of mitotic centrosome proteins and complexes	0.0670428503887508	-2.7024233059802	73	7	0.0173267326732673	404	8202	5577,80254,80321,22981,7840,10806,7277	PRKAR2B,CEP63,CEP70,NINL,ALMS1,SDCCAG8,TUBA4A
R-HSA-5668914	Diseases of metabolism	0.068795418304287	-2.67661813067478	45	5	0.0123762376237624	404	8202	5096,2992,5095,7957,56922	PCCB,GYG1,PCCA,EPM2A,MCCC1
R-HSA-2243919	Crosslinking of collagen fibrils	0.0692583928318821	-2.66991094513009	9	2	0.00495049504950495	404	8202	7092,7093	TLL1,TLL2
R-HSA-428543	Inactivation of Cdc42 and Rac	0.0692583928318821	-2.66991094513009	9	2	0.00495049504950495	404	8202	9901,57522	SRGAP3,SRGAP1
R-HSA-447041	CHL1 interactions	0.0692583928318821	-2.66991094513009	9	2	0.00495049504950495	404	8202	8829,3673	NRP1,ITGA2
R-HSA-198693	AKT phosphorylates targets in the nucleus	0.0692583928318821	-2.66991094513009	9	2	0.00495049504950495	404	8202	3164,2309	NR4A1,FOXO3
R-HSA-5663202	Diseases of signal transduction	0.0696251305744947	-2.66462970533976	268	19	0.047029702970297	404	8202	9208,2247,79718,3164,1950,1523,5682,9542,3714,7048,2309,9965,5291,9372,9734,22943,8660,2534,6907	LRRFIP1,FGF2,TBL1XR1,NR4A1,EGF,CUX1,PSMA1,NRG2,JAG2,TGFBR2,FOXO3,FGF19,PIK3CB,ZFYVE9,HDAC9,DKK1,IRS2,FYN,TBL1X
R-HSA-451326	Activation of Kainate Receptors upon glutamate binding	0.0702852471165665	-2.65519335828275	32	4	0.0099009900990099	404	8202	23236,5330,2792,1739	PLCB1,PLCB2,GNGT1,DLG1
R-HSA-376176	Signaling by Robo receptor	0.0702852471165665	-2.65519335828275	32	4	0.0099009900990099	404	8202	5217,5062,9901,57522	PFN2,PAK2,SRGAP3,SRGAP1
R-HSA-187037	NGF signalling via TRKA from the plasma membrane	0.0705221193395437	-2.65182886887592	355	24	0.0594059405940594	404	8202	6712,200734,8831,2247,3164,5922,4914,1950,1852,5682,283455,9542,5577,9252,2309,5291,9965,5581,8660,57761,2534,6196,409,4208	SPTBN2,SPRED2,SYNGAP1,FGF2,NR4A1,RASA2,NTRK1,EGF,DUSP9,PSMA1,KSR2,NRG2,PRKAR2B,RPS6KA5,FOXO3,PIK3CB,FGF19,PRKCE,IRS2,TRIB3,FYN,RPS6KA2,ARRB2,MEF2C
R-HSA-418217	G beta:gamma signalling through PLC beta	0.0726183414349847	-2.62253775221318	20	3	0.00742574257425743	404	8202	23236,5330,2792	PLCB1,PLCB2,GNGT1
R-HSA-112043	PLC beta mediated events	0.0742210325783194	-2.60070771104658	46	5	0.0123762376237624	404	8202	5332,5577,2781,23236,5330	PLCB4,PRKAR2B,GNAZ,PLCB1,PLCB2
R-HSA-416482	G alpha (12/13) signalling events	0.0752532361222912	-2.58689637133045	75	7	0.0173267326732673	404	8202	84033,9828,23263,2792,29,1894,50649	OBSCN,ARHGEF17,MCF2L,GNGT1,ABR,ECT2,ARHGEF4
R-HSA-112040	G-protein mediated events	0.0798726665971468	-2.52732157989241	47	5	0.0123762376237624	404	8202	5332,5577,2781,23236,5330	PLCB4,PRKAR2B,GNAZ,PLCB1,PLCB2
R-HSA-500657	Presynaptic function of Kainate receptors	0.0817521199545249	-2.50406353737556	21	3	0.00742574257425743	404	8202	23236,5330,2792	PLCB1,PLCB2,GNGT1
R-HSA-5621575	CD209 (DC-SIGN) signaling	0.0817521199545249	-2.50406353737556	21	3	0.00742574257425743	404	8202	2534,9252,5062	FYN,RPS6KA5,PAK2
R-HSA-198753	ERK/MAPK targets	0.0817521199545249	-2.50406353737556	21	3	0.00742574257425743	404	8202	6196,9252,4208	RPS6KA2,RPS6KA5,MEF2C
R-HSA-5663084	Diseases of carbohydrate metabolism	0.0838270953293733	-2.47899899046896	10	2	0.00495049504950495	404	8202	2992,7957	GYG1,EPM2A
R-HSA-381183	ATF6-alpha activates chaperone genes	0.0838270953293733	-2.47899899046896	10	2	0.00495049504950495	404	8202	22926,1649	ATF6,DDIT3
R-HSA-3229121	Glycogen storage diseases	0.0838270953293733	-2.47899899046896	10	2	0.00495049504950495	404	8202	2992,7957	GYG1,EPM2A
R-HSA-74749	Signal attenuation	0.0838270953293733	-2.47899899046896	10	2	0.00495049504950495	404	8202	8660,2887	IRS2,GRB10
R-HSA-418886	Netrin mediated repulsion signals	0.0838270953293733	-2.47899899046896	10	2	0.00495049504950495	404	8202	2534,90249	FYN,UNC5A
R-HSA-3785653	Myoclonic epilepsy of Lafora	0.0838270953293733	-2.47899899046896	10	2	0.00495049504950495	404	8202	2992,7957	GYG1,EPM2A
R-HSA-399997	Acetylcholine regulates insulin secretion	0.0838270953293733	-2.47899899046896	10	2	0.00495049504950495	404	8202	23236,5330	PLCB1,PLCB2
R-HSA-418889	Ligand-independent caspase activation via DCC	0.0838270953293733	-2.47899899046896	10	2	0.00495049504950495	404	8202	90249,9500	UNC5A,MAGED1
R-HSA-194315	Signaling by Rho GTPases	0.086561370041481	-2.4469016363581	399	26	0.0643564356435644	404	8202	10152,64411,58504,1894,4983,84033,9743,5585,81624,115703,5217,9901,29,84144,1123,644150,23263,5062,4638,57522,101928168,9828,90627,114793,81929,50649	ABI2,ARAP3,ARHGAP22,ECT2,OPHN1,OBSCN,ARHGAP32,PKN1,DIAPH3,ARHGAP33,PFN2,SRGAP3,ABR,SYDE2,CHN1,WIPF3,MCF2L,PAK2,MYLK,SRGAP1,LOC101928168,ARHGEF17,STARD13,FMNL2,SEH1L,ARHGEF4
R-HSA-203765	eNOS activation and regulation	0.091352520972947	-2.39302939968125	22	3	0.00742574257425743	404	8202	115677,857,2644	NOSTRIN,CAV1,GCHFR
R-HSA-202131	Metabolism of nitric oxide	0.091352520972947	-2.39302939968125	22	3	0.00742574257425743	404	8202	115677,857,2644	NOSTRIN,CAV1,GCHFR
R-HSA-211728	Regulation of PAK-2p34 activity by PS-GAP/RHG10	0.0960920871842712	-2.3424483057896	2	1	0.00247524752475248	404	8202	5062	PAK2
R-HSA-3828062	Glycogen storage disease type 0 (muscle GYS1)	0.0960920871842712	-2.3424483057896	2	1	0.00247524752475248	404	8202	2992	GYG1
R-HSA-5638303	Inhibition of Signaling by Overexpressed EGFR	0.0960920871842712	-2.3424483057896	2	1	0.00247524752475248	404	8202	1950	EGF
R-HSA-380612	Metabolism of serotonin	0.0960920871842712	-2.3424483057896	2	1	0.00247524752475248	404	8202	217	ALDH2
R-HSA-3642279	TGFBR2 MSI Frameshift Mutants in Cancer	0.0960920871842712	-2.3424483057896	2	1	0.00247524752475248	404	8202	7048	TGFBR2
R-HSA-888568	GABA synthesis	0.0960920871842712	-2.3424483057896	2	1	0.00247524752475248	404	8202	2571	GAD1
R-HSA-165160	PDE3B signalling	0.0960920871842712	-2.3424483057896	2	1	0.00247524752475248	404	8202	5140	PDE3B
R-HSA-380615	Serotonin clearance from the synaptic cleft	0.0960920871842712	-2.3424483057896	2	1	0.00247524752475248	404	8202	217	ALDH2
R-HSA-5357609	Glycogen storage disease type II (GAA)	0.0960920871842712	-2.3424483057896	2	1	0.00247524752475248	404	8202	2992	GYG1
R-HSA-211736	Stimulation of the cell death response by PAK-2p34	0.0960920871842712	-2.3424483057896	2	1	0.00247524752475248	404	8202	5062	PAK2
R-HSA-187042	TRKA activation by NGF	0.0960920871842712	-2.3424483057896	2	1	0.00247524752475248	404	8202	4914	NTRK1
R-HSA-3814836	Glycogen storage disease type XV (GYG1)	0.0960920871842712	-2.3424483057896	2	1	0.00247524752475248	404	8202	2992	GYG1
R-HSA-141333	Biogenic amines are oxidatively deaminated to aldehydes by MAOA and MAOB	0.0960920871842712	-2.3424483057896	2	1	0.00247524752475248	404	8202	4129	MAOB
R-HSA-5638302	Signaling by Overexpressed Wild-Type EGFR in Cancer	0.0960920871842712	-2.3424483057896	2	1	0.00247524752475248	404	8202	1950	EGF
R-HSA-422356	Regulation of insulin secretion	0.0982441686472611	-2.3202993821849	80	7	0.0173267326732673	404	8202	5577,776,775,6812,23236,5330,2792	PRKAR2B,CACNA1D,CACNA1C,STXBP1,PLCB1,PLCB2,GNGT1
R-HSA-199983	Golgi to ER Retrograde Transport	0.0992201878392735	-2.31041377895165	11	2	0.00495049504950495	404	8202	9276,22820	COPB2,COPG1
R-HSA-199997	COPI Mediated Transport	0.0992201878392735	-2.31041377895165	11	2	0.00495049504950495	404	8202	9276,22820	COPB2,COPG1
R-HSA-71064	Lysine catabolism	0.0992201878392735	-2.31041377895165	11	2	0.00495049504950495	404	8202	85007,2639	PHYKPL,GCDH
R-HSA-73980	RNA Polymerase III Transcription Termination	0.101395268101586	-2.28872885457876	23	3	0.00742574257425743	404	8202	4782,4774,4784	NFIC,NFIA,NFIX
R-HSA-2565942	Regulation of PLK1 Activity at G2/M Transition	0.103259450480994	-2.27051052124735	81	7	0.0173267326732673	404	8202	5577,80254,80321,22981,7840,10806,7277	PRKAR2B,CEP63,CEP70,NINL,ALMS1,SDCCAG8,TUBA4A
R-HSA-373760	L1CAM interactions	0.10459516489934	-2.25765795309141	97	8	0.0198019801980198	404	8202	6712,6196,287,3673,1739,23114,8829,9252	SPTBN2,RPS6KA2,ANK2,ITGA2,DLG1,NFASC,NRP1,RPS6KA5
R-HSA-1592230	Mitochondrial biogenesis	0.104681701435626	-2.25683094776843	51	5	0.0123762376237624	404	8202	5563,6907,4209,79718,4208	PRKAA2,TBL1X,MEF2D,TBL1XR1,MEF2C
R-HSA-176187	Activation of ATR in response to replication stress	0.106966651149632	-2.23523816459865	37	4	0.0099009900990099	404	8202	5984,545,4171,3364	RFC4,ATR,MCM2,HUS1
R-HSA-194138	Signaling by VEGF	0.10885104913983	-2.21777485294812	320	21	0.051980198019802	404	8202	6712,10152,200734,8831,2247,5922,1950,1852,5682,283455,9542,857,7422,5291,9965,8660,57761,2534,5062,8829,409	SPTBN2,ABI2,SPRED2,SYNGAP1,FGF2,RASA2,EGF,DUSP9,PSMA1,KSR2,NRG2,CAV1,VEGFA,PIK3CB,FGF19,IRS2,TRIB3,FYN,PAK2,NRP1,ARRB2
R-HSA-216083	Integrin cell surface interactions	0.111067981651736	-2.19761281782618	67	6	0.0148514851485149	404	8202	6696,1285,3687,3339,3684,3673	SPP1,COL4A3,ITGAX,HSPG2,ITGAM,ITGA2
R-HSA-373755	Semaphorin interactions	0.111067981651736	-2.19761281782618	67	6	0.0148514851485149	404	8202	23129,2534,5361,8829,4233,5062	PLXND1,FYN,PLXNA1,NRP1,MET,PAK2
R-HSA-1852241	Organelle biogenesis and maintenance	0.111420679765495	-2.1944423334792	321	21	0.051980198019802	404	8202	5563,80321,79718,5577,4209,27031,56945,85476,22981,50807,10806,55764,60412,92482,6907,80254,7840,11222,57129,4208,7277	PRKAA2,CEP70,TBL1XR1,PRKAR2B,MEF2D,NPHP3,MRPS22,GFM1,NINL,ASAP1,SDCCAG8,IFT122,EXOC4,BBIP1,TBL1X,CEP63,ALMS1,MRPL3,MRPL47,MEF2C,TUBA4A
R-HSA-198725	Nuclear Events (kinase and transcription factor activation)	0.111855198611127	-2.19055011370743	24	3	0.00742574257425743	404	8202	6196,9252,4208	RPS6KA2,RPS6KA5,MEF2C
R-HSA-210500	Glutamate Neurotransmitter Release Cycle	0.111855198611127	-2.19055011370743	24	3	0.00742574257425743	404	8202	6507,6857,6812	SLC1A3,SYT1,STXBP1
R-HSA-69275	G2/M Transition	0.113186025047921	-2.17872257447436	115	9	0.0222772277227723	404	8202	902,80321,22981,10806,5520,5577,80254,7840,7277	CCNH,CEP70,NINL,SDCCAG8,PPP2R2A,PRKAR2B,CEP63,ALMS1,TUBA4A
R-HSA-69236	G1 Phase	0.115169195380047	-2.16135296769329	38	4	0.0099009900990099	404	8202	5520,902,7029,1021	PPP2R2A,CCNH,TFDP2,CDK6
R-HSA-1442490	Collagen degradation	0.115169195380047	-2.16135296769329	38	4	0.0099009900990099	404	8202	85007,4316,9313,1303	PHYKPL,MMP7,MMP20,COL12A1
R-HSA-69231	Cyclin D associated events in G1	0.115169195380047	-2.16135296769329	38	4	0.0099009900990099	404	8202	5520,902,7029,1021	PPP2R2A,CCNH,TFDP2,CDK6
R-HSA-381033	ATF6-alpha activates chaperones	0.115321576843598	-2.16003073267034	12	2	0.00495049504950495	404	8202	22926,1649	ATF6,DDIT3
R-HSA-389359	CD28 dependent Vav1 pathway	0.115321576843598	-2.16003073267034	12	2	0.00495049504950495	404	8202	2534,5062	FYN,PAK2
R-HSA-2454202	Fc epsilon receptor (FCERI) signaling	0.119575467320488	-2.12380758124455	342	22	0.0544554455445545	404	8202	5599,6712,5530,200734,8831,2247,3164,5922,1950,1852,5682,283455,9542,2309,5291,9965,7462,8660,57761,2534,5062,409	MAPK8,SPTBN2,PPP3CA,SPRED2,SYNGAP1,FGF2,NR4A1,RASA2,EGF,DUSP9,PSMA1,KSR2,NRG2,FOXO3,PIK3CB,FGF19,LAT2,IRS2,TRIB3,FYN,PAK2,ARRB2
R-HSA-1433557	Signaling by SCF-KIT	0.121729711042463	-2.10595217532125	307	20	0.0495049504950495	404	8202	6712,200734,8831,2247,3164,5922,1950,1852,5682,283455,9542,2309,9965,5291,10019,8660,57761,2534,2887,409	SPTBN2,SPRED2,SYNGAP1,FGF2,NR4A1,RASA2,EGF,DUSP9,PSMA1,KSR2,NRG2,FOXO3,FGF19,PIK3CB,SH2B3,IRS2,TRIB3,FYN,GRB10,ARRB2
R-HSA-453274	Mitotic G2-G2/M phases	0.122330827108608	-2.10102620665615	117	9	0.0222772277227723	404	8202	902,80321,22981,10806,5520,5577,80254,7840,7277	CCNH,CEP70,NINL,SDCCAG8,PPP2R2A,PRKAR2B,CEP63,ALMS1,TUBA4A
R-HSA-5654716	Downstream signaling of activated FGFR4	0.13034701293803	-2.03755505456884	310	20	0.0495049504950495	404	8202	6712,200734,8831,2247,3164,5922,1950,1852,5682,283455,9542,5577,2309,9965,5291,5581,8660,57761,2534,409	SPTBN2,SPRED2,SYNGAP1,FGF2,NR4A1,RASA2,EGF,DUSP9,PSMA1,KSR2,NRG2,PRKAR2B,FOXO3,FGF19,PIK3CB,PRKCE,IRS2,TRIB3,FYN,ARRB2
R-HSA-5654687	Downstream signaling of activated FGFR1	0.13034701293803	-2.03755505456884	310	20	0.0495049504950495	404	8202	6712,200734,8831,2247,3164,5922,1950,1852,5682,283455,9542,5577,2309,9965,5291,5581,8660,57761,2534,409	SPTBN2,SPRED2,SYNGAP1,FGF2,NR4A1,RASA2,EGF,DUSP9,PSMA1,KSR2,NRG2,PRKAR2B,FOXO3,FGF19,PIK3CB,PRKCE,IRS2,TRIB3,FYN,ARRB2
R-HSA-5654708	Downstream signaling of activated FGFR3	0.13034701293803	-2.03755505456884	310	20	0.0495049504950495	404	8202	6712,200734,8831,2247,3164,5922,1950,1852,5682,283455,9542,5577,2309,9965,5291,5581,8660,57761,2534,409	SPTBN2,SPRED2,SYNGAP1,FGF2,NR4A1,RASA2,EGF,DUSP9,PSMA1,KSR2,NRG2,PRKAR2B,FOXO3,FGF19,PIK3CB,PRKCE,IRS2,TRIB3,FYN,ARRB2
R-HSA-5654696	Downstream signaling of activated FGFR2	0.13034701293803	-2.03755505456884	310	20	0.0495049504950495	404	8202	6712,200734,8831,2247,3164,5922,1950,1852,5682,283455,9542,5577,2309,9965,5291,5581,8660,57761,2534,409	SPTBN2,SPRED2,SYNGAP1,FGF2,NR4A1,RASA2,EGF,DUSP9,PSMA1,KSR2,NRG2,PRKAR2B,FOXO3,FGF19,PIK3CB,PRKCE,IRS2,TRIB3,FYN,ARRB2
R-HSA-2029480	Fcgamma receptor (FCGR) dependent phagocytosis	0.130350177648707	-2.03753077574428	86	7	0.0173267326732673	404	8202	5581,10152,2534,5337,644150,8398,5291	PRKCE,ABI2,FYN,PLD1,WIPF3,PLA2G6,PIK3CB
R-HSA-5210891	Uptake and function of anthrax toxins	0.132024556206507	-2.02476734183007	13	2	0.00495049504950495	404	8202	118429,84168	ANTXR2,ANTXR1
R-HSA-75892	Platelet Adhesion to exposed collagen	0.132024556206507	-2.02476734183007	13	2	0.00495049504950495	404	8202	2534,3673	FYN,ITGA2
R-HSA-749476	RNA Polymerase III Abortive And Retractive Initiation	0.132363943320967	-2.0222000039808	40	4	0.0099009900990099	404	8202	4782,10302,4774,4784	NFIC,SNAPC5,NFIA,NFIX
R-HSA-74158	RNA Polymerase III Transcription	0.132363943320967	-2.0222000039808	40	4	0.0099009900990099	404	8202	4782,10302,4774,4784	NFIC,SNAPC5,NFIA,NFIX
R-HSA-4420097	VEGFA-VEGFR2 Pathway	0.136287969147651	-1.99298521161748	312	20	0.0495049504950495	404	8202	6712,10152,200734,8831,2247,5922,1950,1852,5682,283455,9542,857,7422,5291,9965,8660,57761,2534,5062,409	SPTBN2,ABI2,SPRED2,SYNGAP1,FGF2,RASA2,EGF,DUSP9,PSMA1,KSR2,NRG2,CAV1,VEGFA,PIK3CB,FGF19,IRS2,TRIB3,FYN,PAK2,ARRB2
R-HSA-5654741	Signaling by FGFR3	0.139316914588474	-1.97100397995068	313	20	0.0495049504950495	404	8202	6712,200734,8831,2247,3164,5922,1950,1852,5682,283455,9542,5577,2309,9965,5291,5581,8660,57761,2534,409	SPTBN2,SPRED2,SYNGAP1,FGF2,NR4A1,RASA2,EGF,DUSP9,PSMA1,KSR2,NRG2,PRKAR2B,FOXO3,FGF19,PIK3CB,PRKCE,IRS2,TRIB3,FYN,ARRB2
R-HSA-5654743	Signaling by FGFR4	0.139316914588474	-1.97100397995068	313	20	0.0495049504950495	404	8202	6712,200734,8831,2247,3164,5922,1950,1852,5682,283455,9542,5577,2309,9965,5291,5581,8660,57761,2534,409	SPTBN2,SPRED2,SYNGAP1,FGF2,NR4A1,RASA2,EGF,DUSP9,PSMA1,KSR2,NRG2,PRKAR2B,FOXO3,FGF19,PIK3CB,PRKCE,IRS2,TRIB3,FYN,ARRB2
R-HSA-77108	Utilization of Ketone Bodies	0.140626086792558	-1.96165077775068	3	1	0.00247524752475248	404	8202	622	BDH1
R-HSA-428359	Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA	0.140626086792558	-1.96165077775068	3	1	0.00247524752475248	404	8202	10644	IGF2BP2
R-HSA-198745	Signalling to STAT3	0.140626086792558	-1.96165077775068	3	1	0.00247524752475248	404	8202	4914	NTRK1
R-HSA-111446	Activation of BIM and translocation to mitochondria	0.140626086792558	-1.96165077775068	3	1	0.00247524752475248	404	8202	5599	MAPK8
R-HSA-5357572	Lysosomal glycogen catabolism	0.140626086792558	-1.96165077775068	3	1	0.00247524752475248	404	8202	2992	GYG1
R-HSA-3249367	STAT6-mediated induction of chemokines	0.140626086792558	-1.96165077775068	3	1	0.00247524752475248	404	8202	340061	TMEM173
R-HSA-5250958	Toxicity of botulinum toxin type B (BoNT/B)	0.140626086792558	-1.96165077775068	3	1	0.00247524752475248	404	8202	6857	SYT1
R-HSA-139910	Activation of BMF and translocation to mitochondria	0.140626086792558	-1.96165077775068	3	1	0.00247524752475248	404	8202	5599	MAPK8
R-HSA-5635851	GLI proteins bind promoters of Hh responsive genes to promote transcription	0.140626086792558	-1.96165077775068	3	1	0.00247524752475248	404	8202	2736	GLI2
R-HSA-5250989	Toxicity of botulinum toxin type G (BoNT/G)	0.140626086792558	-1.96165077775068	3	1	0.00247524752475248	404	8202	6857	SYT1
R-HSA-1307965	betaKlotho-mediated ligand binding	0.140626086792558	-1.96165077775068	3	1	0.00247524752475248	404	8202	9965	FGF19
R-HSA-5654736	Signaling by FGFR1	0.142384645045457	-1.94922311555527	314	20	0.0495049504950495	404	8202	6712,200734,8831,2247,3164,5922,1950,1852,5682,283455,9542,5577,2309,9965,5291,5581,8660,57761,2534,409	SPTBN2,SPRED2,SYNGAP1,FGF2,NR4A1,RASA2,EGF,DUSP9,PSMA1,KSR2,NRG2,PRKAR2B,FOXO3,FGF19,PIK3CB,PRKCE,IRS2,TRIB3,FYN,ARRB2
R-HSA-1980143	Signaling by NOTCH1	0.142671723174043	-1.94720892988782	72	6	0.0148514851485149	404	8202	3714,6907,409,79718,7090,9734	JAG2,TBL1X,ARRB2,TBL1XR1,TLE3,HDAC9
R-HSA-170834	Signaling by TGF-beta Receptor Complex	0.142671723174043	-1.94720892988782	72	6	0.0148514851485149	404	8202	6498,7029,7048,9372,25937,56288	SKIL,TFDP2,TGFBR2,ZFYVE9,WWTR1,PARD3
R-HSA-881907	Gastrin-CREB signalling pathway via PKC and MAPK	0.144261812722906	-1.93612548632005	424	26	0.0643564356435644	404	8202	6712,200734,8831,2247,5922,2792,1950,1852,5682,9542,283455,8527,23236,23566,9965,84634,8660,5581,2534,6196,5332,409,1608,11343,5330,3269	SPTBN2,SPRED2,SYNGAP1,FGF2,RASA2,GNGT1,EGF,DUSP9,PSMA1,NRG2,KSR2,DGKD,PLCB1,LPAR3,FGF19,KISS1R,IRS2,PRKCE,FYN,RPS6KA2,PLCB4,ARRB2,DGKG,MGLL,PLCB2,HRH1
R-HSA-69481	G2/M Checkpoints	0.145376323974856	-1.92842956087709	105	8	0.0198019801980198	404	8202	5984,9577,51720,545,165918,4171,9656,3364	RFC4,BRE,UIMC1,ATR,RNF168,MCM2,MDC1,HUS1
R-HSA-180024	DARPP-32 events	0.14547822302258	-1.92772887352016	27	3	0.00742574257425743	404	8202	5577,5530,5144	PRKAR2B,PPP3CA,PDE4D
R-HSA-168138	Toll Like Receptor 9 (TLR9) Cascade	0.148147681298404	-1.90954565612518	89	7	0.0173267326732673	404	8202	5599,6196,9252,170506,8411,4208,30849	MAPK8,RPS6KA2,RPS6KA5,DHX36,EEA1,MEF2C,PIK3R4
R-HSA-5654738	Signaling by FGFR2	0.148635795288179	-1.90625629220572	316	20	0.0495049504950495	404	8202	6712,200734,8831,2247,3164,5922,1950,1852,5682,283455,9542,5577,2309,9965,5291,5581,8660,57761,2534,409	SPTBN2,SPRED2,SYNGAP1,FGF2,NR4A1,RASA2,EGF,DUSP9,PSMA1,KSR2,NRG2,PRKAR2B,FOXO3,FGF19,PIK3CB,PRKCE,IRS2,TRIB3,FYN,ARRB2
R-HSA-190322	FGFR4 ligand binding and activation	0.149231167752534	-1.9022587138832	14	2	0.00495049504950495	404	8202	2247,9965	FGF2,FGF19
R-HSA-373752	Netrin-1 signaling	0.150539055214002	-1.89353272537524	42	4	0.0099009900990099	404	8202	7220,2534,90249,6478	TRPC1,FYN,UNC5A,SIAH2
R-HSA-2151201	Transcriptional activation of mitochondrial biogenesis	0.150539055214002	-1.89353272537524	42	4	0.0099009900990099	404	8202	6907,4209,79718,4208	TBL1X,MEF2D,TBL1XR1,MEF2C
R-HSA-190236	Signaling by FGFR	0.151818846473566	-1.88506726840969	317	20	0.0495049504950495	404	8202	6712,200734,8831,2247,3164,5922,1950,1852,5682,283455,9542,5577,2309,9965,5291,5581,8660,57761,2534,409	SPTBN2,SPRED2,SYNGAP1,FGF2,NR4A1,RASA2,EGF,DUSP9,PSMA1,KSR2,NRG2,PRKAR2B,FOXO3,FGF19,PIK3CB,PRKCE,IRS2,TRIB3,FYN,ARRB2
R-HSA-5620912	Anchoring of the basal body to the plasma membrane	0.154323612423774	-1.86870350200277	90	7	0.0173267326732673	404	8202	5577,80254,80321,7840,22981,10806,7277	PRKAR2B,CEP63,CEP70,ALMS1,NINL,SDCCAG8,TUBA4A
R-HSA-177929	Signaling by EGFR	0.154441649241116	-1.86793892879621	336	21	0.051980198019802	404	8202	6712,200734,8831,2247,3164,5922,1950,1852,5682,283455,9542,5577,2309,5291,9965,5581,8660,57761,2534,409,5796	SPTBN2,SPRED2,SYNGAP1,FGF2,NR4A1,RASA2,EGF,DUSP9,PSMA1,KSR2,NRG2,PRKAR2B,FOXO3,PIK3CB,FGF19,PRKCE,IRS2,TRIB3,FYN,ARRB2,PTPRK
R-HSA-163685	Integration of energy metabolism	0.156646283329944	-1.85376498781533	107	8	0.0198019801980198	404	8202	5563,775,2792,5577,776,5330,23236,6812	PRKAA2,CACNA1C,GNGT1,PRKAR2B,CACNA1D,PLCB2,PLCB1,STXBP1
R-HSA-400042	Adrenaline,noradrenaline inhibits insulin secretion	0.157345714580908	-1.84930989079075	28	3	0.00742574257425743	404	8202	776,775,2792	CACNA1D,CACNA1C,GNGT1
R-HSA-5218920	VEGFR2 mediated vascular permeability	0.157345714580908	-1.84930989079075	28	3	0.00742574257425743	404	8202	57761,857,5062	TRIB3,CAV1,PAK2
R-HSA-1296072	Voltage gated Potassium channels	0.159965646695263	-1.83279619495601	43	4	0.0099009900990099	404	8202	3784,3749,3755,8514	KCNQ1,KCNC4,KCNG1,KCNAB2
R-HSA-432040	Vasopressin regulates renal water homeostasis via Aquaporins	0.159965646695263	-1.83279619495601	43	4	0.0099009900990099	404	8202	4645,5577,22841,2792	MYO5B,PRKAR2B,RAB11FIP2,GNGT1
R-HSA-1227986	Signaling by ERBB2	0.161595394436128	-1.8226596330777	320	20	0.0495049504950495	404	8202	6712,200734,8831,2247,3164,5922,1950,1852,5682,283455,9542,5577,2309,9965,5291,5581,8660,57761,2534,409	SPTBN2,SPRED2,SYNGAP1,FGF2,NR4A1,RASA2,EGF,DUSP9,PSMA1,KSR2,NRG2,PRKAR2B,FOXO3,FGF19,PIK3CB,PRKCE,IRS2,TRIB3,FYN,ARRB2
R-HSA-535734	Fatty acid, triacylglycerol, and ketone body metabolism	0.161685710980141	-1.82210088377346	212	14	0.0346534653465347	404	8202	7296,5563,57761,5096,1490,79718,5095,56895,622,25937,406,6907,9575,23175	TXNRD1,PRKAA2,TRIB3,PCCB,CTGF,TBL1XR1,PCCA,AGPAT4,BDH1,WWTR1,ARNTL,TBL1X,CLOCK,LPIN1
R-HSA-2871796	FCERI mediated MAPK activation	0.162854317151769	-1.81489923762191	248	16	0.0396039603960396	404	8202	5599,6712,200734,8831,2247,5922,1950,1852,5682,283455,9542,9965,8660,2534,5062,409	MAPK8,SPTBN2,SPRED2,SYNGAP1,FGF2,RASA2,EGF,DUSP9,PSMA1,KSR2,NRG2,FGF19,IRS2,FYN,PAK2,ARRB2
R-HSA-3322077	Glycogen synthesis	0.16685160183133	-1.79065047340333	15	2	0.00495049504950495	404	8202	2992,7957	GYG1,EPM2A
R-HSA-975577	N-Glycan antennae elongation	0.16685160183133	-1.79065047340333	15	2	0.00495049504950495	404	8202	6480,4249	ST6GAL1,MGAT5
R-HSA-186763	Downstream signal transduction	0.168300215416274	-1.7820058978321	322	20	0.0495049504950495	404	8202	6712,200734,8831,2247,3164,5922,1950,1852,5682,283455,9542,5577,2309,9965,5291,5581,8660,57761,2534,409	SPTBN2,SPRED2,SYNGAP1,FGF2,NR4A1,RASA2,EGF,DUSP9,PSMA1,KSR2,NRG2,PRKAR2B,FOXO3,FGF19,PIK3CB,PRKCE,IRS2,TRIB3,FYN,ARRB2
R-HSA-917977	Transferrin endocytosis and recycling	0.169499110586276	-1.77490759945401	29	3	0.00742574257425743	404	8202	90423,7037,261729	ATP6V1E2,TFRC,STEAP2
R-HSA-445095	Interaction between L1 and Ankyrins	0.169499110586276	-1.77490759945401	29	3	0.00742574257425743	404	8202	6712,23114,287	SPTBN2,NFASC,ANK2
R-HSA-1839124	FGFR1 mutant receptor activation	0.169499110586276	-1.77490759945401	29	3	0.00742574257425743	404	8202	9208,2247,1523	LRRFIP1,FGF2,CUX1
R-HSA-170984	ARMS-mediated activation	0.170440777997062	-1.7693673857219	232	15	0.0371287128712871	404	8202	8660,6712,200734,2534,8831,2247,5922,4914,1950,1852,5682,283455,9542,409,9965	IRS2,SPTBN2,SPRED2,FYN,SYNGAP1,FGF2,RASA2,NTRK1,EGF,DUSP9,PSMA1,KSR2,NRG2,ARRB2,FGF19
R-HSA-187706	Signalling to p38 via RIT and RIN	0.170440777997062	-1.7693673857219	232	15	0.0371287128712871	404	8202	8660,6712,200734,2534,8831,2247,5922,4914,1950,1852,5682,283455,9542,409,9965	IRS2,SPTBN2,SPRED2,FYN,SYNGAP1,FGF2,RASA2,NTRK1,EGF,DUSP9,PSMA1,KSR2,NRG2,ARRB2,FGF19
R-HSA-157118	Signaling by NOTCH	0.174298777300218	-1.74698434139633	110	8	0.0198019801980198	404	8202	79718,7090,4242,6907,3714,7029,409,9734	TBL1XR1,TLE3,MFNG,TBL1X,JAG2,TFDP2,ARRB2,HDAC9
R-HSA-170968	Frs2-mediated activation	0.174498655240301	-1.74583824372865	233	15	0.0371287128712871	404	8202	8660,6712,200734,2534,8831,2247,5922,4914,1950,1852,5682,283455,9542,409,9965	IRS2,SPTBN2,SPRED2,FYN,SYNGAP1,FGF2,RASA2,NTRK1,EGF,DUSP9,PSMA1,KSR2,NRG2,ARRB2,FGF19
R-HSA-5617833	Assembly of the primary cilium	0.176768513927459	-1.73291423328385	180	12	0.0297029702970297	404	8202	80321,50807,22981,10806,55764,60412,92482,5577,80254,27031,7840,7277	CEP70,ASAP1,NINL,SDCCAG8,IFT122,EXOC4,BBIP1,PRKAR2B,CEP63,NPHP3,ALMS1,TUBA4A
R-HSA-2424491	DAP12 signaling	0.178632760222642	-1.72242319946224	325	20	0.0495049504950495	404	8202	6712,200734,8831,2247,3164,5922,1950,1852,5682,283455,9542,5577,2309,5291,9965,8660,5581,57761,2534,409	SPTBN2,SPRED2,SYNGAP1,FGF2,NR4A1,RASA2,EGF,DUSP9,PSMA1,KSR2,NRG2,PRKAR2B,FOXO3,PIK3CB,FGF19,IRS2,PRKCE,TRIB3,FYN,ARRB2
R-HSA-112316	Neuronal System	0.180872285673173	-1.70996410078761	289	18	0.0445544554455446	404	8202	217,84254,2550,2792,3784,6507,6857,785,23236,3770,3749,6196,3755,1739,2571,5330,6812,8514	ALDH2,CAMKK1,GABBR1,GNGT1,KCNQ1,SLC1A3,SYT1,CACNB4,PLCB1,KCNJ14,KCNC4,RPS6KA2,KCNG1,DLG1,GAD1,PLCB2,STXBP1,KCNAB2
R-HSA-72086	mRNA Capping	0.181912294094399	-1.70423060863697	30	3	0.00742574257425743	404	8202	22916,902,8731	NCBP2,CCNH,RNMT
R-HSA-169893	Prolonged ERK activation events	0.182759820711149	-1.69958244329461	235	15	0.0371287128712871	404	8202	8660,6712,200734,2534,8831,2247,5922,4914,1950,1852,5682,283455,9542,409,9965	IRS2,SPTBN2,SPRED2,FYN,SYNGAP1,FGF2,RASA2,NTRK1,EGF,DUSP9,PSMA1,KSR2,NRG2,ARRB2,FGF19
R-HSA-3642278	Loss of Function of TGFBR2 in Cancer	0.182971136303963	-1.69842686369559	4	1	0.00247524752475248	404	8202	7048	TGFBR2
R-HSA-3645790	TGFBR2 Kinase Domain Mutants in Cancer	0.182971136303963	-1.69842686369559	4	1	0.00247524752475248	404	8202	7048	TGFBR2
R-HSA-204626	Hypusine synthesis from eIF5A-lysine	0.182971136303963	-1.69842686369559	4	1	0.00247524752475248	404	8202	56648	EIF5A2
R-HSA-210455	Astrocytic Glutamate-Glutamine Uptake And Metabolism	0.182971136303963	-1.69842686369559	4	1	0.00247524752475248	404	8202	6507	SLC1A3
R-HSA-111448	Activation of NOXA and translocation to mitochondria	0.182971136303963	-1.69842686369559	4	1	0.00247524752475248	404	8202	5366	PMAIP1
R-HSA-3656535	TGFBR1 LBD Mutants in Cancer	0.182971136303963	-1.69842686369559	4	1	0.00247524752475248	404	8202	7048	TGFBR2
R-HSA-1296053	Classical Kir channels	0.182971136303963	-1.69842686369559	4	1	0.00247524752475248	404	8202	3770	KCNJ14
R-HSA-194306	Neurophilin interactions with VEGF and VEGFR	0.182971136303963	-1.69842686369559	4	1	0.00247524752475248	404	8202	8829	NRP1
R-HSA-3878781	Glycogen storage disease type IV (GBE1)	0.182971136303963	-1.69842686369559	4	1	0.00247524752475248	404	8202	2992	GYG1
R-HSA-433692	Proton-coupled monocarboxylate transport	0.182971136303963	-1.69842686369559	4	1	0.00247524752475248	404	8202	9194	SLC16A7
R-HSA-140179	Amine Oxidase reactions	0.182971136303963	-1.69842686369559	4	1	0.00247524752475248	404	8202	4129	MAOB
R-HSA-165158	Activation of AKT2	0.182971136303963	-1.69842686369559	4	1	0.00247524752475248	404	8202	57761	TRIB3
R-HSA-390650	Histamine receptors	0.182971136303963	-1.69842686369559	4	1	0.00247524752475248	404	8202	3269	HRH1
R-HSA-112313	Neurotransmitter uptake and Metabolism In Glial Cells	0.182971136303963	-1.69842686369559	4	1	0.00247524752475248	404	8202	6507	SLC1A3
R-HSA-1433559	Regulation of KIT signaling	0.184803635455824	-1.68846144758805	16	2	0.00495049504950495	404	8202	10019,2534	SH2B3,FYN
R-HSA-2173791	TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition)	0.184803635455824	-1.68846144758805	16	2	0.00495049504950495	404	8202	7048,56288	TGFBR2,PARD3
R-HSA-5693567	HDR through Homologous Recombination (HR) or Single Strand Annealing (SSA)	0.184993173041946	-1.68743635706069	129	9	0.0222772277227723	404	8202	5984,9577,11073,51720,545,165918,7486,9656,3364	RFC4,BRE,TOPBP1,UIMC1,ATR,RNF168,WRN,MDC1,HUS1
R-HSA-1989781	PPARA activates gene expression	0.186540183352926	-1.67910860276911	112	8	0.0198019801980198	404	8202	7296,57761,1490,79718,25937,406,6907,9575	TXNRD1,TRIB3,CTGF,TBL1XR1,WWTR1,ARNTL,TBL1X,CLOCK
R-HSA-1483249	Inositol phosphate metabolism	0.189457850228953	-1.66358870543248	46	4	0.0099009900990099	404	8202	5332,23007,23236,5330	PLCB4,PLCH1,PLCB1,PLCB2
R-HSA-5683057	MAPK family signaling cascades	0.189569099019916	-1.66300168229664	273	17	0.0420792079207921	404	8202	10602,6712,200734,8831,2247,5922,1950,1852,5682,283455,9542,2309,9965,8660,2534,5062,409	CDC42EP3,SPTBN2,SPRED2,SYNGAP1,FGF2,RASA2,EGF,DUSP9,PSMA1,KSR2,NRG2,FOXO3,FGF19,IRS2,FYN,PAK2,ARRB2
R-HSA-1296065	Inwardly rectifying K+ channels	0.194559510511078	-1.63701719608395	31	3	0.00742574257425743	404	8202	3770,2550,2792	KCNJ14,GABBR1,GNGT1
R-HSA-2022928	HS-GAG biosynthesis	0.194559510511078	-1.63701719608395	31	3	0.00742574257425743	404	8202	90161,3339,266722	HS6ST2,HSPG2,HS6ST3
R-HSA-912526	Interleukin receptor SHC signaling	0.195506069980723	-1.63216385154396	238	15	0.0371287128712871	404	8202	8660,6712,200734,2534,8831,2247,5922,1950,1852,5682,283455,9542,409,5291,9965	IRS2,SPTBN2,SPRED2,FYN,SYNGAP1,FGF2,RASA2,EGF,DUSP9,PSMA1,KSR2,NRG2,ARRB2,PIK3CB,FGF19
R-HSA-1500931	Cell-Cell communication	0.196627887101894	-1.62644223442151	131	9	0.0222772277227723	404	8202	5599,2534,84063,5584,4868,5291,56288,140885,3914	MAPK8,FYN,KIRREL2,PRKCI,NPHS1,PIK3CB,PARD3,SIRPA,LAMB3
R-HSA-2122947	NOTCH1 Intracellular Domain Regulates Transcription	0.199651820800087	-1.61118032555413	47	4	0.0099009900990099	404	8202	6907,79718,7090,9734	TBL1X,TBL1XR1,TLE3,HDAC9
R-HSA-167044	Signalling to RAS	0.199846784530035	-1.61020428337113	239	15	0.0371287128712871	404	8202	8660,6712,200734,2534,8831,2247,5922,4914,1950,1852,5682,283455,9542,409,9965	IRS2,SPTBN2,SPRED2,FYN,SYNGAP1,FGF2,RASA2,NTRK1,EGF,DUSP9,PSMA1,KSR2,NRG2,ARRB2,FGF19
R-HSA-77289	Mitochondrial Fatty Acid Beta-Oxidation	0.203012105819049	-1.59448966714183	17	2	0.00495049504950495	404	8202	5096,5095	PCCB,PCCA
R-HSA-264642	Acetylcholine Neurotransmitter Release Cycle	0.203012105819049	-1.59448966714183	17	2	0.00495049504950495	404	8202	6857,6812	SYT1,STXBP1
R-HSA-400206	Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)	0.205564356348561	-1.58199612449383	115	8	0.0198019801980198	404	8202	7296,57761,1490,79718,25937,406,6907,9575	TXNRD1,TRIB3,CTGF,TBL1XR1,WWTR1,ARNTL,TBL1X,CLOCK
R-HSA-1168372	Downstream signaling events of B Cell Receptor (BCR)	0.205675872258277	-1.58145378498183	168	11	0.0272277227722772	404	8202	8660,57761,2534,2247,3164,1950,5682,9542,2309,9965,5291	IRS2,TRIB3,FYN,FGF2,NR4A1,EGF,PSMA1,NRG2,FOXO3,FGF19,PIK3CB
R-HSA-389356	CD28 co-stimulation	0.207415468795825	-1.5730314016101	32	3	0.00742574257425743	404	8202	57761,2534,5062	TRIB3,FYN,PAK2
R-HSA-159227	Transport of the SLBP independent Mature mRNA	0.207415468795825	-1.5730314016101	32	3	0.00742574257425743	404	8202	22916,23225,81929	NCBP2,NUP210,SEH1L
R-HSA-114608	Platelet degranulation	0.2083777414961	-1.56840278144776	81	6	0.0148514851485149	404	8202	7273,10257,7042,7422,1950,7277	TTN,ABCC4,TGFB2,VEGFA,EGF,TUBA4A
R-HSA-5218921	VEGFR2 mediated cell proliferation	0.20866204048326	-1.56703936700393	241	15	0.0371287128712871	404	8202	8660,6712,200734,2534,8831,2247,5922,1950,1852,5682,283455,9542,7422,409,9965	IRS2,SPTBN2,SPRED2,FYN,SYNGAP1,FGF2,RASA2,EGF,DUSP9,PSMA1,KSR2,NRG2,VEGFA,ARRB2,FGF19
R-HSA-5654228	Phospholipase C-mediated cascade; FGFR4	0.210006732353819	-1.56061568995083	48	4	0.0099009900990099	404	8202	5581,5577,2247,9965	PRKCE,PRKAR2B,FGF2,FGF19
R-HSA-168249	Innate Immune System	0.212773475449618	-1.54752717472706	752	42	0.103960396039604	404	8202	5599,9208,6712,200734,3684,5922,1950,5646,30849,9542,5027,9252,2309,8411,9965,5581,6196,5062,8398,10152,5530,1604,8831,2247,3164,1852,5682,283455,9140,5577,5291,7462,8660,57761,2534,644150,84166,5337,409,170506,340061,4208	MAPK8,LRRFIP1,SPTBN2,SPRED2,ITGAM,RASA2,EGF,PRSS3,PIK3R4,NRG2,P2RX7,RPS6KA5,FOXO3,EEA1,FGF19,PRKCE,RPS6KA2,PAK2,PLA2G6,ABI2,PPP3CA,CD55,SYNGAP1,FGF2,NR4A1,DUSP9,PSMA1,KSR2,ATG12,PRKAR2B,PIK3CB,LAT2,IRS2,TRIB3,FYN,WIPF3,NLRC5,PLD1,ARRB2,DHX36,TMEM173,MEF2C
R-HSA-1296071	Potassium Channels	0.214821100721026	-1.53794968690289	99	7	0.0173267326732673	404	8202	3784,3749,3770,2550,2792,3755,8514	KCNQ1,KCNC4,KCNJ14,GABBR1,GNGT1,KCNG1,KCNAB2
R-HSA-5685942	HDR through Homologous Recombination (HRR)	0.215391825118959	-1.53529646707402	65	5	0.0123762376237624	404	8202	5984,545,7486,11073,3364	RFC4,ATR,WRN,TOPBP1,HUS1
R-HSA-1643685	Disease	0.215496108107359	-1.53481242942806	657	37	0.0915841584158416	404	8202	9208,3339,1950,56922,9542,2992,3714,7048,2309,9965,7957,9372,9734,23225,5062,81929,7296,5096,118429,902,2247,79718,8731,3164,5095,1523,5682,84168,6857,5291,22943,8660,6165,3840,2534,22916,6907	LRRFIP1,HSPG2,EGF,MCCC1,NRG2,GYG1,JAG2,TGFBR2,FOXO3,FGF19,EPM2A,ZFYVE9,HDAC9,NUP210,PAK2,SEH1L,TXNRD1,PCCB,ANTXR2,CCNH,FGF2,TBL1XR1,RNMT,NR4A1,PCCA,CUX1,PSMA1,ANTXR1,SYT1,PIK3CB,DKK1,IRS2,RPL35A,KPNA4,FYN,NCBP2,TBL1X
R-HSA-159230	Transport of the SLBP Dependant Mature mRNA	0.22045542830692	-1.51205974372576	33	3	0.00742574257425743	404	8202	22916,23225,81929	NCBP2,NUP210,SEH1L
R-HSA-5693538	Homology Directed Repair	0.220788501051481	-1.51055004450653	135	9	0.0222772277227723	404	8202	5984,9577,11073,51720,545,165918,7486,9656,3364	RFC4,BRE,TOPBP1,UIMC1,ATR,RNF168,WRN,MDC1,HUS1
R-HSA-1839117	Signaling by FGFR1 fusion mutants	0.2214084170682	-1.5077462419587	18	2	0.00495049504950495	404	8202	9208,1523	LRRFIP1,CUX1
R-HSA-181430	Norepinephrine Neurotransmitter Release Cycle	0.2214084170682	-1.5077462419587	18	2	0.00495049504950495	404	8202	6857,6812	SYT1,STXBP1
R-HSA-912631	Regulation of signaling by CBL	0.2214084170682	-1.5077462419587	18	2	0.00495049504950495	404	8202	2534,5291	FYN,PIK3CB
R-HSA-181429	Serotonin Neurotransmitter Release Cycle	0.2214084170682	-1.5077462419587	18	2	0.00495049504950495	404	8202	6857,6812	SYT1,STXBP1
R-HSA-156584	Cytosolic sulfonation of small molecules	0.2214084170682	-1.5077462419587	18	2	0.00495049504950495	404	8202	6820,25830	SULT2B1,SULT4A1
R-HSA-210993	Tie2 Signaling	0.2214084170682	-1.5077462419587	18	2	0.00495049504950495	404	8202	5291,285	PIK3CB,ANGPT2
R-HSA-3134973	LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production	0.223234573840452	-1.49953215975199	5	1	0.00247524752475248	404	8202	9208	LRRFIP1
R-HSA-3000471	Scavenging by Class B Receptors	0.223234573840452	-1.49953215975199	5	1	0.00247524752475248	404	8202	949	SCARB1
R-HSA-2142850	Hyaluronan biosynthesis and export	0.223234573840452	-1.49953215975199	5	1	0.00247524752475248	404	8202	10057	ABCC5
R-HSA-427652	Sodium-coupled phosphate cotransporters	0.223234573840452	-1.49953215975199	5	1	0.00247524752475248	404	8202	6575	SLC20A2
R-HSA-1306955	GRB7 events in ERBB2 signaling	0.223234573840452	-1.49953215975199	5	1	0.00247524752475248	404	8202	9542	NRG2
R-HSA-187024	NGF-independant TRKA activation	0.223234573840452	-1.49953215975199	5	1	0.00247524752475248	404	8202	4914	NTRK1
R-HSA-163680	AMPK inhibits chREBP transcriptional activation activity	0.223234573840452	-1.49953215975199	5	1	0.00247524752475248	404	8202	5563	PRKAA2
R-HSA-5624138	Trafficking of myristoylated proteins to the cilium	0.223234573840452	-1.49953215975199	5	1	0.00247524752475248	404	8202	27031	NPHP3
R-HSA-426048	Arachidonate production from DAG	0.223234573840452	-1.49953215975199	5	1	0.00247524752475248	404	8202	11343	MGLL
R-HSA-451927	Interleukin-2 signaling	0.226807159023518	-1.48365514226729	245	15	0.0371287128712871	404	8202	8660,6712,200734,2534,8831,2247,5922,1950,1852,5682,283455,9542,409,5291,9965	IRS2,SPTBN2,SPRED2,FYN,SYNGAP1,FGF2,RASA2,EGF,DUSP9,PSMA1,KSR2,NRG2,ARRB2,PIK3CB,FGF19
R-HSA-112310	Neurotransmitter Release Cycle	0.231149629316335	-1.46469003219905	50	4	0.0099009900990099	404	8202	6507,6857,2571,6812	SLC1A3,SYT1,GAD1,STXBP1
R-HSA-187687	Signalling to ERKs	0.231446104219584	-1.46340824370708	246	15	0.0371287128712871	404	8202	8660,6712,200734,2534,8831,2247,5922,4914,1950,1852,5682,283455,9542,409,9965	IRS2,SPTBN2,SPRED2,FYN,SYNGAP1,FGF2,RASA2,NTRK1,EGF,DUSP9,PSMA1,KSR2,NRG2,ARRB2,FGF19
R-HSA-1963640	GRB2 events in ERBB2 signaling	0.233586484283773	-1.45420288807618	228	14	0.0346534653465347	404	8202	8660,6712,200734,2534,8831,2247,5922,1950,1852,5682,283455,9542,409,9965	IRS2,SPTBN2,SPRED2,FYN,SYNGAP1,FGF2,RASA2,EGF,DUSP9,PSMA1,KSR2,NRG2,ARRB2,FGF19
R-HSA-1250347	SHC1 events in ERBB4 signaling	0.233586484283773	-1.45420288807618	228	14	0.0346534653465347	404	8202	8660,6712,200734,2534,8831,2247,5922,1950,1852,5682,283455,9542,409,9965	IRS2,SPTBN2,SPRED2,FYN,SYNGAP1,FGF2,RASA2,EGF,DUSP9,PSMA1,KSR2,NRG2,ARRB2,FGF19
R-HSA-180336	SHC1 events in EGFR signaling	0.233586484283773	-1.45420288807618	228	14	0.0346534653465347	404	8202	8660,6712,200734,2534,8831,2247,5922,1950,1852,5682,283455,9542,409,9965	IRS2,SPTBN2,SPRED2,FYN,SYNGAP1,FGF2,RASA2,EGF,DUSP9,PSMA1,KSR2,NRG2,ARRB2,FGF19
R-HSA-5673001	RAF/MAP kinase cascade	0.233586484283773	-1.45420288807618	228	14	0.0346534653465347	404	8202	8660,6712,200734,2534,8831,2247,5922,1950,1852,5682,283455,9542,409,9965	IRS2,SPTBN2,SPRED2,FYN,SYNGAP1,FGF2,RASA2,EGF,DUSP9,PSMA1,KSR2,NRG2,ARRB2,FGF19
R-HSA-179812	GRB2 events in EGFR signaling	0.233586484283773	-1.45420288807618	228	14	0.0346534653465347	404	8202	8660,6712,200734,2534,8831,2247,5922,1950,1852,5682,283455,9542,409,9965	IRS2,SPTBN2,SPRED2,FYN,SYNGAP1,FGF2,RASA2,EGF,DUSP9,PSMA1,KSR2,NRG2,ARRB2,FGF19
R-HSA-112412	SOS-mediated signalling	0.233586484283773	-1.45420288807618	228	14	0.0346534653465347	404	8202	8660,6712,200734,2534,8831,2247,5922,1950,1852,5682,283455,9542,409,9965	IRS2,SPTBN2,SPRED2,FYN,SYNGAP1,FGF2,RASA2,EGF,DUSP9,PSMA1,KSR2,NRG2,ARRB2,FGF19
R-HSA-1250196	SHC1 events in ERBB2 signaling	0.233586484283773	-1.45420288807618	228	14	0.0346534653465347	404	8202	8660,6712,200734,2534,8831,2247,5922,1950,1852,5682,283455,9542,409,9965	IRS2,SPTBN2,SPRED2,FYN,SYNGAP1,FGF2,RASA2,EGF,DUSP9,PSMA1,KSR2,NRG2,ARRB2,FGF19
R-HSA-3928663	EPHA-mediated growth cone collapse	0.233655272652647	-1.45390844363346	34	3	0.00742574257425743	404	8202	2534,7422,2043	FYN,VEGFA,EPHA4
R-HSA-2172127	DAP12 interactions	0.234940915447523	-1.44842122007776	340	20	0.0495049504950495	404	8202	6712,200734,8831,2247,3164,5922,1950,1852,5682,283455,9542,5577,2309,5291,9965,8660,5581,57761,2534,409	SPTBN2,SPRED2,SYNGAP1,FGF2,NR4A1,RASA2,EGF,DUSP9,PSMA1,KSR2,NRG2,PRKAR2B,FOXO3,PIK3CB,FGF19,IRS2,PRKCE,TRIB3,FYN,ARRB2
R-HSA-112315	Transmission across Chemical Synapses	0.235534771437763	-1.44589672700751	210	13	0.0321782178217822	404	8202	217,6196,84254,2550,2792,1739,6507,6857,2571,785,6812,5330,23236	ALDH2,RPS6KA2,CAMKK1,GABBR1,GNGT1,DLG1,SLC1A3,SYT1,GAD1,CACNB4,STXBP1,PLCB2,PLCB1
R-HSA-5654700	FRS-mediated FGFR2 signaling	0.238471634030555	-1.43350491060943	229	14	0.0346534653465347	404	8202	8660,6712,200734,2534,8831,2247,5922,1950,1852,5682,283455,9542,409,9965	IRS2,SPTBN2,SPRED2,FYN,SYNGAP1,FGF2,RASA2,EGF,DUSP9,PSMA1,KSR2,NRG2,ARRB2,FGF19
R-HSA-5654693	FRS-mediated FGFR1 signaling	0.238471634030555	-1.43350491060943	229	14	0.0346534653465347	404	8202	8660,6712,200734,2534,8831,2247,5922,1950,1852,5682,283455,9542,409,9965	IRS2,SPTBN2,SPRED2,FYN,SYNGAP1,FGF2,RASA2,EGF,DUSP9,PSMA1,KSR2,NRG2,ARRB2,FGF19
R-HSA-5654712	FRS-mediated FGFR4 signaling	0.238471634030555	-1.43350491060943	229	14	0.0346534653465347	404	8202	8660,6712,200734,2534,8831,2247,5922,1950,1852,5682,283455,9542,409,9965	IRS2,SPTBN2,SPRED2,FYN,SYNGAP1,FGF2,RASA2,EGF,DUSP9,PSMA1,KSR2,NRG2,ARRB2,FGF19
R-HSA-5654706	FRS-mediated FGFR3 signaling	0.238471634030555	-1.43350491060943	229	14	0.0346534653465347	404	8202	8660,6712,200734,2534,8831,2247,5922,1950,1852,5682,283455,9542,409,9965	IRS2,SPTBN2,SPRED2,FYN,SYNGAP1,FGF2,RASA2,EGF,DUSP9,PSMA1,KSR2,NRG2,ARRB2,FGF19
R-HSA-416700	Other semaphorin interactions	0.239930078381522	-1.4274077381649	19	2	0.00495049504950495	404	8202	23129,5361	PLXND1,PLXNA1
R-HSA-445717	Aquaporin-mediated transport	0.241912857215994	-1.4191777118237	51	4	0.0099009900990099	404	8202	4645,5577,22841,2792	MYO5B,PRKAR2B,RAB11FIP2,GNGT1
R-HSA-397795	G-protein beta:gamma signalling	0.241912857215994	-1.4191777118237	51	4	0.0099009900990099	404	8202	23236,5330,5291,2792	PLCB1,PLCB2,PIK3CB,GNGT1
R-HSA-5620920	Cargo trafficking to the periciliary membrane	0.241912857215994	-1.4191777118237	51	4	0.0099009900990099	404	8202	92482,27031,50807,60412	BBIP1,NPHP3,ASAP1,EXOC4
R-HSA-76002	Platelet activation, signaling and aggregation	0.24339745818028	-1.41305954145661	230	14	0.0346534653465347	404	8202	5581,7273,2534,10257,2792,1950,8527,7422,7042,409,1608,11343,5291,7277	PRKCE,TTN,FYN,ABCC4,GNGT1,EGF,DGKD,VEGFA,TGFB2,ARRB2,DGKG,MGLL,PIK3CB,TUBA4A
R-HSA-159231	Transport of Mature mRNA Derived from an Intronless Transcript	0.246991571678939	-1.39840106569369	35	3	0.00742574257425743	404	8202	22916,23225,81929	NCBP2,NUP210,SEH1L
R-HSA-76005	Response to elevated platelet cytosolic Ca2+	0.248792237785236	-1.3911371172162	86	6	0.0148514851485149	404	8202	7273,10257,7042,7422,1950,7277	TTN,ABCC4,TGFB2,VEGFA,EGF,TUBA4A
R-HSA-2028269	Signaling by Hippo	0.258520271373814	-1.35278116886722	20	2	0.00495049504950495	404	8202	51421,25937	AMOTL2,WWTR1
R-HSA-3000170	Syndecan interactions	0.258520271373814	-1.35278116886722	20	2	0.00495049504950495	404	8202	2247,3673	FGF2,ITGA2
R-HSA-163560	Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis	0.258520271373814	-1.35278116886722	20	2	0.00495049504950495	404	8202	857,11343	CAV1,MGLL
R-HSA-167021	PLC-gamma1 signalling	0.26044163285214	-1.34537650104267	36	3	0.00742574257425743	404	8202	5581,5577,4914	PRKCE,PRKAR2B,NTRK1
R-HSA-159234	Transport of Mature mRNAs Derived from Intronless Transcripts	0.26044163285214	-1.34537650104267	36	3	0.00742574257425743	404	8202	22916,23225,81929	NCBP2,NUP210,SEH1L
R-HSA-5655302	Signaling by FGFR1 in disease	0.26044163285214	-1.34537650104267	36	3	0.00742574257425743	404	8202	9208,2247,1523	LRRFIP1,FGF2,CUX1
R-HSA-212718	EGFR interacts with phospholipase C-gamma	0.26044163285214	-1.34537650104267	36	3	0.00742574257425743	404	8202	5581,5577,1950	PRKCE,PRKAR2B,EGF
R-HSA-5336415	Uptake and function of diphtheria toxin	0.261518486515251	-1.34125030384489	6	1	0.00247524752475248	404	8202	7296	TXNRD1
R-HSA-1482883	Acyl chain remodeling of DAG and TAG	0.261518486515251	-1.34125030384489	6	1	0.00247524752475248	404	8202	11343	MGLL
R-HSA-190370	FGFR1b ligand binding and activation	0.261518486515251	-1.34125030384489	6	1	0.00247524752475248	404	8202	2247	FGF2
R-HSA-1482798	Acyl chain remodeling of CL	0.261518486515251	-1.34125030384489	6	1	0.00247524752475248	404	8202	8398	PLA2G6
R-HSA-171319	Telomere Extension By Telomerase	0.261518486515251	-1.34125030384489	6	1	0.00247524752475248	404	8202	8607	RUVBL1
R-HSA-77111	Synthesis of Ketone Bodies	0.261518486515251	-1.34125030384489	6	1	0.00247524752475248	404	8202	622	BDH1
R-HSA-1606341	IRF3 mediated activation of type 1 IFN	0.261518486515251	-1.34125030384489	6	1	0.00247524752475248	404	8202	340061	TMEM173
R-HSA-187015	Activation of TRKA receptors	0.261518486515251	-1.34125030384489	6	1	0.00247524752475248	404	8202	4914	NTRK1
R-HSA-3065679	SUMO is proteolytically processed	0.261518486515251	-1.34125030384489	6	1	0.00247524752475248	404	8202	205564	SENP5
R-HSA-442717	CREB phosphorylation through the activation of CaMKK	0.261518486515251	-1.34125030384489	6	1	0.00247524752475248	404	8202	84254	CAMKK1
R-HSA-444257	RSK activation	0.261518486515251	-1.34125030384489	6	1	0.00247524752475248	404	8202	6196	RPS6KA2
R-HSA-5339717	Misspliced LRP5 mutants have enhanced beta-catenin-dependent signaling	0.261518486515251	-1.34125030384489	6	1	0.00247524752475248	404	8202	22943	DKK1
R-HSA-1169410	Antiviral mechanism by IFN-stimulated genes	0.261579010532415	-1.34101889758592	70	5	0.0123762376237624	404	8202	8672,3840,23225,81929,1974	EIF4G3,KPNA4,NUP210,SEH1L,EIF4A2
R-HSA-1169408	ISG15 antiviral mechanism	0.261579010532415	-1.34101889758592	70	5	0.0123762376237624	404	8202	8672,3840,23225,81929,1974	EIF4G3,KPNA4,NUP210,SEH1L,EIF4A2
R-HSA-69473	G2/M DNA damage checkpoint	0.261579010532415	-1.34101889758592	70	5	0.0123762376237624	404	8202	51720,165918,545,9577,9656	UIMC1,RNF168,ATR,BRE,MDC1
R-HSA-5684996	MAPK1/MAPK3 signaling	0.26348738360926	-1.33374979218777	234	14	0.0346534653465347	404	8202	8660,6712,200734,2534,8831,2247,5922,1950,1852,5682,283455,9542,409,9965	IRS2,SPTBN2,SPRED2,FYN,SYNGAP1,FGF2,RASA2,EGF,DUSP9,PSMA1,KSR2,NRG2,ARRB2,FGF19
R-HSA-512988	Interleukin-3, 5 and GM-CSF signaling	0.269904010770422	-1.30968889885954	254	15	0.0371287128712871	404	8202	8660,6712,200734,2534,8831,2247,5922,1950,1852,5682,283455,9542,409,5291,9965	IRS2,SPTBN2,SPRED2,FYN,SYNGAP1,FGF2,RASA2,EGF,DUSP9,PSMA1,KSR2,NRG2,ARRB2,PIK3CB,FGF19
R-HSA-983705	Signaling by the B Cell Receptor (BCR)	0.270130930013382	-1.30884851154688	198	12	0.0297029702970297	404	8202	8660,57761,2534,2247,3164,1950,5682,7220,9542,2309,9965,5291	IRS2,TRIB3,FYN,FGF2,NR4A1,EGF,PSMA1,TRPC1,NRG2,FOXO3,FGF19,PIK3CB
R-HSA-2586552	Signaling by Leptin	0.273749778642456	-1.29554080646379	236	14	0.0346534653465347	404	8202	8660,6712,200734,2534,8831,2247,5922,1950,1852,5682,283455,9542,409,9965	IRS2,SPTBN2,SPRED2,FYN,SYNGAP1,FGF2,RASA2,EGF,DUSP9,PSMA1,KSR2,NRG2,ARRB2,FGF19
R-HSA-1251932	PLCG1 events in ERBB2 signaling	0.273983543008315	-1.29468723641131	37	3	0.00742574257425743	404	8202	5581,5577,1950	PRKCE,PRKAR2B,EGF
R-HSA-5693532	DNA Double-Strand Break Repair	0.276226050838414	-1.2865357237059	162	10	0.0247524752475248	404	8202	5599,5984,9577,11073,51720,545,165918,7486,9656,3364	MAPK8,RFC4,BRE,TOPBP1,UIMC1,ATR,RNF168,WRN,MDC1,HUS1
R-HSA-1236394	Signaling by ERBB4	0.276358590241658	-1.28605601654094	312	18	0.0445544554455446	404	8202	6712,200734,8831,2247,3164,5922,1950,1852,5682,283455,9542,2309,9965,5291,8660,57761,2534,409	SPTBN2,SPRED2,SYNGAP1,FGF2,NR4A1,RASA2,EGF,DUSP9,PSMA1,KSR2,NRG2,FOXO3,FGF19,PIK3CB,IRS2,TRIB3,FYN,ARRB2
R-HSA-389357	CD28 dependent PI3K/Akt signaling	0.277127445213082	-1.28327778758226	21	2	0.00495049504950495	404	8202	57761,2534	TRIB3,FYN
R-HSA-379726	Mitochondrial tRNA aminoacylation	0.277127445213082	-1.28327778758226	21	2	0.00495049504950495	404	8202	10667,2617	FARS2,GARS
R-HSA-5620916	VxPx cargo-targeting to cilium	0.277127445213082	-1.28327778758226	21	2	0.00495049504950495	404	8202	50807,60412	ASAP1,EXOC4
R-HSA-196854	Metabolism of vitamins and cofactors	0.282591672308025	-1.26375227729037	90	6	0.0148514851485149	404	8202	5096,349565,5095,5646,60490,56922	PCCB,NMNAT3,PCCA,PRSS3,PPCDC,MCCC1
R-HSA-196849	Metabolism of water-soluble vitamins and cofactors	0.282591672308025	-1.26375227729037	90	6	0.0148514851485149	404	8202	5096,349565,5095,5646,60490,56922	PCCB,NMNAT3,PCCA,PRSS3,PPCDC,MCCC1
R-HSA-168276	NS1 Mediated Effects on Host Pathways	0.287596201376439	-1.24619786123207	38	3	0.00742574257425743	404	8202	3840,23225,81929	KPNA4,NUP210,SEH1L
R-HSA-69273	Cyclin A/B1 associated events during G2/M transition	0.295704937633131	-1.21839315414634	22	2	0.00495049504950495	404	8202	5520,902	PPP2R2A,CCNH
R-HSA-2453902	The canonical retinoid cycle in rods (twilight vision)	0.295704937633131	-1.21839315414634	22	2	0.00495049504950495	404	8202	8630,8608	HSD17B6,RDH16
R-HSA-975576	N-glycan antennae elongation in the medial/trans-Golgi	0.295704937633131	-1.21839315414634	22	2	0.00495049504950495	404	8202	6480,4249	ST6GAL1,MGAT5
R-HSA-447043	Neurofascin interactions	0.297919966680991	-1.21093039673222	7	1	0.00247524752475248	404	8202	23114	NFASC
R-HSA-447038	NrCAM interactions	0.297919966680991	-1.21093039673222	7	1	0.00247524752475248	404	8202	1739	DLG1
R-HSA-2660826	Constitutive Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant	0.297919966680991	-1.21093039673222	7	1	0.00247524752475248	404	8202	3714	JAG2
R-HSA-74182	Ketone body metabolism	0.297919966680991	-1.21093039673222	7	1	0.00247524752475248	404	8202	622	BDH1
R-HSA-2660825	Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant	0.297919966680991	-1.21093039673222	7	1	0.00247524752475248	404	8202	3714	JAG2
R-HSA-448706	Interleukin-1 processing	0.297919966680991	-1.21093039673222	7	1	0.00247524752475248	404	8202	3606	IL18
R-HSA-2393930	Phosphate bond hydrolysis by NUDT proteins	0.297919966680991	-1.21093039673222	7	1	0.00247524752475248	404	8202	131870	NUDT16
R-HSA-5693565	Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks	0.300029112796493	-1.20387576637929	74	5	0.0123762376237624	404	8202	51720,5599,165918,9577,9656	UIMC1,MAPK8,RNF168,BRE,MDC1
R-HSA-392499	Metabolism of proteins	0.307808109047047	-1.1782787127423	943	50	0.123762376237624	404	8202	23145,3339,6480,23621,7095,3800,51726,55757,9656,84002,23243,58477,6184,440,23225,149111,89978,146712,374378,205564,4249,81929,7277,83696,8893,10274,1974,56648,2137,22955,467,7486,131118,79623,27230,10195,2591,6165,80012,29927,1978,286053,60412,1803,6747,22926,165918,1649,170690,10331	SSPO,HSPG2,ST6GAL1,BACE1,SEC62,KIF5C,DNAJB11,UGGT2,MDC1,B3GNT5,ANKRD28,SRPRB,RPN1,ASNS,NUP210,CNIH3,DPH6,B3GNTL1,GALNT18,SENP5,MGAT5,SEH1L,TUBA4A,TRAPPC9,EIF2B5,STAG1,EIF4A2,EIF5A2,EXTL3,SCMH1,ATF3,WRN,DNAJC19,GALNT14,SERP1,ALG3,GALNT3,RPL35A,PHC3,SEC61A1,EIF4EBP1,NSMCE2,EXOC4,DPP4,SSR3,ATF6,RNF168,DDIT3,ADAMTS16,B3GNT3
R-HSA-162582	Signal Transduction	0.307904584283268	-1.17796533529189	2357	121	0.299504950495049	404	8202	10602,5599,6712,200734,2736,3339,9500,58504,1950,9542,8527,81624,115703,23566,9372,84894,6196,2781,9628,5144,9828,11343,81929,5796,1604,10616,1285,4914,8608,1894,283455,5577,857,4919,26108,7422,29,3363,8660,6498,2534,8607,644150,1978,55764,25937,4638,2887,797,7029,8829,409,90627,56288,4208,59352,30817,5563,64411,5922,2792,2550,30849,4983,90423,1287,3714,5585,9252,5217,7048,2309,9965,1293,84144,9734,10019,1123,5581,6696,58191,3480,23263,5062,57522,5584,1608,5330,4543,114793,51421,10152,5530,8831,79718,2247,3164,7090,4242,5682,1852,84033,8630,9743,5140,23236,5291,9901,50940,22943,84634,57761,55733,6259,2914,5332,101928168,2863,6907,50649,3269	CDC42EP3,MAPK8,SPTBN2,SPRED2,GLI2,HSPG2,MAGED1,ARHGAP22,EGF,NRG2,DGKD,DIAPH3,ARHGAP33,LPAR3,ZFYVE9,LINGO1,RPS6KA2,GNAZ,RGS6,PDE4D,ARHGEF17,MGLL,SEH1L,PTPRK,CD55,RBCK1,COL4A3,NTRK1,RDH16,ECT2,KSR2,PRKAR2B,CAV1,ROR1,PYGO1,VEGFA,ABR,HTR7,IRS2,SKIL,FYN,RUVBL1,WIPF3,EIF4EBP1,IFT122,WWTR1,MYLK,GRB10,CALCB,TFDP2,NRP1,ARRB2,STARD13,PARD3,MEF2C,LGR6,ADGRE2,PRKAA2,ARAP3,RASA2,GNGT1,GABBR1,PIK3R4,OPHN1,ATP6V1E2,COL4A5,JAG2,PKN1,RPS6KA5,PFN2,TGFBR2,FOXO3,FGF19,COL6A3,SYDE2,HDAC9,SH2B3,CHN1,PRKCE,SPP1,CXCL16,IGF1R,MCF2L,PAK2,SRGAP1,PRKCI,DGKG,PLCB2,MTNR1A,FMNL2,AMOTL2,ABI2,PPP3CA,SYNGAP1,TBL1XR1,FGF2,NR4A1,TLE3,MFNG,PSMA1,DUSP9,OBSCN,HSD17B6,ARHGAP32,PDE3B,PLCB1,PIK3CB,SRGAP3,PDE11A,DKK1,KISS1R,TRIB3,HHAT,RYK,GRM4,PLCB4,LOC101928168,GPR39,TBL1X,ARHGEF4,HRH1
R-HSA-2894858	Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer	0.308416329219765	-1.17630469051125	57	4	0.0099009900990099	404	8202	6907,3714,79718,9734	TBL1X,JAG2,TBL1XR1,HDAC9
R-HSA-2644602	Signaling by NOTCH1 PEST Domain Mutants in Cancer	0.308416329219765	-1.17630469051125	57	4	0.0099009900990099	404	8202	6907,3714,79718,9734	TBL1X,JAG2,TBL1XR1,HDAC9
R-HSA-2644606	Constitutive Signaling by NOTCH1 PEST Domain Mutants	0.308416329219765	-1.17630469051125	57	4	0.0099009900990099	404	8202	6907,3714,79718,9734	TBL1X,JAG2,TBL1XR1,HDAC9
R-HSA-2894862	Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants	0.308416329219765	-1.17630469051125	57	4	0.0099009900990099	404	8202	6907,3714,79718,9734	TBL1X,JAG2,TBL1XR1,HDAC9
R-HSA-2644603	Signaling by NOTCH1 in Cancer	0.308416329219765	-1.17630469051125	57	4	0.0099009900990099	404	8202	6907,3714,79718,9734	TBL1X,JAG2,TBL1XR1,HDAC9
R-HSA-5693606	DNA Double Strand Break Response	0.309787484940198	-1.17186874903873	75	5	0.0123762376237624	404	8202	51720,5599,165918,9577,9656	UIMC1,MAPK8,RNF168,BRE,MDC1
R-HSA-70895	Branched-chain amino acid catabolism	0.314210620448549	-1.15769175217698	23	2	0.00495049504950495	404	8202	594,56922	BCKDHB,MCCC1
R-HSA-429947	Deadenylation of mRNA	0.314210620448549	-1.15769175217698	23	2	0.00495049504950495	404	8202	57472,1974	CNOT6,EIF4A2
R-HSA-5627123	RHO GTPases activate PAKs	0.314210620448549	-1.15769175217698	23	2	0.00495049504950495	404	8202	5062,4638	PAK2,MYLK
R-HSA-5654719	SHC-mediated cascade:FGFR4	0.314210620448549	-1.15769175217698	23	2	0.00495049504950495	404	8202	2247,9965	FGF2,FGF19
R-HSA-212676	Dopamine Neurotransmitter Release Cycle	0.314210620448549	-1.15769175217698	23	2	0.00495049504950495	404	8202	6857,6812	SYT1,STXBP1
R-HSA-2142691	Synthesis of Leukotrienes (LT) and Eoxins (EX)	0.314210620448549	-1.15769175217698	23	2	0.00495049504950495	404	8202	1800,57834	DPEP1,CYP4F11
R-HSA-168253	Host Interactions with Influenza Factors	0.314953566675995	-1.15533005839983	40	3	0.00742574257425743	404	8202	3840,23225,81929	KPNA4,NUP210,SEH1L
R-HSA-109703	PKB-mediated events	0.314953566675995	-1.15533005839983	40	3	0.00742574257425743	404	8202	5563,5140,1978	PRKAA2,PDE3B,EIF4EBP1
R-HSA-70153	Glucose transport	0.328660327790992	-1.11273049987359	41	3	0.00742574257425743	404	8202	23225,81929,3099	NUP210,SEH1L,HK2
R-HSA-416550	Sema4D mediated inhibition of cell attachment and migration	0.332531355758739	-1.10102112029868	8	1	0.00247524752475248	404	8202	4233	MET
R-HSA-111453	BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members	0.332531355758739	-1.10102112029868	8	1	0.00247524752475248	404	8202	5366	PMAIP1
R-HSA-195399	VEGF binds to VEGFR leading to receptor dimerization	0.332531355758739	-1.10102112029868	8	1	0.00247524752475248	404	8202	7422	VEGFA
R-HSA-73928	Depyrimidination	0.332531355758739	-1.10102112029868	8	1	0.00247524752475248	404	8202	8930	MBD4
R-HSA-110329	Cleavage of the damaged pyrimidine	0.332531355758739	-1.10102112029868	8	1	0.00247524752475248	404	8202	8930	MBD4
R-HSA-389887	Beta-oxidation of pristanoyl-CoA	0.332531355758739	-1.10102112029868	8	1	0.00247524752475248	404	8202	8309	ACOX2
R-HSA-199418	Negative regulation of the PI3K/AKT network	0.332531355758739	-1.10102112029868	8	1	0.00247524752475248	404	8202	57761	TRIB3
R-HSA-112311	Neurotransmitter Clearance In The Synaptic Cleft	0.332531355758739	-1.10102112029868	8	1	0.00247524752475248	404	8202	217	ALDH2
R-HSA-196783	Coenzyme A biosynthesis	0.332531355758739	-1.10102112029868	8	1	0.00247524752475248	404	8202	60490	PPCDC
R-HSA-5358493	Synthesis of diphthamide-EEF2	0.332531355758739	-1.10102112029868	8	1	0.00247524752475248	404	8202	89978	DPH6
R-HSA-194313	VEGF ligand-receptor interactions	0.332531355758739	-1.10102112029868	8	1	0.00247524752475248	404	8202	7422	VEGFA
R-HSA-72731	Recycling of eIF2:GDP	0.332531355758739	-1.10102112029868	8	1	0.00247524752475248	404	8202	8893	EIF2B5
R-HSA-1483148	Synthesis of PG	0.332531355758739	-1.10102112029868	8	1	0.00247524752475248	404	8202	5337	PLD1
R-HSA-193634	Axonal growth inhibition (RHOA activation)	0.332531355758739	-1.10102112029868	8	1	0.00247524752475248	404	8202	84894	LINGO1
R-HSA-110328	Recognition and association of DNA glycosylase with site containing an affected pyrimidine	0.332531355758739	-1.10102112029868	8	1	0.00247524752475248	404	8202	8930	MBD4
R-HSA-5674400	Constitutive Signaling by AKT1 E17K in Cancer	0.332606567885337	-1.10079496531865	24	2	0.00495049504950495	404	8202	3164,2309	NR4A1,FOXO3
R-HSA-193368	Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol	0.332606567885337	-1.10079496531865	24	2	0.00495049504950495	404	8202	8309,80270	ACOX2,HSD3B7
R-HSA-416476	G alpha (q) signalling events	0.334230624296333	-1.0959240323801	190	11	0.0272277227722772	404	8202	5581,2792,5332,8527,1608,11343,5330,23236,23566,84634,3269	PRKCE,GNGT1,PLCB4,DGKD,DGKG,MGLL,PLCB2,PLCB1,LPAR3,KISS1R,HRH1
R-HSA-418346	Platelet homeostasis	0.339296172564522	-1.08088188764308	78	5	0.0123762376237624	404	8202	10335,4842,5140,2792,50940	MRVI1,NOS1,PDE3B,GNGT1,PDE11A
R-HSA-1566948	Elastic fibre formation	0.342361964144372	-1.07188672691201	42	3	0.00742574257425743	404	8202	4052,7042,84467	LTBP1,TGFB2,FBN3
R-HSA-450294	MAP kinase activation in TLR cascade	0.342387548106099	-1.07181200188839	60	4	0.0099009900990099	404	8202	5599,6196,9252,4208	MAPK8,RPS6KA2,RPS6KA5,MEF2C
R-HSA-73923	Lipid digestion, mobilization, and transport	0.342387548106099	-1.07181200188839	60	4	0.0099009900990099	404	8202	857,949,3339,11343	CAV1,SCARB1,HSPG2,MGLL
R-HSA-997272	Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits	0.350858746562621	-1.04737156795906	25	2	0.00495049504950495	404	8202	2550,2792	GABBR1,GNGT1
R-HSA-1296059	G protein gated Potassium channels	0.350858746562621	-1.04737156795906	25	2	0.00495049504950495	404	8202	2550,2792	GABBR1,GNGT1
R-HSA-114452	Activation of BH3-only proteins	0.350858746562621	-1.04737156795906	25	2	0.00495049504950495	404	8202	5599,5366	MAPK8,PMAIP1
R-HSA-3295583	TRP channels	0.350858746562621	-1.04737156795906	25	2	0.00495049504950495	404	8202	7220,162514	TRPC1,TRPV3
R-HSA-1296041	Activation of G protein gated Potassium channels	0.350858746562621	-1.04737156795906	25	2	0.00495049504950495	404	8202	2550,2792	GABBR1,GNGT1
R-HSA-4086398	Ca2+ pathway	0.353745788995623	-1.03917673399484	61	4	0.0099009900990099	404	8202	5530,23236,5330,2792	PPP3CA,PLCB1,PLCB2,GNGT1
R-HSA-917937	Iron uptake and transport	0.356041687957541	-1.03270745398157	43	3	0.00742574257425743	404	8202	90423,7037,261729	ATP6V1E2,TFRC,STEAP2
R-HSA-2173793	Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer	0.356041687957541	-1.03270745398157	43	3	0.00742574257425743	404	8202	6498,7029,25937	SKIL,TFDP2,WWTR1
R-HSA-1362409	Mitochondrial iron-sulfur cluster biogenesis	0.365440476121445	-1.00665186908367	9	1	0.00247524752475248	404	8202	57128	LYRM4
R-HSA-110357	Displacement of DNA glycosylase by APEX1	0.365440476121445	-1.00665186908367	9	1	0.00247524752475248	404	8202	8930	MBD4
R-HSA-1300642	Sperm Motility And Taxes	0.365440476121445	-1.00665186908367	9	1	0.00247524752475248	404	8202	79820	CATSPERB
R-HSA-425986	Sodium/Proton exchangers	0.365440476121445	-1.00665186908367	9	1	0.00247524752475248	404	8202	285195	SLC9A9
R-HSA-70635	Urea cycle	0.365440476121445	-1.00665186908367	9	1	0.00247524752475248	404	8202	384	ARG2
R-HSA-73614	Pyrimidine salvage reactions	0.365440476121445	-1.00665186908367	9	1	0.00247524752475248	404	8202	7378	UPP1
R-HSA-446107	Type I hemidesmosome assembly	0.365440476121445	-1.00665186908367	9	1	0.00247524752475248	404	8202	3914	LAMB3
R-HSA-419408	Lysosphingolipid and LPA receptors	0.365440476121445	-1.00665186908367	9	1	0.00247524752475248	404	8202	23566	LPAR3
R-HSA-1234158	Regulation of gene expression by Hypoxia-inducible Factor	0.365440476121445	-1.00665186908367	9	1	0.00247524752475248	404	8202	7422	VEGFA
R-HSA-193697	p75NTR regulates axonogenesis	0.365440476121445	-1.00665186908367	9	1	0.00247524752475248	404	8202	84894	LINGO1
R-HSA-2428933	SHC-related events triggered by IGF1R	0.365440476121445	-1.00665186908367	9	1	0.00247524752475248	404	8202	3480	IGF1R
R-HSA-3215018	Processing and activation of SUMO	0.365440476121445	-1.00665186908367	9	1	0.00247524752475248	404	8202	205564	SENP5
R-HSA-1462054	Alpha-defensins	0.365440476121445	-1.00665186908367	9	1	0.00247524752475248	404	8202	5646	PRSS3
R-HSA-1474165	Reproduction	0.368936725594194	-0.997130124999677	26	2	0.00495049504950495	404	8202	79820,7784	CATSPERB,ZP3
R-HSA-264876	Insulin processing	0.368936725594194	-0.997130124999677	26	2	0.00495049504950495	404	8202	3800,60412	KIF5C,EXOC4
R-HSA-2173788	Downregulation of TGF-beta receptor signaling	0.368936725594194	-0.997130124999677	26	2	0.00495049504950495	404	8202	7048,9372	TGFBR2,ZFYVE9
R-HSA-1187000	Fertilization	0.368936725594194	-0.997130124999677	26	2	0.00495049504950495	404	8202	79820,7784	CATSPERB,ZP3
R-HSA-425366	Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds	0.379396983545453	-0.969172172104677	101	6	0.0148514851485149	404	8202	54716,6533,55356,6536,64116,9194	SLC6A20,SLC6A6,SLC22A15,SLC6A9,SLC39A8,SLC16A7
R-HSA-1226099	Signaling by FGFR in disease	0.383272608484546	-0.95900877149057	45	3	0.00742574257425743	404	8202	9208,2247,1523	LRRFIP1,FGF2,CUX1
R-HSA-168898	Toll-Like Receptors Cascades	0.385141403494667	-0.954144730321474	140	8	0.0198019801980198	404	8202	5599,6196,3684,30849,9252,8411,170506,4208	MAPK8,RPS6KA2,ITGAM,PIK3R4,RPS6KA5,EEA1,DHX36,MEF2C
R-HSA-182971	EGFR downregulation	0.386813405796378	-0.94981285779164	27	2	0.00495049504950495	404	8202	1950,5796	EGF,PTPRK
R-HSA-192105	Synthesis of bile acids and bile salts	0.386813405796378	-0.94981285779164	27	2	0.00495049504950495	404	8202	8309,80270	ACOX2,HSD3B7
R-HSA-5357769	Caspase activation via extrinsic apoptotic signalig pathway	0.386813405796378	-0.94981285779164	27	2	0.00495049504950495	404	8202	90249,9500	UNC5A,MAGED1
R-HSA-437239	Recycling pathway of L1	0.386813405796378	-0.94981285779164	27	2	0.00495049504950495	404	8202	6196,9252	RPS6KA2,RPS6KA5
R-HSA-111367	SLBP independent Processing of Histone Pre-mRNAs	0.396730851762046	-0.924497183469865	10	1	0.00247524752475248	404	8202	22916	NCBP2
R-HSA-2151209	Activation of PPARGC1A (PGC-1alpha) by phosphorylation	0.396730851762046	-0.924497183469865	10	1	0.00247524752475248	404	8202	5563	PRKAA2
R-HSA-168799	Neurotoxicity of clostridium toxins	0.396730851762046	-0.924497183469865	10	1	0.00247524752475248	404	8202	6857	SYT1
R-HSA-1660517	Synthesis of PIPs at the late endosome membrane	0.396730851762046	-0.924497183469865	10	1	0.00247524752475248	404	8202	30849	PIK3R4
R-HSA-73929	Base-Excision Repair, AP Site Formation	0.396730851762046	-0.924497183469865	10	1	0.00247524752475248	404	8202	8930	MBD4
R-HSA-901032	ER Quality Control Compartment (ERQC)	0.396730851762046	-0.924497183469865	10	1	0.00247524752475248	404	8202	55757	UGGT2
R-HSA-2470946	Cohesin Loading onto Chromatin	0.396730851762046	-0.924497183469865	10	1	0.00247524752475248	404	8202	10274	STAG1
R-HSA-549127	Organic cation transport	0.396730851762046	-0.924497183469865	10	1	0.00247524752475248	404	8202	55356	SLC22A15
R-HSA-442380	Zinc influx into cells by the SLC39 gene family	0.396730851762046	-0.924497183469865	10	1	0.00247524752475248	404	8202	64116	SLC39A8
R-HSA-419812	Calcitonin-like ligand receptors	0.396730851762046	-0.924497183469865	10	1	0.00247524752475248	404	8202	797	CALCB
R-HSA-1300644	Interaction With The Zona Pellucida	0.396730851762046	-0.924497183469865	10	1	0.00247524752475248	404	8202	7784	ZP3
R-HSA-450341	Activation of the AP-1 family of transcription factors	0.396730851762046	-0.924497183469865	10	1	0.00247524752475248	404	8202	5599	MAPK8
R-HSA-5621480	Dectin-2 family	0.396730851762046	-0.924497183469865	10	1	0.00247524752475248	404	8202	2534	FYN
R-HSA-190377	FGFR2b ligand binding and activation	0.396730851762046	-0.924497183469865	10	1	0.00247524752475248	404	8202	2247	FGF2
R-HSA-418890	Role of second messengers in netrin-1 signaling	0.396730851762046	-0.924497183469865	10	1	0.00247524752475248	404	8202	7220	TRPC1
R-HSA-5654227	Phospholipase C-mediated cascade; FGFR3	0.396794568364449	-0.924336592262768	46	3	0.00742574257425743	404	8202	5581,5577,2247	PRKCE,PRKAR2B,FGF2
R-HSA-418597	G alpha (z) signalling events	0.396794568364449	-0.924336592262768	46	3	0.00742574257425743	404	8202	5581,2781,2792	PRKCE,GNAZ,GNGT1
R-HSA-1630316	Glycosaminoglycan metabolism	0.403311682777184	-0.908045609565066	123	7	0.0173267326732673	404	8202	29940,90161,3339,9435,10331,10057,266722	DSE,HS6ST2,HSPG2,CHST2,B3GNT3,ABCC5,HS6ST3
R-HSA-2022854	Keratan sulfate biosynthesis	0.404464766663834	-0.905190649704177	28	2	0.00495049504950495	404	8202	9435,10331	CHST2,B3GNT3
R-HSA-164952	The role of Nef in HIV-1 replication and disease pathogenesis	0.404464766663834	-0.905190649704177	28	2	0.00495049504950495	404	8202	2534,5062	FYN,PAK2
R-HSA-77075	RNA Pol II CTD phosphorylation and interaction with CE	0.404464766663834	-0.905190649704177	28	2	0.00495049504950495	404	8202	902,8731	CCNH,RNMT
R-HSA-167160	RNA Pol II CTD phosphorylation and interaction with CE	0.404464766663834	-0.905190649704177	28	2	0.00495049504950495	404	8202	902,8731	CCNH,RNMT
R-HSA-202040	G-protein activation	0.404464766663834	-0.905190649704177	28	2	0.00495049504950495	404	8202	2781,2792	GNAZ,GNGT1
R-HSA-1483166	Synthesis of PA	0.404464766663834	-0.905190649704177	28	2	0.00495049504950495	404	8202	5337,56895	PLD1,AGPAT4
R-HSA-975155	MyD88 dependent cascade initiated on endosome	0.408634136739238	-0.894935054471034	85	5	0.0123762376237624	404	8202	5599,6196,9252,170506,4208	MAPK8,RPS6KA2,RPS6KA5,DHX36,MEF2C
R-HSA-168181	Toll Like Receptor 7/8 (TLR7/8) Cascade	0.408634136739238	-0.894935054471034	85	5	0.0123762376237624	404	8202	5599,6196,9252,170506,4208	MAPK8,RPS6KA2,RPS6KA5,DHX36,MEF2C
R-HSA-189200	Hexose transport	0.410236119338399	-0.891022384225659	47	3	0.00742574257425743	404	8202	23225,81929,3099	NUP210,SEH1L,HK2
R-HSA-4839726	Chromatin organization	0.410323656755588	-0.890809023980444	261	14	0.0346534653465347	404	8202	80853,8464,7403,55167,8607,79718,63976,84159,6907,9575,80854,55689,86,2122	KDM7A,SUPT3H,KDM6A,MSL2,RUVBL1,TBL1XR1,PRDM16,ARID5B,TBL1X,CLOCK,SETD7,YEATS2,ACTL6A,MECOM
R-HSA-3247509	Chromatin modifying enzymes	0.410323656755588	-0.890809023980444	261	14	0.0346534653465347	404	8202	80853,8464,7403,55167,8607,79718,63976,84159,6907,9575,80854,55689,86,2122	KDM7A,SUPT3H,KDM6A,MSL2,RUVBL1,TBL1XR1,PRDM16,ARID5B,TBL1X,CLOCK,SETD7,YEATS2,ACTL6A,MECOM
R-HSA-3858494	Beta-catenin independent WNT signaling	0.415504660336486	-0.878261448536574	144	8	0.0198019801980198	404	8202	5530,2792,6259,5682,4919,5330,23236,409	PPP3CA,GNGT1,RYK,PSMA1,ROR1,PLCB2,PLCB1,ARRB2
R-HSA-5658442	Regulation of RAS by GAPs	0.421584599926105	-0.86373481011164	67	4	0.0099009900990099	404	8202	5682,200734,8831,5922	PSMA1,SPRED2,SYNGAP1,RASA2
R-HSA-168333	NEP/NS2 Interacts with the Cellular Export Machinery	0.42186963007705	-0.863058946142606	29	2	0.00495049504950495	404	8202	23225,81929	NUP210,SEH1L
R-HSA-375170	CDO in myogenesis	0.42186963007705	-0.863058946142606	29	2	0.00495049504950495	404	8202	4209,4208	MEF2D,MEF2C
R-HSA-170822	Regulation of Glucokinase by Glucokinase Regulatory Protein	0.42186963007705	-0.863058946142606	29	2	0.00495049504950495	404	8202	23225,81929	NUP210,SEH1L
R-HSA-180786	Extension of Telomeres	0.42186963007705	-0.863058946142606	29	2	0.00495049504950495	404	8202	5984,8607	RFC4,RUVBL1
R-HSA-168271	Transport of Ribonucleoproteins into the Host Nucleus	0.42186963007705	-0.863058946142606	29	2	0.00495049504950495	404	8202	23225,81929	NUP210,SEH1L
R-HSA-525793	Myogenesis	0.42186963007705	-0.863058946142606	29	2	0.00495049504950495	404	8202	4209,4208	MEF2D,MEF2C
R-HSA-3928665	EPH-ephrin mediated repulsion of cells	0.423584745135615	-0.859001678331077	48	3	0.00742574257425743	404	8202	2534,2047,2043	FYN,EPHB1,EPHA4
R-HSA-3214842	HDMs demethylate histones	0.423584745135615	-0.859001678331077	48	3	0.00742574257425743	404	8202	80853,7403,84159	KDM7A,KDM6A,ARID5B
R-HSA-2022923	Dermatan sulfate biosynthesis	0.426481918154092	-0.852185308836374	11	1	0.00247524752475248	404	8202	29940	DSE
R-HSA-73817	Purine ribonucleoside monophosphate biosynthesis	0.426481918154092	-0.852185308836374	11	1	0.00247524752475248	404	8202	8833	GMPS
R-HSA-2485179	Activation of the phototransduction cascade	0.426481918154092	-0.852185308836374	11	1	0.00247524752475248	404	8202	2792	GNGT1
R-HSA-376172	DSCAM interactions	0.426481918154092	-0.852185308836374	11	1	0.00247524752475248	404	8202	5599	MAPK8
R-HSA-1980148	Signaling by NOTCH3	0.426481918154092	-0.852185308836374	11	1	0.00247524752475248	404	8202	3714	JAG2
R-HSA-2468052	Establishment of Sister Chromatid Cohesion	0.426481918154092	-0.852185308836374	11	1	0.00247524752475248	404	8202	10274	STAG1
R-HSA-975110	TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling	0.426481918154092	-0.852185308836374	11	1	0.00247524752475248	404	8202	170506	DHX36
R-HSA-200425	Import of palmitoyl-CoA into the mitochondrial matrix	0.426481918154092	-0.852185308836374	11	1	0.00247524752475248	404	8202	5563	PRKAA2
R-HSA-2514853	Condensation of Prometaphase Chromosomes	0.426481918154092	-0.852185308836374	11	1	0.00247524752475248	404	8202	10051	SMC4
R-HSA-196807	Nicotinate metabolism	0.426481918154092	-0.852185308836374	11	1	0.00247524752475248	404	8202	349565	NMNAT3
R-HSA-1839122	Signaling by activated point mutants of FGFR1	0.426481918154092	-0.852185308836374	11	1	0.00247524752475248	404	8202	2247	FGF2
R-HSA-1980150	Signaling by NOTCH4	0.426481918154092	-0.852185308836374	11	1	0.00247524752475248	404	8202	3714	JAG2
R-HSA-77588	SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs	0.426481918154092	-0.852185308836374	11	1	0.00247524752475248	404	8202	22916	NCBP2
R-HSA-1483257	Phospholipid metabolism	0.430671975354843	-0.842408556708341	146	8	0.0198019801980198	404	8202	56895,30849,5337,11343,5305,5291,8398,23175	AGPAT4,PIK3R4,PLD1,MGLL,PIP4K2A,PIK3CB,PLA2G6,LPIN1
R-HSA-72766	Translation	0.430671975354843	-0.842408556708341	146	8	0.0198019801980198	404	8202	58477,6184,6165,8893,29927,1978,1974,6747	SRPRB,RPN1,RPL35A,EIF2B5,SEC61A1,EIF4EBP1,EIF4A2,SSR3
R-HSA-5693571	Nonhomologous End-Joining (NHEJ)	0.43275809864601	-0.837576370725401	68	4	0.0099009900990099	404	8202	51720,165918,9577,9656	UIMC1,RNF168,BRE,MDC1
R-HSA-418555	G alpha (s) signalling events	0.435944772004696	-0.830239713370389	127	7	0.0173267326732673	404	8202	3363,797,5144,2781,5140,2792,50940	HTR7,CALCB,PDE4D,GNAZ,PDE3B,GNGT1,PDE11A
R-HSA-5654219	Phospholipase C-mediated cascade: FGFR1	0.436828741142721	-0.828214057396706	49	3	0.00742574257425743	404	8202	5581,5577,2247	PRKCE,PRKAR2B,FGF2
R-HSA-2122948	Activated NOTCH1 Transmits Signal to the Nucleus	0.43900943978542	-0.823234363210086	30	2	0.00495049504950495	404	8202	3714,409	JAG2,ARRB2
R-HSA-174824	Lipoprotein metabolism	0.43900943978542	-0.823234363210086	30	2	0.00495049504950495	404	8202	949,3339	SCARB1,HSPG2
R-HSA-2559585	Oncogene Induced Senescence	0.43900943978542	-0.823234363210086	30	2	0.00495049504950495	404	8202	2113,1021	ETS1,CDK6
R-HSA-420029	Tight junction interactions	0.43900943978542	-0.823234363210086	30	2	0.00495049504950495	404	8202	56288,5584	PARD3,PRKCI
R-HSA-191859	snRNP Assembly	0.449957195095164	-0.798602822752904	50	3	0.00742574257425743	404	8202	22916,23225,81929	NCBP2,NUP210,SEH1L
R-HSA-194441	Metabolism of non-coding RNA	0.449957195095164	-0.798602822752904	50	3	0.00742574257425743	404	8202	22916,23225,81929	NCBP2,NUP210,SEH1L
R-HSA-2980766	Nuclear Envelope Breakdown	0.449957195095164	-0.798602822752904	50	3	0.00742574257425743	404	8202	23225,81929,23175	NUP210,SEH1L,LPIN1
R-HSA-429914	Deadenylation-dependent mRNA decay	0.449957195095164	-0.798602822752904	50	3	0.00742574257425743	404	8202	57472,54464,1974	CNOT6,XRN1,EIF4A2
R-HSA-159236	Transport of Mature mRNA derived from an Intron-Containing Transcript	0.449957195095164	-0.798602822752904	50	3	0.00742574257425743	404	8202	22916,23225,81929	NCBP2,NUP210,SEH1L
R-HSA-156581	Methylation	0.454769221923315	-0.787965193267075	12	1	0.00247524752475248	404	8202	4144	MAT2A
R-HSA-203615	eNOS activation	0.454769221923315	-0.787965193267075	12	1	0.00247524752475248	404	8202	857	CAV1
R-HSA-1839130	Signaling by activated point mutants of FGFR3	0.454769221923315	-0.787965193267075	12	1	0.00247524752475248	404	8202	2247	FGF2
R-HSA-190373	FGFR1c ligand binding and activation	0.454769221923315	-0.787965193267075	12	1	0.00247524752475248	404	8202	2247	FGF2
R-HSA-451308	Activation of Ca-permeable Kainate Receptor	0.454769221923315	-0.787965193267075	12	1	0.00247524752475248	404	8202	1739	DLG1
R-HSA-3656237	Defective EXT2 causes exostoses 2	0.454769221923315	-0.787965193267075	12	1	0.00247524752475248	404	8202	3339	HSPG2
R-HSA-451306	Ionotropic activity of Kainate Receptors	0.454769221923315	-0.787965193267075	12	1	0.00247524752475248	404	8202	1739	DLG1
R-HSA-390666	Serotonin receptors	0.454769221923315	-0.787965193267075	12	1	0.00247524752475248	404	8202	3363	HTR7
R-HSA-210990	PECAM1 interactions	0.454769221923315	-0.787965193267075	12	1	0.00247524752475248	404	8202	2534	FYN
R-HSA-199220	Vitamin B5 (pantothenate) metabolism	0.454769221923315	-0.787965193267075	12	1	0.00247524752475248	404	8202	60490	PPCDC
R-HSA-73621	Pyrimidine catabolism	0.454769221923315	-0.787965193267075	12	1	0.00247524752475248	404	8202	7378	UPP1
R-HSA-71384	Ethanol oxidation	0.454769221923315	-0.787965193267075	12	1	0.00247524752475248	404	8202	217	ALDH2
R-HSA-211958	Miscellaneous substrates	0.454769221923315	-0.787965193267075	12	1	0.00247524752475248	404	8202	57834	CYP4F11
R-HSA-176974	Unwinding of DNA	0.454769221923315	-0.787965193267075	12	1	0.00247524752475248	404	8202	4171	MCM2
R-HSA-190239	FGFR3 ligand binding and activation	0.454769221923315	-0.787965193267075	12	1	0.00247524752475248	404	8202	2247	FGF2
R-HSA-3656253	Defective EXT1 causes exostoses 1, TRPS2 and CHDS	0.454769221923315	-0.787965193267075	12	1	0.00247524752475248	404	8202	3339	HSPG2
R-HSA-2033514	FGFR3 mutant receptor activation	0.454769221923315	-0.787965193267075	12	1	0.00247524752475248	404	8202	2247	FGF2
R-HSA-844456	The NLRP3 inflammasome	0.454769221923315	-0.787965193267075	12	1	0.00247524752475248	404	8202	5027	P2RX7
R-HSA-211979	Eicosanoids	0.454769221923315	-0.787965193267075	12	1	0.00247524752475248	404	8202	57834	CYP4F11
R-HSA-1474151	Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation	0.454769221923315	-0.787965193267075	12	1	0.00247524752475248	404	8202	2644	GCHFR
R-HSA-190372	FGFR3c ligand binding and activation	0.454769221923315	-0.787965193267075	12	1	0.00247524752475248	404	8202	2247	FGF2
R-HSA-5654733	Negative regulation of FGFR4 signaling	0.455868055598262	-0.785551863096245	31	2	0.00495049504950495	404	8202	2247,9965	FGF2,FGF19
R-HSA-2129379	Molecules associated with elastic fibres	0.455868055598262	-0.785551863096245	31	2	0.00495049504950495	404	8202	4052,7042	LTBP1,TGFB2
R-HSA-2173796	SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription	0.455868055598262	-0.785551863096245	31	2	0.00495049504950495	404	8202	7029,25937	TFDP2,WWTR1
R-HSA-168274	Export of Viral Ribonucleoproteins from Nucleus	0.455868055598262	-0.785551863096245	31	2	0.00495049504950495	404	8202	23225,81929	NUP210,SEH1L
R-HSA-1592389	Activation of Matrix Metalloproteinases	0.455868055598262	-0.785551863096245	31	2	0.00495049504950495	404	8202	4316,7077	MMP7,TIMP2
R-HSA-180746	Nuclear import of Rev protein	0.455868055598262	-0.785551863096245	31	2	0.00495049504950495	404	8202	23225,81929	NUP210,SEH1L
R-HSA-180910	Vpr-mediated nuclear import of PICs	0.455868055598262	-0.785551863096245	31	2	0.00495049504950495	404	8202	23225,81929	NUP210,SEH1L
R-HSA-1483255	PI Metabolism	0.462959966207849	-0.770114694708069	51	3	0.00742574257425743	404	8202	5291,5305,30849	PIK3CB,PIP4K2A,PIK3R4
R-HSA-5654221	Phospholipase C-mediated cascade; FGFR2	0.462959966207849	-0.770114694708069	51	3	0.00742574257425743	404	8202	5581,5577,2247	PRKCE,PRKAR2B,FGF2
R-HSA-449147	Signaling by Interleukins	0.465870614020742	-0.763847335725037	311	16	0.0396039603960396	404	8202	6712,200734,8831,2247,5922,1950,1852,5682,283455,9542,3606,5291,9965,8660,2534,409	SPTBN2,SPRED2,SYNGAP1,FGF2,RASA2,EGF,DUSP9,PSMA1,KSR2,NRG2,IL18,PIK3CB,FGF19,IRS2,FYN,ARRB2
R-HSA-165054	Rev-mediated nuclear export of HIV RNA	0.472431561383979	-0.749862386170982	32	2	0.00495049504950495	404	8202	23225,81929	NUP210,SEH1L
R-HSA-456926	Thrombin signalling through proteinase activated receptors (PARs)	0.472431561383979	-0.749862386170982	32	2	0.00495049504950495	404	8202	409,2792	ARRB2,GNGT1
R-HSA-2173789	TGF-beta receptor signaling activates SMADs	0.472431561383979	-0.749862386170982	32	2	0.00495049504950495	404	8202	7048,9372	TGFBR2,ZFYVE9
R-HSA-2029481	FCGR activation	0.481664610731763	-0.730507235489787	13	1	0.00247524752475248	404	8202	2534	FYN
R-HSA-400511	Synthesis, secretion, and inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP)	0.481664610731763	-0.730507235489787	13	1	0.00247524752475248	404	8202	1803	DPP4
R-HSA-3270619	IRF3-mediated induction of type I IFN	0.481664610731763	-0.730507235489787	13	1	0.00247524752475248	404	8202	340061	TMEM173
R-HSA-3134963	DEx/H-box helicases activate type I IFN and inflammatory cytokines production	0.481664610731763	-0.730507235489787	13	1	0.00247524752475248	404	8202	170506	DHX36
R-HSA-112308	Depolarization of the Presynaptic Terminal Triggers the Opening of Calcium Channels	0.481664610731763	-0.730507235489787	13	1	0.00247524752475248	404	8202	785	CACNB4
R-HSA-2995383	Initiation of Nuclear Envelope Reformation	0.481664610731763	-0.730507235489787	13	1	0.00247524752475248	404	8202	5520	PPP2R2A
R-HSA-209543	p75NTR recruits signalling complexes	0.481664610731763	-0.730507235489787	13	1	0.00247524752475248	404	8202	5584	PRKCI
R-HSA-5140745	WNT5A-dependent internalization of FZD2, FZD5 and ROR2	0.481664610731763	-0.730507235489787	13	1	0.00247524752475248	404	8202	4919	ROR1
R-HSA-1358803	Downregulation of ERBB2:ERBB3 signaling	0.481664610731763	-0.730507235489787	13	1	0.00247524752475248	404	8202	9542	NRG2
R-HSA-1660516	Synthesis of PIPs at the early endosome membrane	0.481664610731763	-0.730507235489787	13	1	0.00247524752475248	404	8202	30849	PIK3R4
R-HSA-2995410	Nuclear Envelope Reassembly	0.481664610731763	-0.730507235489787	13	1	0.00247524752475248	404	8202	5520	PPP2R2A
R-HSA-4641265	Repression of WNT target genes	0.481664610731763	-0.730507235489787	13	1	0.00247524752475248	404	8202	7090	TLE3
R-HSA-391160	Signal regulatory protein (SIRP) family interactions	0.481664610731763	-0.730507235489787	13	1	0.00247524752475248	404	8202	140885	SIRPA
R-HSA-1483213	Synthesis of PE	0.481664610731763	-0.730507235489787	13	1	0.00247524752475248	404	8202	23175	LPIN1
R-HSA-190375	FGFR2c ligand binding and activation	0.481664610731763	-0.730507235489787	13	1	0.00247524752475248	404	8202	2247	FGF2
R-HSA-177504	Retrograde neurotrophin signalling	0.481664610731763	-0.730507235489787	13	1	0.00247524752475248	404	8202	4914	NTRK1
R-HSA-5607763	CLEC7A (Dectin-1) induces NFAT activation	0.481664610731763	-0.730507235489787	13	1	0.00247524752475248	404	8202	5530	PPP3CA
R-HSA-5628897	TP53 Regulates Metabolic Genes	0.487600849755916	-0.718258138644964	73	4	0.0099009900990099	404	8202	7296,5563,83667,54541	TXNRD1,PRKAA2,SESN2,DDIT4
R-HSA-3700989	Transcriptional Regulation by TP53	0.487600849755916	-0.718258138644964	73	4	0.0099009900990099	404	8202	7296,5563,83667,54541	TXNRD1,PRKAA2,SESN2,DDIT4
R-HSA-452723	Transcriptional regulation of pluripotent stem cells	0.488688086099064	-0.716030853765086	33	2	0.00495049504950495	404	8202	2247,57167	FGF2,SALL4
R-HSA-3301854	Nuclear Pore Complex (NPC) Disassembly	0.488688086099064	-0.716030853765086	33	2	0.00495049504950495	404	8202	23225,81929	NUP210,SEH1L
R-HSA-69190	DNA strand elongation	0.488688086099064	-0.716030853765086	33	2	0.00495049504950495	404	8202	5984,4171	RFC4,MCM2
R-HSA-1638074	Keratan sulfate/keratin metabolism	0.488688086099064	-0.716030853765086	33	2	0.00495049504950495	404	8202	9435,10331	CHST2,B3GNT3
R-HSA-1660499	Synthesis of PIPs at the plasma membrane	0.488688086099064	-0.716030853765086	33	2	0.00495049504950495	404	8202	5291,5305	PIK3CB,PIP4K2A
R-HSA-1638091	Heparan sulfate/heparin (HS-GAG) metabolism	0.501123876397039	-0.690901950183039	54	3	0.00742574257425743	404	8202	90161,3339,266722	HS6ST2,HSPG2,HS6ST3
R-HSA-72202	Transport of Mature Transcript to Cytoplasm	0.501123876397039	-0.690901950183039	54	3	0.00742574257425743	404	8202	22916,23225,81929	NCBP2,NUP210,SEH1L
R-HSA-113418	Formation of the Early Elongation Complex	0.504627636944088	-0.683934474270864	34	2	0.00495049504950495	404	8202	22916,902	NCBP2,CCNH
R-HSA-1489509	DAG and IP3 signaling	0.504627636944088	-0.683934474270864	34	2	0.00495049504950495	404	8202	5581,5577	PRKCE,PRKAR2B
R-HSA-1222556	ROS production in response to bacteria	0.504627636944088	-0.683934474270864	34	2	0.00495049504950495	404	8202	90423,4842	ATP6V1E2,NOS1
R-HSA-177243	Interactions of Rev with host cellular proteins	0.504627636944088	-0.683934474270864	34	2	0.00495049504950495	404	8202	23225,81929	NUP210,SEH1L
R-HSA-176033	Interactions of Vpr with host cellular proteins	0.504627636944088	-0.683934474270864	34	2	0.00495049504950495	404	8202	23225,81929	NUP210,SEH1L
R-HSA-167158	Formation of the HIV-1 Early Elongation Complex	0.504627636944088	-0.683934474270864	34	2	0.00495049504950495	404	8202	22916,902	NCBP2,CCNH
R-HSA-936440	Negative regulators of RIG-I/MDA5 signaling	0.504627636944088	-0.683934474270864	34	2	0.00495049504950495	404	8202	9140,84166	ATG12,NLRC5
R-HSA-948021	Transport to the Golgi and subsequent modification	0.505448470918596	-0.682309182574903	95	5	0.0123762376237624	404	8202	23243,83696,149111,6480,4249	ANKRD28,TRAPPC9,CNIH3,ST6GAL1,MGAT5
R-HSA-2682334	EPH-Ephrin signaling	0.505448470918596	-0.682309182574903	95	5	0.0123762376237624	404	8202	2534,2047,7422,5062,2043	FYN,EPHB1,VEGFA,PAK2,EPHA4
R-HSA-2162123	Synthesis of Prostaglandins (PG) and Thromboxanes (TX)	0.507236414022971	-0.678778084226874	14	1	0.00247524752475248	404	8202	5742	PTGS1
R-HSA-68884	Mitotic Telophase/Cytokinesis	0.507236414022971	-0.678778084226874	14	1	0.00247524752475248	404	8202	10274	STAG1
R-HSA-77595	Processing of Intronless Pre-mRNAs	0.507236414022971	-0.678778084226874	14	1	0.00247524752475248	404	8202	22916	NCBP2
R-HSA-428540	Activation of Rac	0.507236414022971	-0.678778084226874	14	1	0.00247524752475248	404	8202	5062	PAK2
R-HSA-193775	Synthesis of bile acids and bile salts via 24-hydroxycholesterol	0.507236414022971	-0.678778084226874	14	1	0.00247524752475248	404	8202	80270	HSD3B7
R-HSA-174411	Polymerase switching on the C-strand of the telomere	0.507236414022971	-0.678778084226874	14	1	0.00247524752475248	404	8202	5984	RFC4
R-HSA-418885	DCC mediated attractive signaling	0.507236414022971	-0.678778084226874	14	1	0.00247524752475248	404	8202	2534	FYN
R-HSA-69091	Polymerase switching	0.507236414022971	-0.678778084226874	14	1	0.00247524752475248	404	8202	5984	RFC4
R-HSA-69109	Leading Strand Synthesis	0.507236414022971	-0.678778084226874	14	1	0.00247524752475248	404	8202	5984	RFC4
R-HSA-2142753	Arachidonic acid metabolism	0.513537145045134	-0.66643291523822	55	3	0.00742574257425743	404	8202	1800,5742,57834	DPEP1,PTGS1,CYP4F11
R-HSA-1483206	Glycerophospholipid biosynthesis	0.514816488795454	-0.663944774255901	96	5	0.0123762376237624	404	8202	5337,11343,8398,56895,23175	PLD1,MGLL,PLA2G6,AGPAT4,LPIN1
R-HSA-983231	Factors involved in megakaryocyte development and platelet production	0.5159640869263	-0.661718114902733	137	7	0.0173267326732673	404	8202	2625,10019,5577,1795,80005,2624,4602	GATA3,SH2B3,PRKAR2B,DOCK3,DOCK5,GATA2,MYB
R-HSA-73933	Resolution of Abasic Sites (AP sites)	0.520241943931183	-0.653461298823611	35	2	0.00495049504950495	404	8202	5984,8930	RFC4,MBD4
R-HSA-73884	Base Excision Repair	0.520241943931183	-0.653461298823611	35	2	0.00495049504950495	404	8202	5984,8930	RFC4,MBD4
R-HSA-194068	Bile acid and bile salt metabolism	0.520241943931183	-0.653461298823611	35	2	0.00495049504950495	404	8202	8309,80270	ACOX2,HSD3B7
R-HSA-69620	Cell Cycle Checkpoints	0.523928654392902	-0.646399759669866	179	9	0.0222772277227723	404	8202	5984,9577,5682,51720,545,165918,4171,9656,3364	RFC4,BRE,PSMA1,UIMC1,ATR,RNF168,MCM2,MDC1,HUS1
R-HSA-3000178	ECM proteoglycans	0.525784794580451	-0.642863285741915	56	3	0.00742574257425743	404	8202	7042,3687,3673	TGFB2,ITGAX,ITGA2
R-HSA-70326	Glucose metabolism	0.529872972663784	-0.635117975381701	77	4	0.0099009900990099	404	8202	2992,5106,7957,3099	GYG1,PCK2,EPM2A,HK2
R-HSA-430039	mRNA decay by 5' to 3' exoribonuclease	0.531549614901627	-0.63195873672972	15	1	0.00247524752475248	404	8202	54464	XRN1
R-HSA-4419969	Depolymerisation of the Nuclear Lamina	0.531549614901627	-0.63195873672972	15	1	0.00247524752475248	404	8202	23175	LPIN1
R-HSA-2691232	Constitutive Signaling by NOTCH1 HD Domain Mutants	0.531549614901627	-0.63195873672972	15	1	0.00247524752475248	404	8202	3714	JAG2
R-HSA-193807	Synthesis of bile acids and bile salts via 27-hydroxycholesterol	0.531549614901627	-0.63195873672972	15	1	0.00247524752475248	404	8202	80270	HSD3B7
R-HSA-211935	Fatty acids	0.531549614901627	-0.63195873672972	15	1	0.00247524752475248	404	8202	57834	CYP4F11
R-HSA-3134975	Regulation of innate immune responses to cytosolic DNA	0.531549614901627	-0.63195873672972	15	1	0.00247524752475248	404	8202	340061	TMEM173
R-HSA-901042	Calnexin/calreticulin cycle	0.531549614901627	-0.63195873672972	15	1	0.00247524752475248	404	8202	55757	UGGT2
R-HSA-549132	Organic cation/anion/zwitterion transport	0.531549614901627	-0.63195873672972	15	1	0.00247524752475248	404	8202	55356	SLC22A15
R-HSA-5637812	Signaling by EGFRvIII in Cancer	0.531549614901627	-0.63195873672972	15	1	0.00247524752475248	404	8202	1950	EGF
R-HSA-194223	HDL-mediated lipid transport	0.531549614901627	-0.63195873672972	15	1	0.00247524752475248	404	8202	949	SCARB1
R-HSA-205043	NRIF signals cell death from the nucleus	0.531549614901627	-0.63195873672972	15	1	0.00247524752475248	404	8202	5599	MAPK8
R-HSA-2691230	Signaling by NOTCH1 HD Domain Mutants in Cancer	0.531549614901627	-0.63195873672972	15	1	0.00247524752475248	404	8202	3714	JAG2
R-HSA-3772470	Negative regulation of TCF-dependent signaling by WNT ligand antagonists	0.531549614901627	-0.63195873672972	15	1	0.00247524752475248	404	8202	22943	DKK1
R-HSA-5637810	Constitutive Signaling by EGFRvIII	0.531549614901627	-0.63195873672972	15	1	0.00247524752475248	404	8202	1950	EGF
R-HSA-5099900	WNT5A-dependent internalization of FZD4	0.531549614901627	-0.63195873672972	15	1	0.00247524752475248	404	8202	409	ARRB2
R-HSA-163841	Gamma carboxylation, hypusine formation and arylsulfatase activation	0.535524315161203	-0.624508983661678	36	2	0.00495049504950495	404	8202	89978,56648	DPH6,EIF5A2
R-HSA-5663213	RHO GTPases Activate WASPs and WAVEs	0.535524315161203	-0.624508983661678	36	2	0.00495049504950495	404	8202	10152,644150	ABI2,WIPF3
R-HSA-983695	Antigen activates B Cell Receptor (BCR) leading to generation of second messengers	0.535524315161203	-0.624508983661678	36	2	0.00495049504950495	404	8202	7220,2534	TRPC1,FYN
R-HSA-73894	DNA Repair	0.546558592614957	-0.604113762812574	306	15	0.0371287128712871	404	8202	55120,5599,5984,9577,902,11073,8607,51720,545,165918,7486,9656,86,3364,8930	FANCL,MAPK8,RFC4,BRE,CCNH,TOPBP1,RUVBL1,UIMC1,ATR,RNF168,WRN,MDC1,ACTL6A,HUS1,MBD4
R-HSA-438064	Post NMDA receptor activation events	0.550469502150302	-0.596983724625986	37	2	0.00495049504950495	404	8202	6196,84254	RPS6KA2,CAMKK1
R-HSA-112314	Neurotransmitter Receptor Binding And Downstream Transmission In The  Postsynaptic Cell	0.554473071179155	-0.589737037520397	142	7	0.0173267326732673	404	8202	6196,23236,5330,84254,2550,2792,1739	RPS6KA2,PLCB1,PLCB2,CAMKK1,GABBR1,GNGT1,DLG1
R-HSA-110312	Translesion synthesis by REV1	0.554666013528133	-0.589389123803201	16	1	0.00247524752475248	404	8202	5984	RFC4
R-HSA-193639	p75NTR signals via NF-kB	0.554666013528133	-0.589389123803201	16	1	0.00247524752475248	404	8202	5584	PRKCI
R-HSA-450321	JNK (c-Jun kinases) phosphorylation and  activation mediated by activated human TAK1	0.554666013528133	-0.589389123803201	16	1	0.00247524752475248	404	8202	5599	MAPK8
R-HSA-163615	PKA activation	0.554666013528133	-0.589389123803201	16	1	0.00247524752475248	404	8202	5577	PRKAR2B
R-HSA-1834941	STING mediated induction of host immune responses	0.554666013528133	-0.589389123803201	16	1	0.00247524752475248	404	8202	340061	TMEM173
R-HSA-190242	FGFR1 ligand binding and activation	0.554666013528133	-0.589389123803201	16	1	0.00247524752475248	404	8202	2247	FGF2
R-HSA-5674135	MAP2K and MAPK activation	0.56507357441502	-0.570799336110035	38	2	0.00495049504950495	404	8202	283455,409	KSR2,ARRB2
R-HSA-109606	Intrinsic Pathway for Apoptosis	0.56507357441502	-0.570799336110035	38	2	0.00495049504950495	404	8202	5599,5366	MAPK8,PMAIP1
R-HSA-5696394	DNA Damage Recognition in GG-NER	0.56507357441502	-0.570799336110035	38	2	0.00495049504950495	404	8202	8607,86	RUVBL1,ACTL6A
R-HSA-2033519	Activated point mutants of FGFR2	0.576644382768448	-0.550529523503133	17	1	0.00247524752475248	404	8202	2247	FGF2
R-HSA-111931	PKA-mediated phosphorylation of CREB	0.576644382768448	-0.550529523503133	17	1	0.00247524752475248	404	8202	5577	PRKAR2B
R-HSA-1839126	FGFR2 mutant receptor activation	0.576644382768448	-0.550529523503133	17	1	0.00247524752475248	404	8202	2247	FGF2
R-HSA-5656121	Translesion synthesis by POLI	0.576644382768448	-0.550529523503133	17	1	0.00247524752475248	404	8202	5984	RFC4
R-HSA-5655862	Translesion synthesis by POLK	0.576644382768448	-0.550529523503133	17	1	0.00247524752475248	404	8202	5984	RFC4
R-HSA-532668	N-glycan trimming in the ER and Calnexin/Calreticulin cycle	0.576644382768448	-0.550529523503133	17	1	0.00247524752475248	404	8202	55757	UGGT2
R-HSA-622312	Inflammasomes	0.576644382768448	-0.550529523503133	17	1	0.00247524752475248	404	8202	5027	P2RX7
R-HSA-450385	Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA	0.576644382768448	-0.550529523503133	17	1	0.00247524752475248	404	8202	54464	XRN1
R-HSA-435354	Zinc transporters	0.576644382768448	-0.550529523503133	17	1	0.00247524752475248	404	8202	64116	SLC39A8
R-HSA-2142845	Hyaluronan metabolism	0.576644382768448	-0.550529523503133	17	1	0.00247524752475248	404	8202	10057	ABCC5
R-HSA-164378	PKA activation in glucagon signalling	0.576644382768448	-0.550529523503133	17	1	0.00247524752475248	404	8202	5577	PRKAR2B
R-HSA-174800	Chylomicron-mediated lipid transport	0.576644382768448	-0.550529523503133	17	1	0.00247524752475248	404	8202	3339	HSPG2
R-HSA-70221	Glycogen breakdown (glycogenolysis)	0.576644382768448	-0.550529523503133	17	1	0.00247524752475248	404	8202	2992	GYG1
R-HSA-450513	Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA	0.576644382768448	-0.550529523503133	17	1	0.00247524752475248	404	8202	54464	XRN1
R-HSA-420499	Class C/3 (Metabotropic glutamate/pheromone receptors)	0.579333803037232	-0.545876451059014	39	2	0.00495049504950495	404	8202	2914,2550	GRM4,GABBR1
R-HSA-6783310	Fanconi Anemia Pathway	0.579333803037232	-0.545876451059014	39	2	0.00495049504950495	404	8202	55120,545	FANCL,ATR
R-HSA-977444	GABA B receptor activation	0.579333803037232	-0.545876451059014	39	2	0.00495049504950495	404	8202	2550,2792	GABBR1,GNGT1
R-HSA-6788656	Histidine, lysine, phenylalanine, tyrosine, proline and tryptophan catabolism	0.579333803037232	-0.545876451059014	39	2	0.00495049504950495	404	8202	85007,2639	PHYKPL,GCDH
R-HSA-991365	Activation of GABAB receptors	0.579333803037232	-0.545876451059014	39	2	0.00495049504950495	404	8202	2550,2792	GABBR1,GNGT1
R-HSA-165159	mTOR signalling	0.579333803037232	-0.545876451059014	39	2	0.00495049504950495	404	8202	5563,1978	PRKAA2,EIF4EBP1
R-HSA-5173214	O-glycosylation of TSR domain-containing proteins	0.579333803037232	-0.545876451059014	39	2	0.00495049504950495	404	8202	23145,170690	SSPO,ADAMTS16
R-HSA-15869	Metabolism of nucleotides	0.580188596454388	-0.544402061996107	82	4	0.0099009900990099	404	8202	7296,8833,131870,7378	TXNRD1,GMPS,NUDT16,UPP1
R-HSA-975871	MyD88 cascade initiated on plasma membrane	0.580188596454388	-0.544402061996107	82	4	0.0099009900990099	404	8202	5599,6196,9252,4208	MAPK8,RPS6KA2,RPS6KA5,MEF2C
R-HSA-168176	Toll Like Receptor 5 (TLR5) Cascade	0.580188596454388	-0.544402061996107	82	4	0.0099009900990099	404	8202	5599,6196,9252,4208	MAPK8,RPS6KA2,RPS6KA5,MEF2C
R-HSA-168142	Toll Like Receptor 10 (TLR10) Cascade	0.580188596454388	-0.544402061996107	82	4	0.0099009900990099	404	8202	5599,6196,9252,4208	MAPK8,RPS6KA2,RPS6KA5,MEF2C
R-HSA-975138	TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation	0.589877076216079	-0.527841109185766	83	4	0.0099009900990099	404	8202	5599,6196,9252,4208	MAPK8,RPS6KA2,RPS6KA5,MEF2C
R-HSA-5696399	Global Genome Nucleotide Excision Repair (GG-NER)	0.589877076216079	-0.527841109185766	83	4	0.0099009900990099	404	8202	5984,902,8607,86	RFC4,CCNH,RUVBL1,ACTL6A
R-HSA-71387	Metabolism of carbohydrates	0.596906518777251	-0.515994762812969	274	13	0.0321782178217822	404	8202	23225,90161,3339,3099,2992,5106,29940,9435,7957,81929,10331,10057,266722	NUP210,HS6ST2,HSPG2,HK2,GYG1,PCK2,DSE,CHST2,EPM2A,SEH1L,B3GNT3,ABCC5,HS6ST3
R-HSA-5654704	SHC-mediated cascade:FGFR3	0.597540616038503	-0.5149330208533	18	1	0.00247524752475248	404	8202	2247	FGF2
R-HSA-5635838	Activation of SMO	0.597540616038503	-0.5149330208533	18	1	0.00247524752475248	404	8202	409	ARRB2
R-HSA-1660514	Synthesis of PIPs at the Golgi membrane	0.597540616038503	-0.5149330208533	18	1	0.00247524752475248	404	8202	30849	PIK3R4
R-HSA-1912420	Pre-NOTCH Processing in Golgi	0.597540616038503	-0.5149330208533	18	1	0.00247524752475248	404	8202	4242	MFNG
R-HSA-5389840	Mitochondrial translation elongation	0.59943365054125	-0.511769985299593	84	4	0.0099009900990099	404	8202	56945,85476,11222,57129	MRPS22,GFM1,MRPL3,MRPL47
R-HSA-71291	Metabolism of amino acids and derivatives	0.60261569986692	-0.506475599079157	212	10	0.0247524752475248	404	8202	384,84706,440,29968,594,56922,5682,85007,2639,26227	ARG2,GPT2,ASNS,PSAT1,BCKDHB,MCCC1,PSMA1,PHYKPL,GCDH,PHGDH
R-HSA-2426168	Activation of gene expression by SREBF (SREBP)	0.606817179205663	-0.499527720758772	41	2	0.00495049504950495	404	8202	6907,79718	TBL1X,TBL1XR1
R-HSA-168325	Viral Messenger RNA Synthesis	0.606817179205663	-0.499527720758772	41	2	0.00495049504950495	404	8202	23225,81929	NUP210,SEH1L
R-HSA-442755	Activation of NMDA receptor upon glutamate binding and postsynaptic events	0.606817179205663	-0.499527720758772	41	2	0.00495049504950495	404	8202	6196,84254	RPS6KA2,CAMKK1
R-HSA-1799339	SRP-dependent cotranslational protein targeting to membrane	0.612286094047019	-0.490555631768671	107	5	0.0123762376237624	404	8202	58477,6747,6184,6165,29927	SRPRB,SSR3,RPN1,RPL35A,SEC61A1
R-HSA-3214841	PKMTs methylate histone lysines	0.617203238946806	-0.482556910699373	64	3	0.00742574257425743	404	8202	80854,63976,2122	SETD7,PRDM16,MECOM
R-HSA-5637815	Signaling by Ligand-Responsive EGFR Variants in Cancer	0.61740786812268	-0.482225423032405	19	1	0.00247524752475248	404	8202	1950	EGF
R-HSA-3560801	Defective B3GAT3 causes JDSSDHD	0.61740786812268	-0.482225423032405	19	1	0.00247524752475248	404	8202	3339	HSPG2
R-HSA-5651801	PCNA-Dependent Long Patch Base Excision Repair	0.61740786812268	-0.482225423032405	19	1	0.00247524752475248	404	8202	5984	RFC4
R-HSA-392851	Prostacyclin signalling through prostacyclin receptor	0.61740786812268	-0.482225423032405	19	1	0.00247524752475248	404	8202	2792	GNGT1
R-HSA-110320	Translesion Synthesis by POLH	0.61740786812268	-0.482225423032405	19	1	0.00247524752475248	404	8202	5984	RFC4
R-HSA-389977	Post-chaperonin tubulin folding pathway	0.61740786812268	-0.482225423032405	19	1	0.00247524752475248	404	8202	7277	TUBA4A
R-HSA-3560783	Defective B4GALT7 causes EDS, progeroid type	0.61740786812268	-0.482225423032405	19	1	0.00247524752475248	404	8202	3339	HSPG2
R-HSA-4420332	Defective B3GALT6 causes EDSP2 and SEMDJL1	0.61740786812268	-0.482225423032405	19	1	0.00247524752475248	404	8202	3339	HSPG2
R-HSA-1181150	Signaling by NODAL	0.61740786812268	-0.482225423032405	19	1	0.00247524752475248	404	8202	2309	FOXO3
R-HSA-1236382	Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants	0.61740786812268	-0.482225423032405	19	1	0.00247524752475248	404	8202	1950	EGF
R-HSA-1643713	Signaling by EGFR in Cancer	0.61740786812268	-0.482225423032405	19	1	0.00247524752475248	404	8202	1950	EGF
R-HSA-3769402	Deactivation of the beta-catenin transactivating complex	0.620039939964948	-0.47797138371953	42	2	0.00495049504950495	404	8202	26108,7090	PYGO1,TLE3
R-HSA-3928662	EPHB-mediated forward signaling	0.620039939964948	-0.47797138371953	42	2	0.00495049504950495	404	8202	2534,2047	FYN,EPHB1
R-HSA-381676	Glucagon-like Peptide-1 (GLP1) regulates insulin secretion	0.620039939964948	-0.47797138371953	42	2	0.00495049504950495	404	8202	5577,2792	PRKAR2B,GNGT1
R-HSA-375280	Amine ligand-binding receptors	0.620039939964948	-0.47797138371953	42	2	0.00495049504950495	404	8202	3363,3269	HTR7,HRH1
R-HSA-373080	Class B/2 (Secretin family receptors)	0.62728849974628	-0.46634871698822	87	4	0.0099009900990099	404	8202	30817,797,1604,2792	ADGRE2,CALCB,CD55,GNGT1
R-HSA-167246	Tat-mediated elongation of the HIV-1 transcript	0.632917903482257	-0.457414559589825	43	2	0.00495049504950495	404	8202	22916,902	NCBP2,CCNH
R-HSA-167200	Formation of HIV-1 elongation complex containing HIV-1 Tat	0.632917903482257	-0.457414559589825	43	2	0.00495049504950495	404	8202	22916,902	NCBP2,CCNH
R-HSA-167169	HIV Transcription Elongation	0.632917903482257	-0.457414559589825	43	2	0.00495049504950495	404	8202	22916,902	NCBP2,CCNH
R-HSA-5687128	MAPK6/MAPK4 signaling	0.63629525115094	-0.452092591994657	88	4	0.0099009900990099	404	8202	5682,10602,2309,5062	PSMA1,CDC42EP3,FOXO3,PAK2
R-HSA-1483191	Synthesis of PC	0.636296689002048	-0.452090332274063	20	1	0.00247524752475248	404	8202	23175	LPIN1
R-HSA-190241	FGFR2 ligand binding and activation	0.636296689002048	-0.452090332274063	20	1	0.00247524752475248	404	8202	2247	FGF2
R-HSA-381771	Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1)	0.636296689002048	-0.452090332274063	20	1	0.00247524752475248	404	8202	1803	DPP4
R-HSA-204005	COPII (Coat Protein 2) Mediated Vesicle Transport	0.638109346884574	-0.44924562022174	66	3	0.00742574257425743	404	8202	23243,83696,149111	ANKRD28,TRAPPC9,CNIH3
R-HSA-1834949	Cytosolic sensors of pathogen-associated DNA	0.638109346884574	-0.44924562022174	66	3	0.00742574257425743	404	8202	9208,170506,340061	LRRFIP1,DHX36,TMEM173
R-HSA-211945	Phase 1 - Functionalization of compounds	0.645160206528013	-0.438256610814146	89	4	0.0099009900990099	404	8202	5742,217,4129,57834	PTGS1,ALDH2,MAOB,CYP4F11
R-HSA-167152	Formation of HIV elongation complex in the absence of HIV Tat	0.645452871015612	-0.437803082955631	44	2	0.00495049504950495	404	8202	22916,902	NCBP2,CCNH
R-HSA-75955	RNA Polymerase II Transcription Elongation	0.645452871015612	-0.437803082955631	44	2	0.00495049504950495	404	8202	22916,902	NCBP2,CCNH
R-HSA-112382	Formation of RNA Pol II elongation complex	0.645452871015612	-0.437803082955631	44	2	0.00495049504950495	404	8202	22916,902	NCBP2,CCNH
R-HSA-382556	ABC-family proteins mediated transport	0.645452871015612	-0.437803082955631	44	2	0.00495049504950495	404	8202	10257,10057	ABCC4,ABCC5
R-HSA-167172	Transcription of the HIV genome	0.648258944406503	-0.433465056885312	67	3	0.00742574257425743	404	8202	22916,902,8731	NCBP2,CCNH,RNMT
R-HSA-1632852	Macroautophagy	0.648258944406503	-0.433465056885312	67	3	0.00742574257425743	404	8202	5563,9140,30849	PRKAA2,ATG12,PIK3R4
R-HSA-5368287	Mitochondrial translation	0.653882083654223	-0.424828244003878	90	4	0.0099009900990099	404	8202	56945,85476,11222,57129	MRPS22,GFM1,MRPL3,MRPL47
R-HSA-2024096	HS-GAG degradation	0.654255151215099	-0.424257864136925	21	1	0.00247524752475248	404	8202	3339	HSPG2
R-HSA-5654688	SHC-mediated cascade:FGFR1	0.654255151215099	-0.424257864136925	21	1	0.00247524752475248	404	8202	2247	FGF2
R-HSA-2979096	NOTCH2 Activation and Transmission of Signal to the Nucleus	0.654255151215099	-0.424257864136925	21	1	0.00247524752475248	404	8202	3714	JAG2
R-HSA-4641263	Regulation of FZD by ubiquitination	0.654255151215099	-0.424257864136925	21	1	0.00247524752475248	404	8202	59352	LGR6
R-HSA-390918	Peroxisomal lipid metabolism	0.654255151215099	-0.424257864136925	21	1	0.00247524752475248	404	8202	8309	ACOX2
R-HSA-69186	Lagging Strand Synthesis	0.654255151215099	-0.424257864136925	21	1	0.00247524752475248	404	8202	5984	RFC4
R-HSA-389960	Formation of tubulin folding intermediates by CCT/TriC	0.654255151215099	-0.424257864136925	21	1	0.00247524752475248	404	8202	7277	TUBA4A
R-HSA-445144	Signal transduction by L1	0.654255151215099	-0.424257864136925	21	1	0.00247524752475248	404	8202	8829	NRP1
R-HSA-196741	Cobalamin (Cbl, vitamin B12) transport and metabolism	0.654255151215099	-0.424257864136925	21	1	0.00247524752475248	404	8202	5646	PRSS3
R-HSA-499943	Synthesis and interconversion of nucleotide di- and triphosphates	0.654255151215099	-0.424257864136925	21	1	0.00247524752475248	404	8202	7296	TXNRD1
R-HSA-1912422	Pre-NOTCH Expression and Processing	0.657647301836432	-0.419086506810606	45	2	0.00495049504950495	404	8202	7029,4242	TFDP2,MFNG
R-HSA-3371453	Regulation of HSF1-mediated heat shock response	0.658205137277683	-0.418238637462817	68	3	0.00742574257425743	404	8202	545,23225,81929	ATR,NUP210,SEH1L
R-HSA-388841	Costimulation by the CD28 family	0.658205137277683	-0.418238637462817	68	3	0.00742574257425743	404	8202	57761,2534,5062	TRIB3,FYN,PAK2
R-HSA-199977	ER to Golgi Anterograde Transport	0.658205137277683	-0.418238637462817	68	3	0.00742574257425743	404	8202	23243,83696,149111	ANKRD28,TRAPPC9,CNIH3
R-HSA-453279	Mitotic G1-G1/S phases	0.660087880826396	-0.415382300058443	135	6	0.0148514851485149	404	8202	5682,5520,902,7029,4171,1021	PSMA1,PPP2R2A,CCNH,TFDP2,MCM2,CDK6
R-HSA-5358351	Signaling by Hedgehog	0.660087880826396	-0.415382300058443	135	6	0.0148514851485149	404	8202	5682,5577,2736,409,55764,55733	PSMA1,PRKAR2B,GLI2,ARRB2,IFT122,HHAT
R-HSA-4086400	PCP/CE pathway	0.662459812241282	-0.411795383729574	91	4	0.0099009900990099	404	8202	5682,4919,409,6259	PSMA1,ROR1,ARRB2,RYK
R-HSA-166058	MyD88:Mal cascade initiated on plasma membrane	0.670892525288703	-0.399146325794926	92	4	0.0099009900990099	404	8202	5599,6196,9252,4208	MAPK8,RPS6KA2,RPS6KA5,MEF2C
R-HSA-168188	Toll Like Receptor TLR6:TLR2 Cascade	0.670892525288703	-0.399146325794926	92	4	0.0099009900990099	404	8202	5599,6196,9252,4208	MAPK8,RPS6KA2,RPS6KA5,MEF2C
R-HSA-181438	Toll Like Receptor 2 (TLR2) Cascade	0.670892525288703	-0.399146325794926	92	4	0.0099009900990099	404	8202	5599,6196,9252,4208	MAPK8,RPS6KA2,RPS6KA5,MEF2C
R-HSA-168179	Toll Like Receptor TLR1:TLR2 Cascade	0.670892525288703	-0.399146325794926	92	4	0.0099009900990099	404	8202	5599,6196,9252,4208	MAPK8,RPS6KA2,RPS6KA5,MEF2C
R-HSA-5423646	Aflatoxin activation and detoxification	0.671328970895834	-0.398495992561918	22	1	0.00247524752475248	404	8202	1800	DPEP1
R-HSA-5205685	Pink/Parkin Mediated Mitophagy	0.671328970895834	-0.398495992561918	22	1	0.00247524752475248	404	8202	9140	ATG12
R-HSA-392170	ADP signalling through P2Y purinoceptor 12	0.671328970895834	-0.398495992561918	22	1	0.00247524752475248	404	8202	2792	GNGT1
R-HSA-110373	Resolution of AP sites via the multiple-nucleotide patch replacement pathway	0.671328970895834	-0.398495992561918	22	1	0.00247524752475248	404	8202	5984	RFC4
R-HSA-5655332	Signaling by FGFR3 in disease	0.671328970895834	-0.398495992561918	22	1	0.00247524752475248	404	8202	2247	FGF2
R-HSA-5205647	Mitophagy	0.671328970895834	-0.398495992561918	22	1	0.00247524752475248	404	8202	9140	ATG12
R-HSA-2892247	POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation	0.671328970895834	-0.398495992561918	22	1	0.00247524752475248	404	8202	2247	FGF2
R-HSA-166208	mTORC1-mediated signalling	0.671328970895834	-0.398495992561918	22	1	0.00247524752475248	404	8202	1978	EIF4EBP1
R-HSA-389513	CTLA4 inhibitory signaling	0.671328970895834	-0.398495992561918	22	1	0.00247524752475248	404	8202	2534	FYN
R-HSA-556833	Metabolism of lipids and lipoproteins	0.6727112490933	-0.396439091787286	628	29	0.0717821782178218	404	8202	7296,5563,5096,3339,79718,5095,56895,259230,30849,857,5291,5305,23175,80270,57761,1490,57834,622,406,25937,1800,5742,8309,6907,5337,949,9575,11343,8398	TXNRD1,PRKAA2,PCCB,HSPG2,TBL1XR1,PCCA,AGPAT4,SGMS1,PIK3R4,CAV1,PIK3CB,PIP4K2A,LPIN1,HSD3B7,TRIB3,CTGF,CYP4F11,BDH1,ARNTL,WWTR1,DPEP1,PTGS1,ACOX2,TBL1X,PLD1,SCARB1,CLOCK,MGLL,PLA2G6
R-HSA-446203	Asparagine N-linked glycosylation	0.674427710476965	-0.39389078405653	181	8	0.0198019801980198	404	8202	23243,10195,6184,83696,149111,6480,55757,4249	ANKRD28,ALG3,RPN1,TRAPPC9,CNIH3,ST6GAL1,UGGT2,MGAT5
R-HSA-400508	Incretin synthesis, secretion, and inactivation	0.68756162319395	-0.374603819721619	23	1	0.00247524752475248	404	8202	1803	DPP4
R-HSA-1482839	Acyl chain remodelling of PE	0.68756162319395	-0.374603819721619	23	1	0.00247524752475248	404	8202	8398	PLA2G6
R-HSA-2173795	Downregulation of SMAD2/3:SMAD4 transcriptional activity	0.68756162319395	-0.374603819721619	23	1	0.00247524752475248	404	8202	6498	SKIL
R-HSA-5696397	Gap-filling DNA repair synthesis and ligation in GG-NER	0.68756162319395	-0.374603819721619	23	1	0.00247524752475248	404	8202	5984	RFC4
R-HSA-167242	Abortive elongation of HIV-1 transcript in the absence of Tat	0.68756162319395	-0.374603819721619	23	1	0.00247524752475248	404	8202	22916	NCBP2
R-HSA-428930	Thromboxane signalling through TP receptor	0.68756162319395	-0.374603819721619	23	1	0.00247524752475248	404	8202	2792	GNGT1
R-HSA-75067	Processing of Capped Intronless Pre-mRNA	0.68756162319395	-0.374603819721619	23	1	0.00247524752475248	404	8202	22916	NCBP2
R-HSA-112409	RAF-independent MAPK1/3 activation	0.68756162319395	-0.374603819721619	23	1	0.00247524752475248	404	8202	1852	DUSP9
R-HSA-174417	Telomere C-strand (Lagging Strand) Synthesis	0.68756162319395	-0.374603819721619	23	1	0.00247524752475248	404	8202	5984	RFC4
R-HSA-5620922	BBSome-mediated cargo-targeting to cilium	0.68756162319395	-0.374603819721619	23	1	0.00247524752475248	404	8202	92482	BBIP1
R-HSA-392451	G beta:gamma signalling through PI3Kgamma	0.692220425388556	-0.367850840287095	48	2	0.00495049504950495	404	8202	5291,2792	PIK3CB,GNGT1
R-HSA-1640170	Cell Cycle	0.697410182961095	-0.360381543526429	572	26	0.0643564356435644	404	8202	5984,902,80321,10274,5682,5520,5577,9656,4171,3364,23175,23225,9577,8607,22981,10806,51720,165918,545,80254,7029,7840,1021,81929,10051,7277	RFC4,CCNH,CEP70,STAG1,PSMA1,PPP2R2A,PRKAR2B,MDC1,MCM2,HUS1,LPIN1,NUP210,BRE,RUVBL1,NINL,SDCCAG8,UIMC1,RNF168,ATR,CEP63,TFDP2,ALMS1,CDK6,SEH1L,SMC4,TUBA4A
R-HSA-977606	Regulation of Complement cascade	0.702994451678916	-0.352406279551242	24	1	0.00247524752475248	404	8202	1604	CD55
R-HSA-73848	Pyrimidine metabolism	0.702994451678916	-0.352406279551242	24	1	0.00247524752475248	404	8202	7378	UPP1
R-HSA-5365859	RA biosynthesis pathway	0.702994451678916	-0.352406279551242	24	1	0.00247524752475248	404	8202	8608	RDH16
R-HSA-211733	Regulation of activated PAK-2p34 by proteasome mediated degradation	0.703088156628916	-0.35227299442335	49	2	0.00495049504950495	404	8202	5682,5062	PSMA1,PAK2
R-HSA-937061	TRIF-mediated TLR3/TLR4 signaling	0.710863680762488	-0.341274596446618	97	4	0.0099009900990099	404	8202	5599,6196,9252,4208	MAPK8,RPS6KA2,RPS6KA5,MEF2C
R-HSA-166166	MyD88-independent TLR3/TLR4 cascade	0.710863680762488	-0.341274596446618	97	4	0.0099009900990099	404	8202	5599,6196,9252,4208	MAPK8,RPS6KA2,RPS6KA5,MEF2C
R-HSA-168164	Toll Like Receptor 3 (TLR3) Cascade	0.710863680762488	-0.341274596446618	97	4	0.0099009900990099	404	8202	5599,6196,9252,4208	MAPK8,RPS6KA2,RPS6KA5,MEF2C
R-HSA-3214847	HATs acetylate histones	0.713598909073623	-0.337434226482048	143	6	0.0148514851485149	404	8202	8464,55167,9575,8607,86,55689	SUPT3H,MSL2,CLOCK,RUVBL1,ACTL6A,YEATS2
R-HSA-169911	Regulation of Apoptosis	0.713635280041561	-0.337383259418305	50	2	0.00495049504950495	404	8202	5682,5062	PSMA1,PAK2
R-HSA-977068	Termination of O-glycan biosynthesis	0.717666772738595	-0.331749922484787	25	1	0.00247524752475248	404	8202	6480	ST6GAL1
R-HSA-1482788	Acyl chain remodelling of PC	0.717666772738595	-0.331749922484787	25	1	0.00247524752475248	404	8202	8398	PLA2G6
R-HSA-1538133	G0 and Early G1	0.717666772738595	-0.331749922484787	25	1	0.00247524752475248	404	8202	7029	TFDP2
R-HSA-425410	Metal ion SLC transporters	0.717666772738595	-0.331749922484787	25	1	0.00247524752475248	404	8202	64116	SLC39A8
R-HSA-982772	Growth hormone receptor signaling	0.717666772738595	-0.331749922484787	25	1	0.00247524752475248	404	8202	8660	IRS2
R-HSA-418592	ADP signalling through P2Y purinoceptor 1	0.717666772738595	-0.331749922484787	25	1	0.00247524752475248	404	8202	2792	GNGT1
R-HSA-2262749	Cellular response to hypoxia	0.717666772738595	-0.331749922484787	25	1	0.00247524752475248	404	8202	7422	VEGFA
R-HSA-1234174	Regulation of Hypoxia-inducible Factor (HIF) by oxygen	0.717666772738595	-0.331749922484787	25	1	0.00247524752475248	404	8202	7422	VEGFA
R-HSA-166016	Toll Like Receptor 4 (TLR4) Cascade	0.718229486282119	-0.330966142223788	121	5	0.0123762376237624	404	8202	5599,6196,9252,3684,4208	MAPK8,RPS6KA2,RPS6KA5,ITGAM,MEF2C
R-HSA-2187338	Visual phototransduction	0.71841841926991	-0.330703123027296	98	4	0.0099009900990099	404	8202	8630,3339,8608,2792	HSD17B6,HSPG2,RDH16,GNGT1
R-HSA-383280	Nuclear Receptor transcription pathway	0.723866925492086	-0.323147708059493	51	2	0.00495049504950495	404	8202	3164,7182	NR4A1,NR2C2
R-HSA-1793185	Chondroitin sulfate/dermatan sulfate metabolism	0.723866925492086	-0.323147708059493	51	2	0.00495049504950495	404	8202	29940,3339	DSE,HSPG2
R-HSA-5610787	Hedgehog 'off' state	0.725827063635513	-0.320443496891303	99	4	0.0099009900990099	404	8202	5682,5577,2736,55764	PSMA1,PRKAR2B,GLI2,IFT122
R-HSA-5621481	C-type lectin receptors (CLRs)	0.731544872528511	-0.312596717233843	123	5	0.0123762376237624	404	8202	5682,5530,2534,9252,5062	PSMA1,PPP3CA,FYN,RPS6KA5,PAK2
R-HSA-3560782	Diseases associated with glycosaminoglycan metabolism	0.731615974622514	-0.312499527517214	26	1	0.00247524752475248	404	8202	3339	HSPG2
R-HSA-5693554	Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA)	0.731615974622514	-0.312499527517214	26	1	0.00247524752475248	404	8202	7486	WRN
R-HSA-3781865	Diseases of glycosylation	0.731615974622514	-0.312499527517214	26	1	0.00247524752475248	404	8202	3339	HSPG2
R-HSA-1606322	ZBP1(DAI) mediated induction of type I IFNs	0.731615974622514	-0.312499527517214	26	1	0.00247524752475248	404	8202	340061	TMEM173
R-HSA-1971475	A tetrasaccharide linker sequence is required for GAG synthesis	0.731615974622514	-0.312499527517214	26	1	0.00247524752475248	404	8202	3339	HSPG2
R-HSA-5654699	SHC-mediated cascade:FGFR2	0.731615974622514	-0.312499527517214	26	1	0.00247524752475248	404	8202	2247	FGF2
R-HSA-77387	Insulin receptor recycling	0.731615974622514	-0.312499527517214	26	1	0.00247524752475248	404	8202	90423	ATP6V1E2
R-HSA-5357956	TNFR1-induced NFkappaB signaling pathway	0.731615974622514	-0.312499527517214	26	1	0.00247524752475248	404	8202	10616	RBCK1
R-HSA-195721	Signaling by Wnt	0.741373025013627	-0.29925137277739	326	14	0.0346534653465347	404	8202	5530,8607,7090,2792,6259,5682,857,4919,26108,409,23236,5330,22943,59352	PPP3CA,RUVBL1,TLE3,GNGT1,RYK,PSMA1,CAV1,ROR1,PYGO1,ARRB2,PLCB1,PLCB2,DKK1,LGR6
R-HSA-69242	S Phase	0.74440008744911	-0.295176636738082	125	5	0.0123762376237624	404	8202	5682,5984,902,10274,4171	PSMA1,RFC4,CCNH,STAG1,MCM2
R-HSA-389957	Prefoldin mediated transfer of substrate  to CCT/TriC	0.744877611878951	-0.294535353455023	27	1	0.00247524752475248	404	8202	7277	TUBA4A
R-HSA-5655253	Signaling by FGFR2 in disease	0.744877611878951	-0.294535353455023	27	1	0.00247524752475248	404	8202	2247	FGF2
R-HSA-400685	Sema4D in semaphorin signaling	0.744877611878951	-0.294535353455023	27	1	0.00247524752475248	404	8202	4233	MET
R-HSA-211859	Biological oxidations	0.746782737142986	-0.291980983351714	194	8	0.0198019801980198	404	8202	217,57834,25830,5742,1800,6820,4129,4144	ALDH2,CYP4F11,SULT4A1,PTGS1,DPEP1,SULT2B1,MAOB,MAT2A
R-HSA-168256	Immune System	0.751945204156619	-0.285091824500219	1371	63	0.155940594059406	404	8202	5599,9208,6712,200734,1958,3684,5922,1950,5646,30849,90423,8672,9542,5027,3606,4842,9252,2309,10666,8411,9965,5581,10225,23225,6196,5062,79876,7220,8398,81929,10152,5530,1604,10616,8831,92369,2247,3164,7879,1974,7328,5682,1852,9140,283455,5577,5291,7462,3669,8660,57761,2534,3840,29927,644150,84166,5337,409,3903,170506,340061,945,4208	MAPK8,LRRFIP1,SPTBN2,SPRED2,EGR1,ITGAM,RASA2,EGF,PRSS3,PIK3R4,ATP6V1E2,EIF4G3,NRG2,P2RX7,IL18,NOS1,RPS6KA5,FOXO3,CD226,EEA1,FGF19,PRKCE,CD96,NUP210,RPS6KA2,PAK2,UBA5,TRPC1,PLA2G6,SEH1L,ABI2,PPP3CA,CD55,RBCK1,SYNGAP1,SPSB4,FGF2,NR4A1,RAB7A,EIF4A2,UBE2H,PSMA1,DUSP9,ATG12,KSR2,PRKAR2B,PIK3CB,LAT2,ISG20,IRS2,TRIB3,FYN,KPNA4,SEC61A1,WIPF3,NLRC5,PLD1,ARRB2,LAIR1,DHX36,TMEM173,CD33,MEF2C
R-HSA-114604	GPVI-mediated activation cascade	0.75272415727285	-0.284056443298494	54	2	0.00495049504950495	404	8202	2534,5291	FYN,PIK3CB
R-HSA-1655829	Regulation of cholesterol biosynthesis by SREBP (SREBF)	0.75272415727285	-0.284056443298494	54	2	0.00495049504950495	404	8202	6907,79718	TBL1X,TBL1XR1
R-HSA-432722	Golgi Associated Vesicle Biogenesis	0.75272415727285	-0.284056443298494	54	2	0.00495049504950495	404	8202	152503,7037	SH3D19,TFRC
R-HSA-162599	Late Phase of HIV Life Cycle	0.756797375066108	-0.278659729714929	127	5	0.0123762376237624	404	8202	22916,23225,902,8731,81929	NCBP2,NUP210,CCNH,RNMT,SEH1L
R-HSA-162909	Host Interactions of HIV factors	0.756797375066108	-0.278659729714929	127	5	0.0123762376237624	404	8202	5682,2534,23225,81929,5062	PSMA1,FYN,NUP210,SEH1L,PAK2
R-HSA-110314	Recognition of DNA damage by PCNA-containing replication complex	0.757485495039751	-0.277750890244322	28	1	0.00247524752475248	404	8202	5984	RFC4
R-HSA-76071	RNA Polymerase III Transcription Initiation From Type 3 Promoter	0.757485495039751	-0.277750890244322	28	1	0.00247524752475248	404	8202	10302	SNAPC5
R-HSA-389958	Cooperation of Prefoldin and TriC/CCT  in actin and tubulin folding	0.757485495039751	-0.277750890244322	28	1	0.00247524752475248	404	8202	7277	TUBA4A
R-HSA-111933	Calmodulin induced events	0.757485495039751	-0.277750890244322	28	1	0.00247524752475248	404	8202	5577	PRKAR2B
R-HSA-111997	CaM pathway	0.757485495039751	-0.277750890244322	28	1	0.00247524752475248	404	8202	5577	PRKAR2B
R-HSA-380972	Energy dependent regulation of mTOR by LKB1-AMPK	0.757485495039751	-0.277750890244322	28	1	0.00247524752475248	404	8202	5563	PRKAA2
R-HSA-977443	GABA receptor activation	0.761750082264561	-0.272136753122152	55	2	0.00495049504950495	404	8202	2550,2792	GABBR1,GNGT1
R-HSA-6784531	tRNA processing in the nucleus	0.761750082264561	-0.272136753122152	55	2	0.00495049504950495	404	8202	23225,81929	NUP210,SEH1L
R-HSA-168928	RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways	0.769196746902399	-0.262408494472505	81	3	0.00742574257425743	404	8202	9140,170506,84166	ATG12,DHX36,NLRC5
R-HSA-1912408	Pre-NOTCH Transcription and Translation	0.769471775935087	-0.262051004822804	29	1	0.00247524752475248	404	8202	7029	TFDP2
R-HSA-445355	Smooth Muscle Contraction	0.769471775935087	-0.262051004822804	29	1	0.00247524752475248	404	8202	4638	MYLK
R-HSA-5654732	Negative regulation of FGFR3 signaling	0.769471775935087	-0.262051004822804	29	1	0.00247524752475248	404	8202	2247	FGF2
R-HSA-3299685	Detoxification of Reactive Oxygen Species	0.769471775935087	-0.262051004822804	29	1	0.00247524752475248	404	8202	7296	TXNRD1
R-HSA-442742	CREB phosphorylation through the activation of Ras	0.769471775935087	-0.262051004822804	29	1	0.00247524752475248	404	8202	6196	RPS6KA2
R-HSA-72662	Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S	0.770489537365403	-0.260729203333756	56	2	0.00495049504950495	404	8202	1978,1974	EIF4EBP1,EIF4A2
R-HSA-399719	Trafficking of AMPA receptors	0.780867028903418	-0.247350401123923	30	1	0.00247524752475248	404	8202	1739	DLG1
R-HSA-111996	Ca-dependent events	0.780867028903418	-0.247350401123923	30	1	0.00247524752475248	404	8202	5577	PRKAR2B
R-HSA-5656169	Termination of translesion DNA synthesis	0.780867028903418	-0.247350401123923	30	1	0.00247524752475248	404	8202	5984	RFC4
R-HSA-420092	Glucagon-type ligand receptors	0.780867028903418	-0.247350401123923	30	1	0.00247524752475248	404	8202	2792	GNGT1
R-HSA-2871809	FCERI mediated Ca+2 mobilization	0.780867028903418	-0.247350401123923	30	1	0.00247524752475248	404	8202	5530	PPP3CA
R-HSA-68962	Activation of the pre-replicative complex	0.780867028903418	-0.247350401123923	30	1	0.00247524752475248	404	8202	4171	MCM2
R-HSA-399721	Glutamate Binding, Activation of AMPA Receptors and Synaptic Plasticity	0.780867028903418	-0.247350401123923	30	1	0.00247524752475248	404	8202	1739	DLG1
R-HSA-5419276	Mitochondrial translation termination	0.790180296644856	-0.23549413595903	84	3	0.00742574257425743	404	8202	56945,11222,57129	MRPS22,MRPL3,MRPL47
R-HSA-5632684	Hedgehog 'on' state	0.790180296644856	-0.23549413595903	84	3	0.00742574257425743	404	8202	5682,2736,409	PSMA1,GLI2,ARRB2
R-HSA-5368286	Mitochondrial translation initiation	0.790180296644856	-0.23549413595903	84	3	0.00742574257425743	404	8202	56945,11222,57129	MRPS22,MRPL3,MRPL47
R-HSA-70263	Gluconeogenesis	0.791700328007016	-0.233572332497627	31	1	0.00247524752475248	404	8202	5106	PCK2
R-HSA-4641262	Disassembly of the destruction complex and recruitment of AXIN to the membrane	0.791700328007016	-0.233572332497627	31	1	0.00247524752475248	404	8202	857	CAV1
R-HSA-73772	RNA Polymerase I Promoter Escape	0.791700328007016	-0.233572332497627	31	1	0.00247524752475248	404	8202	902	CCNH
R-HSA-70171	Glycolysis	0.791700328007016	-0.233572332497627	31	1	0.00247524752475248	404	8202	3099	HK2
R-HSA-5357905	Regulation of TNFR1 signaling	0.791700328007016	-0.233572332497627	31	1	0.00247524752475248	404	8202	10616	RBCK1
R-HSA-5696398	Nucleotide Excision Repair	0.792039083934266	-0.233144539983452	109	4	0.0099009900990099	404	8202	5984,902,8607,86	RFC4,CCNH,RUVBL1,ACTL6A
R-HSA-5610783	Degradation of GLI2 by the proteasome	0.795051876316047	-0.229347913228972	59	2	0.00495049504950495	404	8202	5682,2736	PSMA1,GLI2
R-HSA-1280215	Cytokine Signaling in Immune system	0.795562262499783	-0.228706165882714	539	23	0.0569306930693069	404	8202	6712,200734,8831,1958,2247,5922,1974,1950,1852,5682,8672,9542,283455,3606,5291,9965,3669,8660,2534,23225,3840,409,81929	SPTBN2,SPRED2,SYNGAP1,EGR1,FGF2,RASA2,EIF4A2,EGF,DUSP9,PSMA1,EIF4G3,NRG2,KSR2,IL18,PIK3CB,FGF19,ISG20,IRS2,FYN,NUP210,KPNA4,ARRB2,SEH1L
R-HSA-392518	Signal amplification	0.801999320482462	-0.220647518394707	32	1	0.00247524752475248	404	8202	2792	GNGT1
R-HSA-202433	Generation of second messenger molecules	0.801999320482462	-0.220647518394707	32	1	0.00247524752475248	404	8202	5062	PAK2
R-HSA-1980145	Signaling by NOTCH2	0.801999320482462	-0.220647518394707	32	1	0.00247524752475248	404	8202	3714	JAG2
R-HSA-5654726	Negative regulation of FGFR1 signaling	0.801999320482462	-0.220647518394707	32	1	0.00247524752475248	404	8202	2247	FGF2
R-HSA-73863	RNA Polymerase I Transcription Termination	0.801999320482462	-0.220647518394707	32	1	0.00247524752475248	404	8202	902	CCNH
R-HSA-446728	Cell junction organization	0.803272165963309	-0.219061686018879	86	3	0.00742574257425743	404	8202	56288,5584,3914	PARD3,PRKCI,LAMB3
R-HSA-2980736	Peptide hormone metabolism	0.803272165963309	-0.219061686018879	86	3	0.00742574257425743	404	8202	3800,1803,60412	KIF5C,DPP4,EXOC4
R-HSA-3371556	Cellular response to heat stress	0.803272165963309	-0.219061686018879	86	3	0.00742574257425743	404	8202	545,23225,81929	ATR,NUP210,SEH1L
R-HSA-109581	Apoptosis	0.807240818344162	-0.214133243401423	160	6	0.0148514851485149	404	8202	5682,5599,90249,5366,9500,5062	PSMA1,MAPK8,UNC5A,PMAIP1,MAGED1,PAK2
R-HSA-166054	Activated TLR4 signalling	0.809212590433881	-0.211693614697032	112	4	0.0099009900990099	404	8202	5599,6196,9252,4208	MAPK8,RPS6KA2,RPS6KA5,MEF2C
R-HSA-72737	Cap-dependent Translation Initiation	0.809212590433881	-0.211693614697032	112	4	0.0099009900990099	404	8202	6165,8893,1978,1974	RPL35A,EIF2B5,EIF4EBP1,EIF4A2
R-HSA-72613	Eukaryotic Translation Initiation	0.809212590433881	-0.211693614697032	112	4	0.0099009900990099	404	8202	6165,8893,1978,1974	RPL35A,EIF2B5,EIF4EBP1,EIF4A2
R-HSA-201722	Formation of the beta-catenin:TCF transactivating complex	0.809557296906541	-0.211267727755885	87	3	0.00742574257425743	404	8202	26108,8607,7090	PYGO1,RUVBL1,TLE3
R-HSA-421270	Cell-cell junction organization	0.810110576399791	-0.210584526559035	61	2	0.00495049504950495	404	8202	56288,5584	PARD3,PRKCI
R-HSA-2029482	Regulation of actin dynamics for phagocytic cup formation	0.810110576399791	-0.210584526559035	61	2	0.00495049504950495	404	8202	10152,644150	ABI2,WIPF3
R-HSA-73847	Purine metabolism	0.81179029655476	-0.20851322764858	33	1	0.00247524752475248	404	8202	8833	GMPS
R-HSA-933541	TRAF6 mediated IRF7 activation	0.81179029655476	-0.20851322764858	33	1	0.00247524752475248	404	8202	170506	DHX36
R-HSA-5693568	Resolution of D-loop Structures through Holliday Junction Intermediates	0.81179029655476	-0.20851322764858	33	1	0.00247524752475248	404	8202	7486	WRN
R-HSA-4085001	Sialic acid metabolism	0.81179029655476	-0.20851322764858	33	1	0.00247524752475248	404	8202	6480	ST6GAL1
R-HSA-5694530	Cargo concentration in the ER	0.81179029655476	-0.20851322764858	33	1	0.00247524752475248	404	8202	149111	CNIH3
R-HSA-163359	Glucagon signaling in metabolic regulation	0.81179029655476	-0.20851322764858	33	1	0.00247524752475248	404	8202	5577	PRKAR2B
R-HSA-72187	mRNA 3'-end processing	0.81179029655476	-0.20851322764858	33	1	0.00247524752475248	404	8202	22916	NCBP2
R-HSA-1445148	Translocation of GLUT4 to the plasma membrane	0.81726435671227	-0.201792666432367	62	2	0.00495049504950495	404	8202	5563,60412	PRKAA2,EXOC4
R-HSA-5663205	Infectious disease	0.817407889487659	-0.201617055968446	347	14	0.0346534653465347	404	8202	7296,118429,6165,2534,3840,23225,902,8731,5062,5682,22916,6857,84168,81929	TXNRD1,ANTXR2,RPL35A,FYN,KPNA4,NUP210,CCNH,RNMT,PAK2,PSMA1,NCBP2,SYT1,ANTXR1,SEH1L
R-HSA-5663220	RHO GTPases Activate Formins	0.820007967481946	-0.198441222329646	114	4	0.0099009900990099	404	8202	81624,5217,114793,81929	DIAPH3,PFN2,FMNL2,SEH1L
R-HSA-5357801	Programmed Cell Death	0.820999668202318	-0.197232573668259	163	6	0.0148514851485149	404	8202	5682,5599,90249,5366,9500,5062	PSMA1,MAPK8,UNC5A,PMAIP1,MAGED1,PAK2
R-HSA-390522	Striated Muscle Contraction	0.821098255945631	-0.197112498315891	34	1	0.00247524752475248	404	8202	7273	TTN
R-HSA-4791275	Signaling by WNT in cancer	0.821098255945631	-0.197112498315891	34	1	0.00247524752475248	404	8202	22943	DKK1
R-HSA-5654727	Negative regulation of FGFR2 signaling	0.821098255945631	-0.197112498315891	34	1	0.00247524752475248	404	8202	2247	FGF2
R-HSA-5693537	Resolution of D-Loop Structures	0.821098255945631	-0.197112498315891	34	1	0.00247524752475248	404	8202	7486	WRN
R-HSA-2514859	Inactivation, recovery and regulation of the phototransduction cascade	0.821098255945631	-0.197112498315891	34	1	0.00247524752475248	404	8202	2792	GNGT1
R-HSA-6782210	Gap-filling DNA repair synthesis and ligation in TC-NER	0.824176325598045	-0.19337078458843	63	2	0.00495049504950495	404	8202	5984,902	RFC4,CCNH
R-HSA-198933	Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell	0.825214655420084	-0.192111738102604	115	4	0.0099009900990099	404	8202	10225,3903,10666,945	CD96,LAIR1,CD226,CD33
R-HSA-162587	HIV Life Cycle	0.826567717333348	-0.190473432429626	140	5	0.0123762376237624	404	8202	22916,23225,902,8731,81929	NCBP2,NUP210,CCNH,RNMT,SEH1L
R-HSA-2514856	The phototransduction cascade	0.829946971009012	-0.186393470583156	35	1	0.00247524752475248	404	8202	2792	GNGT1
R-HSA-76046	RNA Polymerase III Transcription Initiation	0.829946971009012	-0.186393470583156	35	1	0.00247524752475248	404	8202	10302	SNAPC5
R-HSA-5358346	Hedgehog ligand biogenesis	0.830852876785192	-0.185302543380547	64	2	0.00495049504950495	404	8202	5682,55733	PSMA1,HHAT
R-HSA-6782135	Dual incision in TC-NER	0.830852876785192	-0.185302543380547	64	2	0.00495049504950495	404	8202	5984,902	RFC4,CCNH
R-HSA-1236974	ER-Phagosome pathway	0.830852876785192	-0.185302543380547	64	2	0.00495049504950495	404	8202	5682,29927	PSMA1,SEC61A1
R-HSA-1430728	Metabolism	0.837095526926296	-0.177817084866067	1691	76	0.188118811881188	404	8202	384,349565,57128,3339,91942,4711,56922,2992,2639,9435,7957,23175,23225,440,90161,1490,775,57834,60490,8309,4129,11343,6820,81929,10057,7378,5577,857,4144,80270,23007,406,25937,949,9575,266722,84706,5563,115677,2792,5646,259230,30849,29940,26227,5305,2644,622,8833,5742,85007,776,5106,5330,6812,8398,7296,5096,217,29968,594,79718,56895,5095,25830,5682,23236,5291,131870,57761,3099,5332,1800,5337,6907,10331	ARG2,NMNAT3,LYRM4,HSPG2,NDUFAF2,NDUFB5,MCCC1,GYG1,GCDH,CHST2,EPM2A,LPIN1,NUP210,ASNS,HS6ST2,CTGF,CACNA1C,CYP4F11,PPCDC,ACOX2,MAOB,MGLL,SULT2B1,SEH1L,ABCC5,UPP1,PRKAR2B,CAV1,MAT2A,HSD3B7,PLCH1,ARNTL,WWTR1,SCARB1,CLOCK,HS6ST3,GPT2,PRKAA2,NOSTRIN,GNGT1,PRSS3,SGMS1,PIK3R4,DSE,PHGDH,PIP4K2A,GCHFR,BDH1,GMPS,PTGS1,PHYKPL,CACNA1D,PCK2,PLCB2,STXBP1,PLA2G6,TXNRD1,PCCB,ALDH2,PSAT1,BCKDHB,TBL1XR1,AGPAT4,PCCA,SULT4A1,PSMA1,PLCB1,PIK3CB,NUDT16,TRIB3,HK2,PLCB4,DPEP1,PLD1,TBL1X,B3GNT3
R-HSA-69202	Cyclin E associated events during G1/S transition	0.83730036241579	-0.177572416933208	65	2	0.00495049504950495	404	8202	5682,902	PSMA1,CCNH
R-HSA-674695	RNA Polymerase II Pre-transcription Events	0.83730036241579	-0.177572416933208	65	2	0.00495049504950495	404	8202	22916,902	NCBP2,CCNH
R-HSA-397014	Muscle contraction	0.83730036241579	-0.177572416933208	65	2	0.00495049504950495	404	8202	7273,4638	TTN,MYLK
R-HSA-1660661	Sphingolipid de novo biosynthesis	0.838359046872164	-0.176308813373473	36	1	0.00247524752475248	404	8202	259230	SGMS1
R-HSA-69656	Cyclin A:Cdk2-associated events at S phase entry	0.843525081642569	-0.170165642236573	66	2	0.00495049504950495	404	8202	5682,902	PSMA1,CCNH
R-HSA-2559580	Oxidative Stress Induced Senescence	0.84481012142019	-0.168643385254148	119	4	0.0099009900990099	404	8202	5599,22955,80012,1021	MAPK8,SCMH1,PHC3,CDK6
R-HSA-110313	Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template	0.846355978683051	-0.16681522929323	37	1	0.00247524752475248	404	8202	5984	RFC4
R-HSA-504046	RNA Polymerase I, RNA Polymerase III, and Mitochondrial Transcription	0.848696746339931	-0.164053345712533	145	5	0.0123762376237624	404	8202	4782,902,10302,4774,4784	NFIC,CCNH,SNAPC5,NFIA,NFIX
R-HSA-913531	Interferon Signaling	0.849071531774661	-0.163611842068427	194	7	0.0173267326732673	404	8202	8672,3840,23225,1958,81929,1974,3669	EIF4G3,KPNA4,NUP210,EGR1,SEH1L,EIF4A2,ISG20
R-HSA-68867	Assembly of the pre-replicative complex	0.849533270490873	-0.16306817384499	67	2	0.00495049504950495	404	8202	5682,4171	PSMA1,MCM2
R-HSA-446193	Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein	0.849533270490873	-0.16306817384499	67	2	0.00495049504950495	404	8202	10195,6480	ALG3,ST6GAL1
R-HSA-425397	Transport of vitamins, nucleosides, and related molecules	0.853958205826553	-0.157873025704304	38	1	0.00247524752475248	404	8202	9197	SLC33A1
R-HSA-166658	Complement cascade	0.853958205826553	-0.157873025704304	38	1	0.00247524752475248	404	8202	1604	CD55
R-HSA-75109	Triglyceride Biosynthesis	0.855331092701031	-0.156266642079385	68	2	0.00495049504950495	404	8202	56895,23175	AGPAT4,LPIN1
R-HSA-909733	Interferon alpha/beta signaling	0.855331092701031	-0.156266642079385	68	2	0.00495049504950495	404	8202	1958,3669	EGR1,ISG20
R-HSA-162906	HIV Infection	0.859325302912213	-0.151607729137897	221	8	0.0198019801980198	404	8202	2534,23225,902,8731,5062,5682,22916,81929	FYN,NUP210,CCNH,RNMT,PAK2,PSMA1,NCBP2,SEH1L
R-HSA-69278	Cell Cycle, Mitotic	0.863541845183171	-0.14671292260062	477	19	0.047029702970297	404	8202	5984,902,80321,10274,5682,5520,5577,4171,23175,23225,22981,10806,80254,7029,7840,1021,81929,10051,7277	RFC4,CCNH,CEP70,STAG1,PSMA1,PPP2R2A,PRKAR2B,MCM2,LPIN1,NUP210,NINL,SDCCAG8,CEP63,TFDP2,ALMS1,CDK6,SEH1L,SMC4,TUBA4A
R-HSA-68949	Orc1 removal from chromatin	0.866319884173632	-0.143501057361311	70	2	0.00495049504950495	404	8202	5682,4171	PSMA1,MCM2
R-HSA-69052	Switching of origins to a post-replicative state	0.866319884173632	-0.143501057361311	70	2	0.00495049504950495	404	8202	5682,4171	PSMA1,MCM2
R-HSA-421837	Clathrin derived vesicle budding	0.866319884173632	-0.143501057361311	70	2	0.00495049504950495	404	8202	152503,7037	SH3D19,TFRC
R-HSA-199992	trans-Golgi Network Vesicle Budding	0.866319884173632	-0.143501057361311	70	2	0.00495049504950495	404	8202	152503,7037	SH3D19,TFRC
R-HSA-1251985	Nuclear signaling by ERBB4	0.868055333313112	-0.141499818297027	40	1	0.00247524752475248	404	8202	9542	NRG2
R-HSA-5675221	Negative regulation of MAPK pathway	0.868055333313112	-0.141499818297027	40	1	0.00247524752475248	404	8202	1852	DUSP9
R-HSA-5696400	Dual Incision in GG-NER	0.868055333313112	-0.141499818297027	40	1	0.00247524752475248	404	8202	5984	RFC4
R-HSA-2173782	Binding and Uptake of Ligands by Scavenger Receptors	0.868055333313112	-0.141499818297027	40	1	0.00247524752475248	404	8202	949	SCARB1
R-HSA-69239	Synthesis of DNA	0.868143242248185	-0.141398552305469	98	3	0.00742574257425743	404	8202	5682,5984,4171	PSMA1,RFC4,MCM2
R-HSA-156580	Phase II conjugation	0.868143242248185	-0.141398552305469	98	3	0.00742574257425743	404	8202	6820,4144,25830	SULT2B1,MAT2A,SULT4A1
R-HSA-75893	TNF signaling	0.874586287159208	-0.134004319111818	41	1	0.00247524752475248	404	8202	10616	RBCK1
R-HSA-5620924	Intraflagellar transport	0.874586287159208	-0.134004319111818	41	1	0.00247524752475248	404	8202	55764	IFT122
R-HSA-69300	Removal of licensing factors from origins	0.876539040773784	-0.131774033942765	72	2	0.00495049504950495	404	8202	5682,4171	PSMA1,MCM2
R-HSA-73856	RNA Polymerase II Transcription Termination	0.880794734657922	-0.126930671500343	42	1	0.00247524752475248	404	8202	22916	NCBP2
R-HSA-975634	Retinoid metabolism and transport	0.880794734657922	-0.126930671500343	42	1	0.00247524752475248	404	8202	3339	HSPG2
R-HSA-109688	Cleavage of Growing Transcript in the Termination Region	0.880794734657922	-0.126930671500343	42	1	0.00247524752475248	404	8202	22916	NCBP2
R-HSA-201681	TCF dependent signaling in response to WNT	0.883632473756414	-0.123714056463227	229	8	0.0198019801980198	404	8202	8607,7090,6259,5682,26108,857,22943,59352	RUVBL1,TLE3,RYK,PSMA1,PYGO1,CAV1,DKK1,LGR6
R-HSA-69304	Regulation of DNA replication	0.89052489173176	-0.115944224108824	75	2	0.00495049504950495	404	8202	5682,4171	PSMA1,MCM2
R-HSA-1221632	Meiotic synapsis	0.89052489173176	-0.115944224108824	75	2	0.00495049504950495	404	8202	545,10274	ATR,STAG1
R-HSA-199991	Membrane Trafficking	0.89086247609722	-0.115565211238746	256	9	0.0222772277227723	404	8202	23243,5563,83696,149111,152503,60412,22820,9276,7037	ANKRD28,PRKAA2,TRAPPC9,CNIH3,SH3D19,EXOC4,COPG1,COPB2,TFRC
R-HSA-5696395	Formation of Incision Complex in GG-NER	0.892306882408642	-0.113945166995117	44	1	0.00247524752475248	404	8202	902	CCNH
R-HSA-5362517	Signaling by Retinoic Acid	0.892306882408642	-0.113945166995117	44	1	0.00247524752475248	404	8202	8608	RDH16
R-HSA-6781827	Transcription-Coupled Nucleotide Excision Repair (TC-NER)	0.89901748218057	-0.106452798447569	77	2	0.00495049504950495	404	8202	5984,902	RFC4,CCNH
R-HSA-2262752	Cellular responses to stress	0.899752598510824	-0.105635443990686	379	14	0.0346534653465347	404	8202	7296,5563,5599,6196,23225,80012,30849,9140,22955,545,7422,2113,1021,81929	TXNRD1,PRKAA2,MAPK8,RPS6KA2,NUP210,PHC3,PIK3R4,ATG12,SCMH1,ATR,VEGFA,ETS1,CDK6,SEH1L
R-HSA-927802	Nonsense-Mediated Decay (NMD)	0.900171211758443	-0.105170298463105	106	3	0.00742574257425743	404	8202	5520,6165,22916	PPP2R2A,RPL35A,NCBP2
R-HSA-975957	Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)	0.900171211758443	-0.105170298463105	106	3	0.00742574257425743	404	8202	5520,6165,22916	PPP2R2A,RPL35A,NCBP2
R-HSA-69306	DNA Replication	0.900171211758443	-0.105170298463105	106	3	0.00742574257425743	404	8202	5682,5984,4171	PSMA1,RFC4,MCM2
R-HSA-418594	G alpha (i) signalling events	0.90195727330569	-0.103188128882151	236	8	0.0198019801980198	404	8202	58191,2781,2550,2792,9628,2914,4543,23566	CXCL16,GNAZ,GABBR1,GNGT1,RGS6,GRM4,MTNR1A,LPAR3
R-HSA-73779	RNA Polymerase II Transcription Pre-Initiation And Promoter Opening	0.902709739385688	-0.102354217564094	46	1	0.00247524752475248	404	8202	902	CCNH
R-HSA-73776	RNA Polymerase II Promoter Escape	0.902709739385688	-0.102354217564094	46	1	0.00247524752475248	404	8202	902	CCNH
R-HSA-167161	HIV Transcription Initiation	0.902709739385688	-0.102354217564094	46	1	0.00247524752475248	404	8202	902	CCNH
R-HSA-76042	RNA Polymerase II Transcription Initiation And Promoter Clearance	0.902709739385688	-0.102354217564094	46	1	0.00247524752475248	404	8202	902	CCNH
R-HSA-73893	DNA Damage Bypass	0.902709739385688	-0.102354217564094	46	1	0.00247524752475248	404	8202	5984	RFC4
R-HSA-75953	RNA Polymerase II Transcription Initiation	0.902709739385688	-0.102354217564094	46	1	0.00247524752475248	404	8202	902	CCNH
R-HSA-167162	RNA Polymerase II HIV Promoter Escape	0.902709739385688	-0.102354217564094	46	1	0.00247524752475248	404	8202	902	CCNH
R-HSA-157579	Telomere Maintenance	0.903030144115329	-0.101999343934806	78	2	0.00495049504950495	404	8202	5984,8607	RFC4,RUVBL1
R-HSA-381340	Transcriptional regulation of white adipocyte differentiation	0.903030144115329	-0.101999343934806	78	2	0.00495049504950495	404	8202	6907,79718	TBL1X,TBL1XR1
R-HSA-73857	RNA Polymerase II Transcription	0.90364005656395	-0.101324165397448	107	3	0.00742574257425743	404	8202	22916,902,8731	NCBP2,CCNH,RNMT
R-HSA-2559583	Cellular Senescence	0.904914734974363	-0.0999145552187114	187	6	0.0148514851485149	404	8202	5599,22955,6196,80012,2113,1021	MAPK8,SCMH1,RPS6KA2,PHC3,ETS1,CDK6
R-HSA-68877	Mitotic Prometaphase	0.906999866234575	-0.097612976348186	108	3	0.00742574257425743	404	8202	10274,81929,10051	STAG1,SEH1L,SMC4
R-HSA-168643	Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways	0.907528923458745	-0.0970298417711348	47	1	0.00247524752475248	404	8202	5027	P2RX7
R-HSA-68875	Mitotic Prophase	0.908642011198547	-0.0958040894392075	136	4	0.0099009900990099	404	8202	23225,81929,23175,10051	NUP210,SEH1L,LPIN1,SMC4
R-HSA-69206	G1/S Transition	0.910253473288789	-0.0940321761812912	109	3	0.00742574257425743	404	8202	5682,902,4171	PSMA1,CCNH,MCM2
R-HSA-73887	Death Receptor Signalling	0.912109955326151	-0.0919947311245835	48	1	0.00247524752475248	404	8202	10616	RBCK1
R-HSA-73762	RNA Polymerase I Transcription Initiation	0.912109955326151	-0.0919947311245835	48	1	0.00247524752475248	404	8202	902	CCNH
R-HSA-611105	Respiratory electron transport	0.914193458577794	-0.0897130684614448	81	2	0.00495049504950495	404	8202	91942,4711	NDUFAF2,NDUFB5
R-HSA-1236975	Antigen processing-Cross presentation	0.914193458577794	-0.0897130684614448	81	2	0.00495049504950495	404	8202	5682,29927	PSMA1,SEC61A1
R-HSA-195253	Degradation of beta-catenin by the destruction complex	0.914193458577794	-0.0897130684614448	81	2	0.00495049504950495	404	8202	5682,7090	PSMA1,TLE3
R-HSA-390466	Chaperonin-mediated protein folding	0.91646457613178	-0.0872318636967317	49	1	0.00247524752475248	404	8202	7277	TUBA4A
R-HSA-1236978	Cross-presentation of soluble exogenous antigens (endosomes)	0.91646457613178	-0.0872318636967317	49	1	0.00247524752475248	404	8202	5682	PSMA1
R-HSA-68874	M/G1 Transition	0.917638938256903	-0.0859512791753063	82	2	0.00495049504950495	404	8202	5682,4171	PSMA1,MCM2
R-HSA-69002	DNA Replication Pre-Initiation	0.917638938256903	-0.0859512791753063	82	2	0.00495049504950495	404	8202	5682,4171	PSMA1,MCM2
R-HSA-69017	CDK-mediated phosphorylation and removal of Cdc6	0.920603949537967	-0.0827253574300901	50	1	0.00247524752475248	404	8202	5682	PSMA1
R-HSA-69229	Ubiquitin-dependent degradation of Cyclin D1	0.920603949537967	-0.0827253574300901	50	1	0.00247524752475248	404	8202	5682	PSMA1
R-HSA-72165	mRNA Splicing - Minor Pathway	0.920603949537967	-0.0827253574300901	50	1	0.00247524752475248	404	8202	22916	NCBP2
R-HSA-75815	Ubiquitin-dependent degradation of Cyclin D	0.920603949537967	-0.0827253574300901	50	1	0.00247524752475248	404	8202	5682	PSMA1
R-HSA-350562	Regulation of ornithine decarboxylase (ODC)	0.920603949537967	-0.0827253574300901	50	1	0.00247524752475248	404	8202	5682	PSMA1
R-HSA-5653656	Vesicle-mediated transport	0.920717114392262	-0.0826024404042065	294	10	0.0247524752475248	404	8202	23243,5563,83696,149111,152503,60412,949,22820,9276,7037	ANKRD28,PRKAA2,TRAPPC9,CNIH3,SH3D19,EXOC4,SCARB1,COPG1,COPB2,TFRC
R-HSA-351202	Metabolism of polyamines	0.924143881280153	-0.0788875037917188	84	2	0.00495049504950495	404	8202	5682,384	PSMA1,ARG2
R-HSA-1461973	Defensins	0.924538690005542	-0.0784603793761772	51	1	0.00247524752475248	404	8202	5646	PRSS3
R-HSA-180534	Vpu mediated degradation of CD4	0.924538690005542	-0.0784603793761772	51	1	0.00247524752475248	404	8202	5682	PSMA1
R-HSA-349425	Autodegradation of the E3 ubiquitin ligase COP1	0.924538690005542	-0.0784603793761772	51	1	0.00247524752475248	404	8202	5682	PSMA1
R-HSA-202403	TCR signaling	0.927698138046893	-0.0750488813887463	115	3	0.00742574257425743	404	8202	5682,5291,5062	PSMA1,PIK3CB,PAK2
R-HSA-1268020	Mitochondrial protein import	0.92827888987981	-0.0744230634576699	52	1	0.00247524752475248	404	8202	131118	DNAJC19
R-HSA-69613	p53-Independent G1/S DNA damage checkpoint	0.92827888987981	-0.0744230634576699	52	1	0.00247524752475248	404	8202	5682	PSMA1
R-HSA-69601	Ubiquitin Mediated Degradation of Phosphorylated Cdc25A	0.92827888987981	-0.0744230634576699	52	1	0.00247524752475248	404	8202	5682	PSMA1
R-HSA-75153	Apoptotic execution  phase	0.92827888987981	-0.0744230634576699	52	1	0.00247524752475248	404	8202	5062	PAK2
R-HSA-69541	Stabilization of p53	0.92827888987981	-0.0744230634576699	52	1	0.00247524752475248	404	8202	5682	PSMA1
R-HSA-446219	Synthesis of substrates in N-glycan biosythesis	0.92827888987981	-0.0744230634576699	52	1	0.00247524752475248	404	8202	6480	ST6GAL1
R-HSA-69610	p53-Independent DNA Damage Response	0.92827888987981	-0.0744230634576699	52	1	0.00247524752475248	404	8202	5682	PSMA1
R-HSA-180585	Vif-mediated degradation of APOBEC3G	0.93183414492355	-0.0706004362232217	53	1	0.00247524752475248	404	8202	5682	PSMA1
R-HSA-450531	Regulation of mRNA stability by proteins that bind AU-rich elements	0.933000800093097	-0.0693492205862894	87	2	0.00495049504950495	404	8202	5682,54464	PSMA1,XRN1
R-HSA-174113	SCF-beta-TrCP mediated degradation of Emi1	0.935213578650746	-0.0669803494143451	54	1	0.00247524752475248	404	8202	5682	PSMA1
R-HSA-4641257	Degradation of AXIN	0.935213578650746	-0.0669803494143451	54	1	0.00247524752475248	404	8202	5682	PSMA1
R-HSA-6781823	Formation of TC-NER Pre-Incision Complex	0.935213578650746	-0.0669803494143451	54	1	0.00247524752475248	404	8202	902	CCNH
R-HSA-977225	Amyloid formation	0.935729366885661	-0.0664289822556489	88	2	0.00495049504950495	404	8202	3339,23621	HSPG2,BACE1
R-HSA-168254	Influenza Infection	0.936365137979366	-0.0657497738967821	147	4	0.0099009900990099	404	8202	6165,3840,23225,81929	RPL35A,KPNA4,NUP210,SEH1L
R-HSA-975956	Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC)	0.938352558574064	-0.0636295385750885	89	2	0.00495049504950495	404	8202	6165,22916	RPL35A,NCBP2
R-HSA-72702	Ribosomal scanning and start codon recognition	0.938425865624119	-0.0635514184846752	55	1	0.00247524752475248	404	8202	1974	EIF4A2
R-HSA-72649	Translation initiation complex formation	0.938425865624119	-0.0635514184846752	55	1	0.00247524752475248	404	8202	1974	EIF4A2
R-HSA-391251	Protein folding	0.938425865624119	-0.0635514184846752	55	1	0.00247524752475248	404	8202	7277	TUBA4A
R-HSA-5387390	Hh mutants abrogate ligand secretion	0.938425865624119	-0.0635514184846752	55	1	0.00247524752475248	404	8202	5682	PSMA1
R-HSA-5362768	Hh mutants that don't undergo autocatalytic processing are degraded by ERAD	0.938425865624119	-0.0635514184846752	55	1	0.00247524752475248	404	8202	5682	PSMA1
R-HSA-450408	AUF1 (hnRNP D0) binds and destabilizes mRNA	0.938425865624119	-0.0635514184846752	55	1	0.00247524752475248	404	8202	5682	PSMA1
R-HSA-380108	Chemokine receptors bind chemokines	0.941479253412553	-0.0603029668021179	56	1	0.00247524752475248	404	8202	58191	CXCL16
R-HSA-187577	SCF(Skp2)-mediated degradation of p27/p21	0.941479253412553	-0.0603029668021179	56	1	0.00247524752475248	404	8202	5682	PSMA1
R-HSA-4641258	Degradation of DVL	0.941479253412553	-0.0603029668021179	56	1	0.00247524752475248	404	8202	5682	PSMA1
R-HSA-69580	p53-Dependent G1/S DNA damage checkpoint	0.944381583579744	-0.0572249746176919	57	1	0.00247524752475248	404	8202	5682	PSMA1
R-HSA-69563	p53-Dependent G1 DNA Damage Response	0.944381583579744	-0.0572249746176919	57	1	0.00247524752475248	404	8202	5682	PSMA1
R-HSA-195258	RHO GTPase Effectors	0.946579244168959	-0.0549005884681534	285	9	0.0222772277227723	404	8202	10152,644150,5062,4638,81624,5585,5217,114793,81929	ABI2,WIPF3,PAK2,MYLK,DIAPH3,PKN1,PFN2,FMNL2,SEH1L
R-HSA-68827	CDT1 association with the CDC6:ORC:origin complex	0.947140311678082	-0.0543080323805242	58	1	0.00247524752475248	404	8202	5682	PSMA1
R-HSA-5676590	NIK-->noncanonical NF-kB signaling	0.947140311678082	-0.0543080323805242	58	1	0.00247524752475248	404	8202	5682	PSMA1
R-HSA-5610785	GLI3 is processed to GLI3R by the proteasome	0.949762526056341	-0.0515432982081744	59	1	0.00247524752475248	404	8202	5682	PSMA1
R-HSA-5610780	Degradation of GLI1 by the proteasome	0.949762526056341	-0.0515432982081744	59	1	0.00247524752475248	404	8202	5682	PSMA1
R-HSA-5607761	Dectin-1 mediated noncanonical NF-kB signaling	0.949762526056341	-0.0515432982081744	59	1	0.00247524752475248	404	8202	5682	PSMA1
R-HSA-72306	tRNA processing	0.950014531379389	-0.0512779983157053	94	2	0.00495049504950495	404	8202	23225,81929	NUP210,SEH1L
R-HSA-3214815	HDACs deacetylate histones	0.950014531379389	-0.0512779983157053	94	2	0.00495049504950495	404	8202	6907,79718	TBL1X,TBL1XR1
R-HSA-69615	G1/S DNA Damage Checkpoints	0.95225496613767	-0.0489224584753844	60	1	0.00247524752475248	404	8202	5682	PSMA1
R-HSA-174084	Autodegradation of Cdh1 by Cdh1:APC/C	0.95225496613767	-0.0489224584753844	60	1	0.00247524752475248	404	8202	5682	PSMA1
R-HSA-168273	Influenza Viral RNA Transcription and Replication	0.953619745096247	-0.0474902770378402	127	3	0.00742574257425743	404	8202	6165,23225,81929	RPL35A,NUP210,SEH1L
R-HSA-202424	Downstream TCR signaling	0.95406383978429	-0.0470246917598785	96	2	0.00495049504950495	404	8202	5682,5291	PSMA1,PIK3CB
R-HSA-211897	Cytochrome P450 - arranged by substrate type	0.954624039301541	-0.0464376921362367	61	1	0.00247524752475248	404	8202	57834	CYP4F11
R-HSA-4608870	Asymmetric localization of PCP proteins	0.959016152081336	-0.0418473616114043	63	1	0.00247524752475248	404	8202	5682	PSMA1
R-HSA-5607764	CLEC7A (Dectin-1) signaling	0.95955576613402	-0.041284845229516	99	2	0.00495049504950495	404	8202	5682,5530	PSMA1,PPP3CA
R-HSA-372790	Signaling by GPCR	0.960847692238553	-0.0399393713981731	1230	49	0.121287128712871	404	8202	30817,6712,200734,5922,2550,2792,1950,9542,8527,9965,23566,5581,58191,6196,2781,23263,9628,5144,9828,1608,4543,5330,11343,5530,1604,8831,2247,1894,1852,5682,283455,84033,5577,5140,23236,5291,29,50940,84634,3363,8660,2534,2914,5332,2863,797,409,50649,3269	ADGRE2,SPTBN2,SPRED2,RASA2,GABBR1,GNGT1,EGF,NRG2,DGKD,FGF19,LPAR3,PRKCE,CXCL16,RPS6KA2,GNAZ,MCF2L,RGS6,PDE4D,ARHGEF17,DGKG,MTNR1A,PLCB2,MGLL,PPP3CA,CD55,SYNGAP1,FGF2,ECT2,DUSP9,PSMA1,KSR2,OBSCN,PRKAR2B,PDE3B,PLCB1,PIK3CB,ABR,PDE11A,KISS1R,HTR7,IRS2,FYN,GRM4,PLCB4,GPR39,CALCB,ARRB2,ARHGEF4,HRH1
R-HSA-174154	APC/C:Cdc20 mediated degradation of Securin	0.96105048978921	-0.0397283325894513	64	1	0.00247524752475248	404	8202	5682	PSMA1
R-HSA-5625886	Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3	0.96105048978921	-0.0397283325894513	64	1	0.00247524752475248	404	8202	5585	PKN1
R-HSA-2500257	Resolution of Sister Chromatid Cohesion	0.961242514985176	-0.039528544944043	100	2	0.00495049504950495	404	8202	10274,81929	STAG1,SEH1L
R-HSA-5578749	Transcriptional regulation by small RNAs	0.962861764260743	-0.0378454244652864	101	2	0.00495049504950495	404	8202	23225,81929	NUP210,SEH1L
R-HSA-163200	Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.	0.964416049692866	-0.0362324906600684	102	2	0.00495049504950495	404	8202	91942,4711	NDUFAF2,NDUFB5
R-HSA-2132295	MHC class II antigen presentation	0.964416049692866	-0.0362324906600684	102	2	0.00495049504950495	404	8202	6712,7879	SPTBN2,RAB7A
R-HSA-1169091	Activation of NF-kappaB in B cells	0.964821916349952	-0.0358117373157765	66	1	0.00247524752475248	404	8202	5682	PSMA1
R-HSA-1280218	Adaptive Immune System	0.964990184222316	-0.0356373494852302	668	24	0.0594059405940594	404	8202	6712,10616,92369,2247,3164,7879,1950,7328,5682,9542,2309,10666,5291,9965,8660,10225,57761,2534,29927,5062,79876,7220,3903,945	SPTBN2,RBCK1,SPSB4,FGF2,NR4A1,RAB7A,EGF,UBE2H,PSMA1,NRG2,FOXO3,CD226,PIK3CB,FGF19,IRS2,CD96,TRIB3,FYN,SEC61A1,PAK2,UBA5,TRPC1,LAIR1,CD33
R-HSA-168255	Influenza Life Cycle	0.9670581015643	-0.0334967009860579	136	3	0.00742574257425743	404	8202	6165,23225,81929	RPL35A,NUP210,SEH1L
R-HSA-156827	L13a-mediated translational silencing of Ceruloplasmin expression	0.96733944780157	-0.0332058132733996	104	2	0.00495049504950495	404	8202	6165,1974	RPL35A,EIF4A2
R-HSA-72706	GTP hydrolysis and joining of the 60S ribosomal subunit	0.968713214564787	-0.0317866710976925	105	2	0.00495049504950495	404	8202	6165,1974	RPL35A,EIF4A2
R-HSA-73886	Chromosome Maintenance	0.968713214564787	-0.0317866710976925	105	2	0.00495049504950495	404	8202	5984,8607	RFC4,RUVBL1
R-HSA-2559582	Senescence-Associated Secretory Phenotype (SASP)	0.968713214564787	-0.0317866710976925	105	2	0.00495049504950495	404	8202	6196,1021	RPS6KA2,CDK6
R-HSA-174184	Cdc20:Phospho-APC/C mediated degradation of Cyclin A	0.969806982099574	-0.0306582148115652	69	1	0.00247524752475248	404	8202	5682	PSMA1
R-HSA-174178	APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1	0.969806982099574	-0.0306582148115652	69	1	0.00247524752475248	404	8202	5682	PSMA1
R-HSA-606279	Deposition of new CENPA-containing nucleosomes at the centromere	0.971306795119911	-0.0291129026960163	70	1	0.00247524752475248	404	8202	8607	RUVBL1
R-HSA-179419	APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint	0.971306795119911	-0.0291129026960163	70	1	0.00247524752475248	404	8202	5682	PSMA1
R-HSA-774815	Nucleosome assembly	0.971306795119911	-0.0291129026960163	70	1	0.00247524752475248	404	8202	8607	RUVBL1
R-HSA-2299718	Condensation of Prophase Chromosomes	0.972732281447023	-0.0276463821926215	71	1	0.00247524752475248	404	8202	10051	SMC4
R-HSA-68882	Mitotic Anaphase	0.973275200016916	-0.0270884001816067	172	4	0.0099009900990099	404	8202	5682,5520,10274,81929	PSMA1,PPP2R2A,STAG1,SEH1L
R-HSA-176409	APC/C:Cdc20 mediated degradation of mitotic proteins	0.974087115804901	-0.0262545380611017	72	1	0.00247524752475248	404	8202	5682	PSMA1
R-HSA-2555396	Mitotic Metaphase and Anaphase	0.974216914509943	-0.0261212952989727	173	4	0.0099009900990099	404	8202	5682,5520,10274,81929	PSMA1,PPP2R2A,STAG1,SEH1L
R-HSA-176814	Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins	0.975374791731181	-0.0249334800721541	73	1	0.00247524752475248	404	8202	5682	PSMA1
R-HSA-3214858	RMTs methylate histone arginines	0.977761788986972	-0.0224892081581722	75	1	0.00247524752475248	404	8202	86	ACTL6A
R-HSA-428157	Sphingolipid metabolism	0.978867269155661	-0.0213592236251125	76	1	0.00247524752475248	404	8202	259230	SGMS1
R-HSA-1500620	Meiosis	0.979718217789748	-0.020490281530624	115	2	0.00495049504950495	404	8202	545,10274	ATR,STAG1
R-HSA-2871837	FCERI mediated NF-kB activation	0.979917924231572	-0.020286461608922	77	1	0.00247524752475248	404	8202	5682	PSMA1
R-HSA-176408	Regulation of APC/C activators between G1/S and early anaphase	0.979917924231572	-0.020286461608922	77	1	0.00247524752475248	404	8202	5682	PSMA1
R-HSA-72203	Processing of Capped Intron-Containing Pre-mRNA	0.98305406298707	-0.0170911623950445	153	3	0.00742574257425743	404	8202	22916,23225,81929	NCBP2,NUP210,SEH1L
R-HSA-453276	Regulation of mitotic cell cycle	0.985213420389082	-0.0148969908339303	83	1	0.00247524752475248	404	8202	5682	PSMA1
R-HSA-174143	APC/C-mediated degradation of cell cycle proteins	0.985213420389082	-0.0148969908339303	83	1	0.00247524752475248	404	8202	5682	PSMA1
R-HSA-192823	Viral mRNA Translation	0.9859491979729	-0.014150449060932	84	1	0.00247524752475248	404	8202	6165	RPL35A
R-HSA-156902	Peptide chain elongation	0.9859491979729	-0.014150449060932	84	1	0.00247524752475248	404	8202	6165	RPL35A
R-HSA-72764	Eukaryotic Translation Termination	0.986648449507658	-0.0134414838394238	85	1	0.00247524752475248	404	8202	6165	RPL35A
R-HSA-983168	Antigen processing: Ubiquitination & Proteasome degradation	0.987356623269121	-0.0127239843743911	223	5	0.0123762376237624	404	8202	7328,5682,10616,92369,79876	UBE2H,PSMA1,RBCK1,SPSB4,UBA5
R-HSA-500792	GPCR ligand binding	0.987672885186611	-0.0124037239237606	444	13	0.0321782178217822	404	8202	3363,30817,58191,1604,2550,2792,2914,2863,797,4543,23566,3269,84634	HTR7,ADGRE2,CXCL16,CD55,GABBR1,GNGT1,GRM4,GPR39,CALCB,MTNR1A,LPAR3,HRH1,KISS1R
R-HSA-2467813	Separation of Sister Chromatids	0.987697280740386	-0.0123790241948725	161	3	0.00742574257425743	404	8202	5682,10274,81929	PSMA1,STAG1,SEH1L
R-HSA-156842	Eukaryotic Translation Elongation	0.988544695209777	-0.0115214222092435	88	1	0.00247524752475248	404	8202	6165	RPL35A
R-HSA-73777	RNA Polymerase I Chain Elongation	0.988544695209777	-0.0115214222092435	88	1	0.00247524752475248	404	8202	902	CCNH
R-HSA-211000	Gene Silencing by RNA	0.989534125982196	-0.0105210264268944	130	2	0.00495049504950495	404	8202	23225,81929	NUP210,SEH1L
R-HSA-5625740	RHO GTPases activate PKNs	0.989657093624143	-0.0103967659300949	90	1	0.00247524752475248	404	8202	5585	PKN1
R-HSA-72689	Formation of a pool of free 40S subunits	0.991568966641431	-0.0084667755578834	94	1	0.00247524752475248	404	8202	6165	RPL35A
R-HSA-68886	M Phase	0.992187489584545	-0.00784318795849258	296	7	0.0173267326732673	404	8202	5682,5520,23225,10274,81929,23175,10051	PSMA1,PPP2R2A,NUP210,STAG1,SEH1L,LPIN1,SMC4
R-HSA-983169	Class I MHC mediated antigen processing & presentation	0.99227224331187	-0.00775777052625963	267	6	0.0148514851485149	404	8202	7328,5682,10616,29927,92369,79876	UBE2H,PSMA1,RBCK1,SEC61A1,SPSB4,UBA5
R-HSA-5668541	TNFR2 non-canonical NF-kB pathway	0.992388275410839	-0.0076408416127185	96	1	0.00247524752475248	404	8202	5682	PSMA1
R-HSA-1428517	The citric acid (TCA) cycle and respiratory electron transport	0.994156812052514	-0.00586032616400376	143	2	0.00495049504950495	404	8202	91942,4711	NDUFAF2,NDUFB5
R-HSA-212436	Generic Transcription Pathway	0.994571457283021	-0.00544333079776052	553	16	0.0396039603960396	404	8202	7296,5563,83667,79718,3164,169841,54541,6498,9668,1490,339500,25937,619279,6907,7029,7182	TXNRD1,PRKAA2,SESN2,TBL1XR1,NR4A1,ZNF169,DDIT4,SKIL,ZNF432,CTGF,ZNF678,WWTR1,ZNF704,TBL1X,TFDP2,NR2C2
R-HSA-427413	NoRC negatively regulates rRNA expression	0.994944319202487	-0.0050685039899123	104	1	0.00247524752475248	404	8202	902	CCNH
R-HSA-5250941	Negative epigenetic regulation of rRNA expression	0.995663948566801	-0.00434547936742399	107	1	0.00247524752475248	404	8202	902	CCNH
R-HSA-73854	RNA Polymerase I Promoter Clearance	0.995663948566801	-0.00434547936742399	107	1	0.00247524752475248	404	8202	902	CCNH
R-HSA-73864	RNA Polymerase I Transcription	0.996085975648049	-0.00392170419120012	109	1	0.00247524752475248	404	8202	902	CCNH
R-HSA-373076	Class A/1 (Rhodopsin-like receptors)	0.996271570035853	-0.00373539788413873	318	7	0.0173267326732673	404	8202	3363,2863,58191,4543,23566,3269,84634	HTR7,GPR39,CXCL16,MTNR1A,LPAR3,HRH1,KISS1R
R-HSA-72163	mRNA Splicing - Major Pathway	0.996811048736112	-0.00319404680480803	113	1	0.00247524752475248	404	8202	22916	NCBP2
R-HSA-72172	mRNA Splicing	0.997772427588416	-0.00223005714163831	120	1	0.00247524752475248	404	8202	22916	NCBP2
R-HSA-212165	Epigenetic regulation of gene expression	0.998185604720305	-0.00181604328853887	124	1	0.00247524752475248	404	8202	902	CCNH
R-HSA-388396	GPCR downstream signaling	0.998282031150591	-0.00171944625022102	928	29	0.0717821782178218	404	8202	2550,2792,1894,84033,8527,23236,5140,5291,23566,29,50940,84634,3363,5581,58191,2781,23263,2914,5332,9628,797,5144,9828,1608,11343,5330,4543,50649,3269	GABBR1,GNGT1,ECT2,OBSCN,DGKD,PLCB1,PDE3B,PIK3CB,LPAR3,ABR,PDE11A,KISS1R,HTR7,PRKCE,CXCL16,GNAZ,MCF2L,GRM4,PLCB4,RGS6,CALCB,PDE4D,ARHGEF17,DGKG,MGLL,PLCB2,MTNR1A,ARHGEF4,HRH1
R-HSA-74160	Gene Expression	0.999280804261086	-0.000719454484236337	1330	44	0.108910891089109	404	8202	833,5563,6301,169841,5520,10667,10644,16,54541,58477,9668,6184,23225,339500,1490,10302,81929,7296,51520,2617,8893,83667,902,8731,79718,3164,1974,4774,5682,4784,6498,6165,29927,1978,25937,619279,6747,22916,57472,4782,54464,6907,7029,7182	CARS,PRKAA2,SARS,ZNF169,PPP2R2A,FARS2,IGF2BP2,AARS,DDIT4,SRPRB,ZNF432,RPN1,NUP210,ZNF678,CTGF,SNAPC5,SEH1L,TXNRD1,LARS,GARS,EIF2B5,SESN2,CCNH,RNMT,TBL1XR1,NR4A1,EIF4A2,NFIA,PSMA1,NFIX,SKIL,RPL35A,SEC61A1,EIF4EBP1,WWTR1,ZNF704,SSR3,NCBP2,CNOT6,NFIC,XRN1,TBL1X,TFDP2,NR2C2
R-HSA-375276	Peptide ligand-binding receptors	0.999416827274167	-0.000583342837186729	193	2	0.00495049504950495	404	8202	58191,84634	CXCL16,KISS1R
R-HSA-381753	Olfactory Signaling Pathway	0.999999997275145	-2.72485503617403e-09	381	1	0.00247524752475248	404	8202	2792	GNGT1
R-HSA-3000480	Scavenging by Class A Receptors	0.999999999983785	-1.62149539271341e-11	19	0	0	404	8202
R-HSA-69618	Mitotic Spindle Checkpoint	0.999999999983785	-1.62149539271341e-11	19	0	0	404	8202
R-HSA-190861	Gap junction assembly	0.999999999983785	-1.62149539271341e-11	19	0	0	404	8202
R-HSA-71403	Citric acid cycle (TCA cycle)	0.999999999983785	-1.62149539271341e-11	19	0	0	404	8202
R-HSA-418360	Platelet calcium homeostasis	0.999999999983785	-1.62149539271341e-11	19	0	0	404	8202
R-HSA-442982	Ras activation uopn Ca2+ infux through NMDA receptor	0.999999999983785	-1.62149539271341e-11	19	0	0	404	8202
R-HSA-1222499	Response of Mtb to phagocytosis	0.999999999987032	-1.29681820837391e-11	1	0	0	404	8202
R-HSA-5340573	WNT ligand secretion is abrogated by the PORCN inhibitor LGK974	0.999999999987032	-1.29681820837391e-11	1	0	0	404	8202
R-HSA-3359454	Defective TCN2 causes hereditary megaloblastic anemia	0.999999999987032	-1.29681820837391e-11	1	0	0	404	8202
R-HSA-5602410	TLR3 deficiency - HSE	0.999999999987032	-1.29681820837391e-11	1	0	0	404	8202
R-HSA-389542	NADPH regeneration	0.999999999987032	-1.29681820837391e-11	1	0	0	404	8202
R-HSA-190840	Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane	0.999999999987032	-1.29681820837391e-11	1	0	0	404	8202
R-HSA-112122	ALKBH2 mediated reversal of alkylation damage	0.999999999987032	-1.29681820837391e-11	1	0	0	404	8202
R-HSA-1299344	TWIK-related spinal cord K+ channel (TRESK)	0.999999999987032	-1.29681820837391e-11	1	0	0	404	8202
R-HSA-1839128	FGFR4 mutant receptor activation	0.999999999987032	-1.29681820837391e-11	1	0	0	404	8202
R-HSA-163316	Mitochondrial transcription termination	0.999999999987032	-1.29681820837391e-11	1	0	0	404	8202
R-HSA-2534343	Interaction With Cumulus Cells	0.999999999987032	-1.29681820837391e-11	1	0	0	404	8202
R-HSA-3248023	Regulation by TREX1	0.999999999987032	-1.29681820837391e-11	1	0	0	404	8202
R-HSA-1222352	Latent infection of Homo sapiens with Mycobacterium tuberculosis	0.999999999987032	-1.29681820837391e-11	1	0	0	404	8202
R-HSA-480985	Synthesis of dolichyl-phosphate-glucose	0.999999999987032	-1.29681820837391e-11	1	0	0	404	8202
R-HSA-169131	Inhibition of PKR	0.999999999987032	-1.29681820837391e-11	1	0	0	404	8202
R-HSA-1855231	Synthesis of IPs in the ER lumen	0.999999999987032	-1.29681820837391e-11	1	0	0	404	8202
R-HSA-5657655	MGMT-mediated DNA damage reversal	0.999999999987032	-1.29681820837391e-11	1	0	0	404	8202
R-HSA-162589	Reverse Transcription of HIV RNA	0.999999999987032	-1.29681820837391e-11	1	0	0	404	8202
R-HSA-211957	Aromatic amines can be N-hydroxylated or N-dealkylated by CYP1A2	0.999999999987032	-1.29681820837391e-11	1	0	0	404	8202
R-HSA-1299287	Tandem pore domain halothane-inhibited K+ channel (THIK)	0.999999999987032	-1.29681820837391e-11	1	0	0	404	8202
R-HSA-1483076	Synthesis of CL	0.999999999987032	-1.29681820837391e-11	1	0	0	404	8202
R-HSA-171286	Synthesis and processing of ENV and VPU	0.999999999987032	-1.29681820837391e-11	1	0	0	404	8202
R-HSA-3359474	Defective MMACHC causes methylmalonic aciduria and homocystinuria type cblC	0.999999999987032	-1.29681820837391e-11	1	0	0	404	8202
R-HSA-168275	Entry of Influenza Virion into Host Cell via Endocytosis	0.999999999987032	-1.29681820837391e-11	1	0	0	404	8202
R-HSA-5619058	Defective SLCO1B3 causes hyperbilirubinemia, Rotor type (HBLRR)	0.999999999987032	-1.29681820837391e-11	1	0	0	404	8202
R-HSA-162585	Uncoating of the HIV Virion	0.999999999987032	-1.29681820837391e-11	1	0	0	404	8202
R-HSA-164525	Plus-strand DNA synthesis	0.999999999987032	-1.29681820837391e-11	1	0	0	404	8202
R-HSA-5678895	Defective CFTR causes cystic fibrosis	0.999999999987032	-1.29681820837391e-11	1	0	0	404	8202
R-HSA-5619110	Defective SLCO1B1 causes hyperbilirubinemia, Rotor type (HBLRR)	0.999999999987032	-1.29681820837391e-11	1	0	0	404	8202
R-HSA-1839120	Signaling by FGFR1 amplification mutants	0.999999999987032	-1.29681820837391e-11	1	0	0	404	8202
R-HSA-164516	Minus-strand DNA synthesis	0.999999999987032	-1.29681820837391e-11	1	0	0	404	8202
R-HSA-5250982	Toxicity of tetanus toxin (TeNT)	0.999999999987032	-1.29681820837391e-11	1	0	0	404	8202
R-HSA-2023837	Signaling by FGFR2 amplification mutants	0.999999999987032	-1.29681820837391e-11	1	0	0	404	8202
R-HSA-2466712	Biosynthesis of A2E, implicated in retinal degradation	0.999999999987032	-1.29681820837391e-11	1	0	0	404	8202
R-HSA-1222449	Mtb iron assimilation by chelation	0.999999999987032	-1.29681820837391e-11	1	0	0	404	8202
R-HSA-1300645	Acrosome Reaction	0.999999999987032	-1.29681820837391e-11	1	0	0	404	8202
R-HSA-5467333	APC truncation mutants are not K63 polyubiquitinated	0.999999999987032	-1.29681820837391e-11	1	0	0	404	8202
R-HSA-3359457	Defective GIF causes intrinsic factor deficiency	0.999999999987032	-1.29681820837391e-11	1	0	0	404	8202
R-HSA-975574	Reactions specific to the hybrid N-glycan synthesis pathway	0.999999999987032	-1.29681820837391e-11	1	0	0	404	8202
R-HSA-2978092	Abnormal conversion of 2-oxoglutarate to 2-hydroxyglutarate	0.999999999987032	-1.29681820837391e-11	1	0	0	404	8202
R-HSA-2142696	Synthesis of Hepoxilins (HX) and Trioxilins (TrX)	0.999999999987032	-1.29681820837391e-11	1	0	0	404	8202
R-HSA-5619084	ABC transporter disorders	0.999999999987032	-1.29681820837391e-11	1	0	0	404	8202
R-HSA-1483196	PI and PC transport between ER and Golgi membranes	0.999999999987032	-1.29681820837391e-11	1	0	0	404	8202
R-HSA-5602415	UNC93B1 deficiency - HSE	0.999999999987032	-1.29681820837391e-11	1	0	0	404	8202
R-HSA-2033515	t(4;14) translocations of FGFR3	0.999999999987032	-1.29681820837391e-11	1	0	0	404	8202
R-HSA-5602680	MyD88 deficiency (TLR5)	0.999999999988173	-1.18267429541092e-11	3	0	0	404	8202
R-HSA-265473	Trafficking of dietary sterols	0.999999999988173	-1.18267429541092e-11	3	0	0	404	8202
R-HSA-5653890	Lactose synthesis	0.999999999988173	-1.18267429541092e-11	3	0	0	404	8202
R-HSA-5627083	RHO GTPases regulate CFTR trafficking	0.999999999988173	-1.18267429541092e-11	3	0	0	404	8202
R-HSA-110330	Recognition and association of DNA glycosylase with site containing an affected purine	0.999999999988173	-1.18267429541092e-11	3	0	0	404	8202
R-HSA-70350	Fructose catabolism	0.999999999988173	-1.18267429541092e-11	3	0	0	404	8202
R-HSA-3359463	Defective CUBN causes hereditary megaloblastic anemia 1	0.999999999988173	-1.18267429541092e-11	3	0	0	404	8202
R-HSA-1483152	Hydrolysis of LPE	0.999999999988173	-1.18267429541092e-11	3	0	0	404	8202
R-HSA-5624958	ARL13B-mediated ciliary trafficking of INPP5E	0.999999999988173	-1.18267429541092e-11	3	0	0	404	8202
R-HSA-1368071	NR1D1 (REV-ERBA) represses gene expression	0.999999999988173	-1.18267429541092e-11	3	0	0	404	8202
R-HSA-964827	Progressive trimming of alpha-1,2-linked mannose residues from Man9/8/7GlcNAc2 to produce Man5GlcNAc2	0.999999999988173	-1.18267429541092e-11	3	0	0	404	8202
R-HSA-191650	Regulation of gap junction activity	0.999999999988173	-1.18267429541092e-11	3	0	0	404	8202
R-HSA-77285	Beta oxidation of myristoyl-CoA to lauroyl-CoA	0.999999999988173	-1.18267429541092e-11	3	0	0	404	8202
R-HSA-191647	c-src mediated regulation of Cx43 function and closure of gap junctions	0.999999999988173	-1.18267429541092e-11	3	0	0	404	8202
R-HSA-111458	Formation of apoptosome	0.999999999988173	-1.18267429541092e-11	3	0	0	404	8202
R-HSA-1299308	Tandem of pore domain in a weak inwardly rectifying K+ channels (TWIK)	0.999999999988173	-1.18267429541092e-11	3	0	0	404	8202
R-HSA-73843	5-Phosphoribose 1-diphosphate biosynthesis	0.999999999988173	-1.18267429541092e-11	3	0	0	404	8202
R-HSA-163282	Mitochondrial transcription initiation	0.999999999988173	-1.18267429541092e-11	3	0	0	404	8202
R-HSA-193681	Ceramide signalling	0.999999999988173	-1.18267429541092e-11	3	0	0	404	8202
R-HSA-3304347	Loss of Function of SMAD4 in Cancer	0.999999999988173	-1.18267429541092e-11	3	0	0	404	8202
R-HSA-379401	Dopamine clearance from the synaptic cleft	0.999999999988173	-1.18267429541092e-11	3	0	0	404	8202
R-HSA-2395516	Electron transport from NADPH to Ferredoxin	0.999999999988173	-1.18267429541092e-11	3	0	0	404	8202
R-HSA-844455	The NLRP1 inflammasome	0.999999999988173	-1.18267429541092e-11	3	0	0	404	8202
R-HSA-177539	Autointegration results in viral DNA circles	0.999999999988173	-1.18267429541092e-11	3	0	0	404	8202
R-HSA-77305	Beta oxidation of palmitoyl-CoA to myristoyl-CoA	0.999999999988173	-1.18267429541092e-11	3	0	0	404	8202
R-HSA-77352	Beta oxidation of butanoyl-CoA to acetyl-CoA	0.999999999988173	-1.18267429541092e-11	3	0	0	404	8202
R-HSA-190704	Oligomerization of connexins into connexons	0.999999999988173	-1.18267429541092e-11	3	0	0	404	8202
R-HSA-3359462	Defective AMN causes hereditary megaloblastic anemia 1	0.999999999988173	-1.18267429541092e-11	3	0	0	404	8202
R-HSA-350864	Regulation of thyroid hormone activity	0.999999999988173	-1.18267429541092e-11	3	0	0	404	8202
R-HSA-110331	Cleavage of the damaged purine	0.999999999988173	-1.18267429541092e-11	3	0	0	404	8202
R-HSA-1299503	TWIK related potassium channel (TREK)	0.999999999988173	-1.18267429541092e-11	3	0	0	404	8202
R-HSA-352238	Breakdown of the nuclear lamina	0.999999999988173	-1.18267429541092e-11	3	0	0	404	8202
R-HSA-173599	Formation of the active cofactor, UDP-glucuronate	0.999999999988173	-1.18267429541092e-11	3	0	0	404	8202
R-HSA-5339700	TCF7L2 mutants don't bind CTBP	0.999999999988173	-1.18267429541092e-11	3	0	0	404	8202
R-HSA-1296067	Potassium transport channels	0.999999999988173	-1.18267429541092e-11	3	0	0	404	8202
R-HSA-392023	Adrenaline signalling through Alpha-2 adrenergic receptor	0.999999999988173	-1.18267429541092e-11	3	0	0	404	8202
R-HSA-2892245	POU5F1 (OCT4), SOX2, NANOG repress genes related to differentiation	0.999999999988173	-1.18267429541092e-11	3	0	0	404	8202
R-HSA-351200	Interconversion of polyamines	0.999999999988173	-1.18267429541092e-11	3	0	0	404	8202
R-HSA-977442	GABA A (rho) receptor activation	0.999999999988173	-1.18267429541092e-11	3	0	0	404	8202
R-HSA-180897	Vpr-mediated induction of apoptosis by mitochondrial outer membrane permeabilization	0.999999999988173	-1.18267429541092e-11	3	0	0	404	8202
R-HSA-175567	Integration of viral DNA into host genomic DNA	0.999999999988173	-1.18267429541092e-11	3	0	0	404	8202
R-HSA-190374	FGFR1c and Klotho ligand binding and activation	0.999999999988173	-1.18267429541092e-11	3	0	0	404	8202
R-HSA-5688031	Defective pro-SFTPB causes pulmonary surfactant metabolism dysfunction 1 (SMDP1) and respiratory distress syndrome (RDS)	0.999999999988173	-1.18267429541092e-11	3	0	0	404	8202
R-HSA-3296197	Hydroxycarboxylic acid-binding receptors	0.999999999988173	-1.18267429541092e-11	3	0	0	404	8202
R-HSA-217271	FMO oxidises nucleophiles	0.999999999988173	-1.18267429541092e-11	3	0	0	404	8202
R-HSA-5602571	TRAF3 deficiency - HSE	0.999999999988173	-1.18267429541092e-11	3	0	0	404	8202
R-HSA-964975	Vitamins B6 activation to pyridoxal phosphate	0.999999999988173	-1.18267429541092e-11	3	0	0	404	8202
R-HSA-1483248	Synthesis of PIPs at the ER membrane	0.999999999988173	-1.18267429541092e-11	3	0	0	404	8202
R-HSA-427589	Type II Na+/Pi cotransporters	0.999999999988173	-1.18267429541092e-11	3	0	0	404	8202
R-HSA-3311021	SMAD4 MH2 Domain Mutants in Cancer	0.999999999988173	-1.18267429541092e-11	3	0	0	404	8202
R-HSA-5250992	Toxicity of botulinum toxin type E (BoNT/E)	0.999999999988173	-1.18267429541092e-11	3	0	0	404	8202
R-HSA-73927	Depurination	0.999999999988173	-1.18267429541092e-11	3	0	0	404	8202
R-HSA-170145	Phosphorylation of proteins involved in the G2/M transition by Cyclin A:Cdc2 complexes	0.999999999988173	-1.18267429541092e-11	3	0	0	404	8202
R-HSA-444411	Rhesus glycoproteins mediate ammonium transport.	0.999999999988173	-1.18267429541092e-11	3	0	0	404	8202
R-HSA-190827	Transport of connexins along the secretory pathway	0.999999999988173	-1.18267429541092e-11	3	0	0	404	8202
R-HSA-844615	The AIM2 inflammasome	0.999999999988173	-1.18267429541092e-11	3	0	0	404	8202
R-HSA-1234162	Oxygen-dependent asparagine hydroxylation of Hypoxia-inducible Factor Alpha	0.999999999988173	-1.18267429541092e-11	3	0	0	404	8202
R-HSA-880009	Interconversion of 2-oxoglutarate and 2-hydroxyglutarate	0.999999999988173	-1.18267429541092e-11	3	0	0	404	8202
R-HSA-5250971	Toxicity of botulinum toxin type C (BoNT/C)	0.999999999988173	-1.18267429541092e-11	3	0	0	404	8202
R-HSA-165181	Inhibition of TSC complex formation by PKB	0.999999999988173	-1.18267429541092e-11	3	0	0	404	8202
R-HSA-162699	Synthesis of dolichyl-phosphate mannose	0.999999999988173	-1.18267429541092e-11	3	0	0	404	8202
R-HSA-168330	Viral RNP Complexes in the Host Cell Nucleus	0.999999999989902	-1.00982052581022e-11	2	0	0	404	8202
R-HSA-68881	Mitotic Metaphase/Anaphase Transition	0.999999999989902	-1.00982052581022e-11	2	0	0	404	8202
R-HSA-916853	Degradation of GABA	0.999999999989902	-1.00982052581022e-11	2	0	0	404	8202
R-HSA-69560	Transcriptional activation of p53 responsive genes	0.999999999989902	-1.00982052581022e-11	2	0	0	404	8202
R-HSA-205017	NFG and proNGF binds to p75NTR	0.999999999989902	-1.00982052581022e-11	2	0	0	404	8202
R-HSA-168277	Influenza Virus Induced Apoptosis	0.999999999989902	-1.00982052581022e-11	2	0	0	404	8202
R-HSA-168268	Virus Assembly and Release	0.999999999989902	-1.00982052581022e-11	2	0	0	404	8202
R-HSA-1483101	Synthesis of PS	0.999999999989902	-1.00982052581022e-11	2	0	0	404	8202
R-HSA-192905	vRNP Assembly	0.999999999989902	-1.00982052581022e-11	2	0	0	404	8202
R-HSA-379397	Enzymatic degradation of dopamine by COMT	0.999999999989902	-1.00982052581022e-11	2	0	0	404	8202
R-HSA-176034	Interactions of Tat with host cellular proteins	0.999999999989902	-1.00982052581022e-11	2	0	0	404	8202
R-HSA-1299361	TWIK-related alkaline pH activated K+ channel (TALK)	0.999999999989902	-1.00982052581022e-11	2	0	0	404	8202
R-HSA-177162	Conjugation of phenylacetate with glutamine	0.999999999989902	-1.00982052581022e-11	2	0	0	404	8202
R-HSA-5652227	Fructose biosynthesis	0.999999999989902	-1.00982052581022e-11	2	0	0	404	8202
R-HSA-3359469	Defective MTR causes methylmalonic aciduria and homocystinuria type cblG	0.999999999989902	-1.00982052581022e-11	2	0	0	404	8202
R-HSA-5579031	Defective ACTH causes Obesity and Pro-opiomelanocortinin deficiency (POMCD)	0.999999999989902	-1.00982052581022e-11	2	0	0	404	8202
R-HSA-141334	PAOs oxidise polyamines to amines	0.999999999989902	-1.00982052581022e-11	2	0	0	404	8202
R-HSA-75102	C6 deamination of adenosine	0.999999999989902	-1.00982052581022e-11	2	0	0	404	8202
R-HSA-844623	The IPAF inflammasome	0.999999999989902	-1.00982052581022e-11	2	0	0	404	8202
R-HSA-5545619	XAV939 inhibits tankyrase, stabilizing AXIN	0.999999999989902	-1.00982052581022e-11	2	0	0	404	8202
R-HSA-1614603	Cysteine formation from homocysteine	0.999999999989902	-1.00982052581022e-11	2	0	0	404	8202
R-HSA-69895	Transcriptional  activation of  cell cycle inhibitor p21	0.999999999989902	-1.00982052581022e-11	2	0	0	404	8202
R-HSA-75064	mRNA Editing: A to I Conversion	0.999999999989902	-1.00982052581022e-11	2	0	0	404	8202
R-HSA-164939	Nef mediated downregulation of CD28 cell surface expression	0.999999999989902	-1.00982052581022e-11	2	0	0	404	8202
R-HSA-156582	Acetylation	0.999999999989902	-1.00982052581022e-11	2	0	0	404	8202
R-HSA-1299316	TWIK-releated acid-sensitive K+ channel (TASK)	0.999999999989902	-1.00982052581022e-11	2	0	0	404	8202
R-HSA-141424	Amplification of signal from the kinetochores	0.999999999989902	-1.00982052581022e-11	2	0	0	404	8202
R-HSA-141444	Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal	0.999999999989902	-1.00982052581022e-11	2	0	0	404	8202
R-HSA-190872	Transport of connexons to the plasma membrane	0.999999999989902	-1.00982052581022e-11	2	0	0	404	8202
R-HSA-5687868	Defective SFTPA2 causes idiopathic pulmonary fibrosis (IPF)	0.999999999989902	-1.00982052581022e-11	2	0	0	404	8202
R-HSA-111457	Release of apoptotic factors from the mitochondria	0.999999999989902	-1.00982052581022e-11	2	0	0	404	8202
R-HSA-168316	Assembly of Viral Components at the Budding Site	0.999999999989902	-1.00982052581022e-11	2	0	0	404	8202
R-HSA-428559	Proton-coupled neutral amino acid transporters	0.999999999989902	-1.00982052581022e-11	2	0	0	404	8202
R-HSA-211994	Sterols are 12-hydroxylated by CYP8B1	0.999999999989902	-1.00982052581022e-11	2	0	0	404	8202
R-HSA-5688354	Defective pro-SFTPC causes pulmonary surfactant metabolism dysfunction 2 (SMDP2) and respiratory distress syndrome (RDS)	0.999999999989902	-1.00982052581022e-11	2	0	0	404	8202
R-HSA-3359467	Defective MTRR causes methylmalonic aciduria and homocystinuria type cblE	0.999999999989902	-1.00982052581022e-11	2	0	0	404	8202
R-HSA-203754	NOSIP mediated eNOS trafficking	0.999999999989902	-1.00982052581022e-11	2	0	0	404	8202
R-HSA-3359478	Defective MUT causes methylmalonic aciduria mut type	0.999999999989902	-1.00982052581022e-11	2	0	0	404	8202
R-HSA-198765	Signalling to ERK5	0.999999999989902	-1.00982052581022e-11	2	0	0	404	8202
R-HSA-351143	Agmatine biosynthesis	0.999999999989902	-1.00982052581022e-11	2	0	0	404	8202
R-HSA-70688	Proline catabolism	0.999999999989902	-1.00982052581022e-11	2	0	0	404	8202
R-HSA-3359475	Defective MMAA causes methylmalonic aciduria type cblA	0.999999999989902	-1.00982052581022e-11	2	0	0	404	8202
R-HSA-114294	Activation, translocation and oligomerization of BAX	0.999999999989902	-1.00982052581022e-11	2	0	0	404	8202
R-HSA-379398	Enzymatic degradation of Dopamine by monoamine oxidase	0.999999999989902	-1.00982052581022e-11	2	0	0	404	8202
R-HSA-75094	Formation of the Editosome	0.999999999989902	-1.00982052581022e-11	2	0	0	404	8202
R-HSA-166020	Transfer of LPS from LBP carrier to CD14	0.999999999989902	-1.00982052581022e-11	2	0	0	404	8202
R-HSA-168315	Inhibition of Host mRNA Processing and RNA Silencing	0.999999999989902	-1.00982052581022e-11	2	0	0	404	8202
R-HSA-5602566	TICAM1 deficiency - HSE	0.999999999989902	-1.00982052581022e-11	2	0	0	404	8202
R-HSA-5602636	IKBKB deficiency causes SCID	0.999999999989902	-1.00982052581022e-11	2	0	0	404	8202
R-HSA-73930	Abasic sugar-phosphate removal via the single-nucleotide replacement pathway	0.999999999989902	-1.00982052581022e-11	2	0	0	404	8202
R-HSA-3359485	Defective CD320 causes methylmalonic aciduria	0.999999999989902	-1.00982052581022e-11	2	0	0	404	8202
R-HSA-3359473	Defective MMADHC causes methylmalonic aciduria and homocystinuria type cblD	0.999999999989902	-1.00982052581022e-11	2	0	0	404	8202
R-HSA-5619107	Defective TRP may confer susceptibility towards thyroid papillary carcinoma (TPC)	0.999999999989902	-1.00982052581022e-11	2	0	0	404	8202
R-HSA-111995	phospho-PLA2 pathway	0.999999999989902	-1.00982052581022e-11	2	0	0	404	8202
R-HSA-451307	Activation of Na-permeable Kainate Receptors	0.999999999989902	-1.00982052581022e-11	2	0	0	404	8202
R-HSA-77042	Formation of editosomes by ADAR proteins	0.999999999989902	-1.00982052581022e-11	2	0	0	404	8202
R-HSA-3858516	Glycogen storage disease type 0 (liver GYS2)	0.999999999989902	-1.00982052581022e-11	2	0	0	404	8202
R-HSA-432030	Transport of glycerol from adipocytes to the liver by Aquaporins	0.999999999989902	-1.00982052581022e-11	2	0	0	404	8202
R-HSA-163754	Insulin effects increased synthesis of Xylulose-5-Phosphate	0.999999999989902	-1.00982052581022e-11	2	0	0	404	8202
R-HSA-111452	Activation and oligomerization of BAK protein	0.999999999989902	-1.00982052581022e-11	2	0	0	404	8202
R-HSA-72200	mRNA Editing: C to U Conversion	0.999999999989902	-1.00982052581022e-11	2	0	0	404	8202
R-HSA-1483226	Synthesis of PI	0.999999999989902	-1.00982052581022e-11	2	0	0	404	8202
R-HSA-5662702	Melanin biosynthesis	0.999999999989902	-1.00982052581022e-11	2	0	0	404	8202
R-HSA-166663	Initial triggering of complement	0.999999999990049	-9.9513195709619e-12	20	0	0	404	8202
R-HSA-210745	Regulation of gene expression in beta cells	0.999999999990049	-9.9513195709619e-12	20	0	0	404	8202
R-HSA-193670	p75NTR negatively regulates cell cycle via SC1	0.999999999990423	-9.57709177266537e-12	6	0	0	404	8202
R-HSA-68952	DNA replication initiation	0.999999999990423	-9.57709177266537e-12	6	0	0	404	8202
R-HSA-70921	Histidine catabolism	0.999999999990423	-9.57709177266537e-12	6	0	0	404	8202
R-HSA-388479	Vasopressin-like receptors	0.999999999990423	-9.57709177266537e-12	6	0	0	404	8202
R-HSA-6782861	Synthesis of wybutosine at G37 of tRNA(Phe)	0.999999999990423	-9.57709177266537e-12	6	0	0	404	8202
R-HSA-500753	Pyrimidine biosynthesis	0.999999999990423	-9.57709177266537e-12	6	0	0	404	8202
R-HSA-171052	LDL-mediated lipid transport	0.999999999990423	-9.57709177266537e-12	6	0	0	404	8202
R-HSA-5660668	CLEC7A/inflammasome pathway	0.999999999990423	-9.57709177266537e-12	6	0	0	404	8202
R-HSA-390247	Beta-oxidation of very long chain fatty acids	0.999999999990423	-9.57709177266537e-12	6	0	0	404	8202
R-HSA-176417	Phosphorylation of Emi1	0.999999999990423	-9.57709177266537e-12	6	0	0	404	8202
R-HSA-1237112	Methionine salvage pathway	0.999999999990423	-9.57709177266537e-12	6	0	0	404	8202
R-HSA-1566977	Fibronectin matrix formation	0.999999999990423	-9.57709177266537e-12	6	0	0	404	8202
R-HSA-2142700	Synthesis of Lipoxins (LX)	0.999999999990423	-9.57709177266537e-12	6	0	0	404	8202
R-HSA-174362	Transport and synthesis of PAPS	0.999999999990423	-9.57709177266537e-12	6	0	0	404	8202
R-HSA-975578	Reactions specific to the complex N-glycan synthesis pathway	0.999999999990423	-9.57709177266537e-12	6	0	0	404	8202
R-HSA-193993	Mineralocorticoid biosynthesis	0.999999999990423	-9.57709177266537e-12	6	0	0	404	8202
R-HSA-5693548	Sensing of DNA Double Strand Breaks	0.999999999990423	-9.57709177266537e-12	6	0	0	404	8202
R-HSA-947581	Molybdenum cofactor biosynthesis	0.999999999990423	-9.57709177266537e-12	6	0	0	404	8202
R-HSA-5626978	TNFR1-mediated ceramide production	0.999999999990423	-9.57709177266537e-12	6	0	0	404	8202
R-HSA-2142712	Synthesis of 12-eicosatetraenoic acid derivatives	0.999999999990423	-9.57709177266537e-12	6	0	0	404	8202
R-HSA-173623	Classical antibody-mediated complement activation	0.999999999990423	-9.57709177266537e-12	6	0	0	404	8202
R-HSA-5579029	Metabolic disorders of biological oxidation enzymes	0.999999999990423	-9.57709177266537e-12	6	0	0	404	8202
R-HSA-3065678	SUMO is transferred from E1 to E2 (UBE2I, UBC9)	0.999999999990423	-9.57709177266537e-12	6	0	0	404	8202
R-HSA-68616	Assembly of the ORC complex at the origin of replication	0.999999999990423	-9.57709177266537e-12	6	0	0	404	8202
R-HSA-205025	NADE modulates death signalling	0.999999999990423	-9.57709177266537e-12	6	0	0	404	8202
R-HSA-2142688	Synthesis of 5-eicosatetraenoic acids	0.999999999990423	-9.57709177266537e-12	6	0	0	404	8202
R-HSA-111957	Cam-PDE 1 activation	0.999999999990423	-9.57709177266537e-12	6	0	0	404	8202
R-HSA-77288	mitochondrial fatty acid beta-oxidation of unsaturated fatty acids	0.999999999990423	-9.57709177266537e-12	6	0	0	404	8202
R-HSA-174430	Telomere C-strand synthesis initiation	0.999999999990423	-9.57709177266537e-12	6	0	0	404	8202
R-HSA-211916	Vitamins	0.999999999990423	-9.57709177266537e-12	6	0	0	404	8202
R-HSA-2142770	Synthesis of 15-eicosatetraenoic acid derivatives	0.999999999990423	-9.57709177266537e-12	6	0	0	404	8202
R-HSA-177135	Conjugation of benzoate with glycine	0.999999999990423	-9.57709177266537e-12	6	0	0	404	8202
R-HSA-73942	DNA Damage Reversal	0.999999999990423	-9.57709177266537e-12	6	0	0	404	8202
R-HSA-428808	Na+-dependent glucose transporters	0.999999999990423	-9.57709177266537e-12	6	0	0	404	8202
R-HSA-166662	Lectin pathway of complement activation	0.999999999990423	-9.57709177266537e-12	6	0	0	404	8202
R-HSA-5674499	Negative feedback regulation of MAPK pathway	0.999999999990423	-9.57709177266537e-12	6	0	0	404	8202
R-HSA-1912399	Pre-NOTCH Processing in the Endoplasmic Reticulum	0.999999999990423	-9.57709177266537e-12	6	0	0	404	8202
R-HSA-3000484	Scavenging by Class F Receptors	0.999999999990423	-9.57709177266537e-12	6	0	0	404	8202
R-HSA-189483	Heme degradation	0.999999999990423	-9.57709177266537e-12	6	0	0	404	8202
R-HSA-74259	Purine catabolism	0.999999999992619	-7.38132869785552e-12	10	0	0	404	8202
R-HSA-975144	IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation	0.999999999992619	-7.38132869785552e-12	10	0	0	404	8202
R-HSA-209968	Thyroxine biosynthesis	0.999999999992619	-7.38132869785552e-12	10	0	0	404	8202
R-HSA-419771	Opsins	0.999999999992619	-7.38132869785552e-12	10	0	0	404	8202
R-HSA-193692	Regulated proteolysis of p75NTR	0.999999999992619	-7.38132869785552e-12	10	0	0	404	8202
R-HSA-418359	Reduction of cytosolic Ca++ levels	0.999999999992619	-7.38132869785552e-12	10	0	0	404	8202
R-HSA-5685939	HDR through MMEJ (alt-NHEJ)	0.999999999992619	-7.38132869785552e-12	10	0	0	404	8202
R-HSA-113507	E2F-enabled inhibition of pre-replication complex formation	0.999999999992619	-7.38132869785552e-12	10	0	0	404	8202
R-HSA-2474795	Diseases associated with visual transduction	0.999999999992619	-7.38132869785552e-12	10	0	0	404	8202
R-HSA-937039	IRAK1 recruits IKK complex	0.999999999992619	-7.38132869785552e-12	10	0	0	404	8202
R-HSA-430116	GP1b-IX-V activation signalling	0.999999999992619	-7.38132869785552e-12	10	0	0	404	8202
R-HSA-110056	MAPK3 (ERK1) activation	0.999999999992619	-7.38132869785552e-12	10	0	0	404	8202
R-HSA-2453864	Retinoid cycle disease events	0.999999999992619	-7.38132869785552e-12	10	0	0	404	8202
R-HSA-2562578	TRIF-mediated programmed cell death	0.999999999992619	-7.38132869785552e-12	10	0	0	404	8202
R-HSA-1433617	Regulation of signaling by NODAL	0.999999999992619	-7.38132869785552e-12	10	0	0	404	8202
R-HSA-170660	Adenylate cyclase activating pathway	0.999999999992619	-7.38132869785552e-12	10	0	0	404	8202
R-HSA-937042	IRAK2 mediated activation of TAK1 complex	0.999999999992619	-7.38132869785552e-12	10	0	0	404	8202
R-HSA-174437	Removal of the Flap Intermediate from the C-strand	0.999999999992619	-7.38132869785552e-12	10	0	0	404	8202
R-HSA-2465910	MASTL Facilitates Mitotic Progression	0.999999999992619	-7.38132869785552e-12	10	0	0	404	8202
R-HSA-190873	Gap junction degradation	0.999999999992619	-7.38132869785552e-12	10	0	0	404	8202
R-HSA-2161522	Abacavir transport and metabolism	0.999999999992619	-7.38132869785552e-12	10	0	0	404	8202
R-HSA-164940	Nef mediated downregulation of MHC class I complex cell surface expression	0.999999999992619	-7.38132869785552e-12	10	0	0	404	8202
R-HSA-1855167	Synthesis of pyrophosphates in the cytosol	0.999999999992619	-7.38132869785552e-12	10	0	0	404	8202
R-HSA-975163	IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation	0.999999999992619	-7.38132869785552e-12	10	0	0	404	8202
R-HSA-5687613	Diseases associated with surfactant metabolism	0.999999999992619	-7.38132869785552e-12	10	0	0	404	8202
R-HSA-446343	Localization of the PINCH-ILK-PARVIN complex to focal adhesions	0.999999999992827	-7.17331478674546e-12	4	0	0	404	8202
R-HSA-5250968	Toxicity of botulinum toxin type A (BoNT/A)	0.999999999992827	-7.17331478674546e-12	4	0	0	404	8202
R-HSA-5221030	TET1,2,3 and TDG demethylate DNA	0.999999999992827	-7.17331478674546e-12	4	0	0	404	8202
R-HSA-71262	Carnitine synthesis	0.999999999992827	-7.17331478674546e-12	4	0	0	404	8202
R-HSA-193144	Estrogen biosynthesis	0.999999999992827	-7.17331478674546e-12	4	0	0	404	8202
R-HSA-428542	Regulation of Commissural axon pathfinding by Slit and Robo	0.999999999992827	-7.17331478674546e-12	4	0	0	404	8202
R-HSA-173736	Alternative complement activation	0.999999999992827	-7.17331478674546e-12	4	0	0	404	8202
R-HSA-1296061	HCN channels	0.999999999992827	-7.17331478674546e-12	4	0	0	404	8202
R-HSA-75072	mRNA Editing	0.999999999992827	-7.17331478674546e-12	4	0	0	404	8202
R-HSA-69200	Phosphorylation of proteins involved in G1/S transition by active Cyclin E:Cdk2 complexes	0.999999999992827	-7.17331478674546e-12	4	0	0	404	8202
R-HSA-6783984	Glycine degradation	0.999999999992827	-7.17331478674546e-12	4	0	0	404	8202
R-HSA-2473224	Antagonism of Activin by Follistatin	0.999999999992827	-7.17331478674546e-12	4	0	0	404	8202
R-HSA-5603037	IRAK4 deficiency (TLR5)	0.999999999992827	-7.17331478674546e-12	4	0	0	404	8202
R-HSA-888593	Reuptake of GABA	0.999999999992827	-7.17331478674546e-12	4	0	0	404	8202
R-HSA-211163	AKT-mediated inactivation of FOXO1A	0.999999999992827	-7.17331478674546e-12	4	0	0	404	8202
R-HSA-427975	Proton/oligopeptide cotransporters	0.999999999992827	-7.17331478674546e-12	4	0	0	404	8202
R-HSA-5579026	Defective CYP11A1 causes Adrenal insufficiency, congenital, with 46,XY sex reversal (AICSR)	0.999999999992827	-7.17331478674546e-12	4	0	0	404	8202
R-HSA-1855191	Synthesis of IPs in the nucleus	0.999999999992827	-7.17331478674546e-12	4	0	0	404	8202
R-HSA-1369007	Mitochondrial ABC transporters	0.999999999992827	-7.17331478674546e-12	4	0	0	404	8202
R-HSA-75896	Plasmalogen biosynthesis	0.999999999992827	-7.17331478674546e-12	4	0	0	404	8202
R-HSA-3000497	Scavenging by Class H Receptors	0.999999999992827	-7.17331478674546e-12	4	0	0	404	8202
R-HSA-399710	Activation of AMPA receptors	0.999999999992827	-7.17331478674546e-12	4	0	0	404	8202
R-HSA-389599	Alpha-oxidation of phytanate	0.999999999992827	-7.17331478674546e-12	4	0	0	404	8202
R-HSA-110381	Resolution of AP sites via the single-nucleotide replacement pathway	0.999999999992827	-7.17331478674546e-12	4	0	0	404	8202
R-HSA-209905	Catecholamine biosynthesis	0.999999999992827	-7.17331478674546e-12	4	0	0	404	8202
R-HSA-209563	Axonal growth stimulation	0.999999999992827	-7.17331478674546e-12	4	0	0	404	8202
R-HSA-417973	Adenosine P1 receptors	0.999999999992827	-7.17331478674546e-12	4	0	0	404	8202
R-HSA-112126	ALKBH3 mediated reversal of alkylation damage	0.999999999992827	-7.17331478674546e-12	4	0	0	404	8202
R-HSA-196819	Vitamin B1 (thiamin) metabolism	0.999999999992827	-7.17331478674546e-12	4	0	0	404	8202
R-HSA-428776	Class II GLUTs	0.999999999992827	-7.17331478674546e-12	4	0	0	404	8202
R-HSA-5619099	Defective AVP causes neurohypophyseal diabetes insipidus (NDI)	0.999999999992827	-7.17331478674546e-12	4	0	0	404	8202
R-HSA-75108	Activation, myristolyation of BID and translocation to mitochondria	0.999999999992827	-7.17331478674546e-12	4	0	0	404	8202
R-HSA-173107	Binding and entry of HIV virion	0.999999999992827	-7.17331478674546e-12	4	0	0	404	8202
R-HSA-75944	Transcription from mitochondrial promoters	0.999999999992827	-7.17331478674546e-12	4	0	0	404	8202
R-HSA-139915	Activation of PUMA and translocation to mitochondria	0.999999999992827	-7.17331478674546e-12	4	0	0	404	8202
R-HSA-442745	Activation of CaMK IV	0.999999999992827	-7.17331478674546e-12	4	0	0	404	8202
R-HSA-1296025	ATP sensitive Potassium channels	0.999999999992827	-7.17331478674546e-12	4	0	0	404	8202
R-HSA-167060	NGF processing	0.999999999992827	-7.17331478674546e-12	4	0	0	404	8202
R-HSA-1482922	Acyl chain remodelling of PI	0.999999999993105	-6.89486361110306e-12	16	0	0	404	8202
R-HSA-2022377	Metabolism of Angiotensinogen to Angiotensins	0.999999999993105	-6.89486361110306e-12	16	0	0	404	8202
R-HSA-2559584	Formation of Senescence-Associated Heterochromatin Foci (SAHF)	0.999999999993105	-6.89486361110306e-12	16	0	0	404	8202
R-HSA-937072	TRAF6 mediated induction of TAK1 complex	0.999999999993105	-6.89486361110306e-12	16	0	0	404	8202
R-HSA-5684264	MAP3K8 (TPL2)-dependent MAPK1/3 activation	0.999999999993105	-6.89486361110306e-12	16	0	0	404	8202
R-HSA-1170546	Prolactin receptor signaling	0.999999999993105	-6.89486361110306e-12	16	0	0	404	8202
R-HSA-156711	Polo-like kinase mediated events	0.999999999993105	-6.89486361110306e-12	16	0	0	404	8202
R-HSA-1295596	Spry regulation of FGF signaling	0.999999999993105	-6.89486361110306e-12	16	0	0	404	8202
R-HSA-162710	Synthesis of glycosylphosphatidylinositol (GPI)	0.999999999993105	-6.89486361110306e-12	16	0	0	404	8202
R-HSA-5218859	Regulated Necrosis	0.999999999993105	-6.89486361110306e-12	16	0	0	404	8202
R-HSA-392517	Rap1 signalling	0.999999999993105	-6.89486361110306e-12	16	0	0	404	8202
R-HSA-418038	Nucleotide-like (purinergic) receptors	0.999999999993105	-6.89486361110306e-12	16	0	0	404	8202
R-HSA-5625900	RHO GTPases activate CIT	0.999999999993105	-6.89486361110306e-12	16	0	0	404	8202
R-HSA-446353	Cell-extracellular matrix interactions	0.999999999993105	-6.89486361110306e-12	16	0	0	404	8202
R-HSA-163210	Formation of ATP by chemiosmotic coupling	0.999999999993105	-6.89486361110306e-12	16	0	0	404	8202
R-HSA-416993	Trafficking of GluR2-containing AMPA receptors	0.999999999993105	-6.89486361110306e-12	16	0	0	404	8202
R-HSA-5213460	RIPK1-mediated regulated necrosis	0.999999999993105	-6.89486361110306e-12	16	0	0	404	8202
R-HSA-69183	Processive synthesis on the lagging strand	0.999999999993105	-6.89486361110306e-12	16	0	0	404	8202
R-HSA-1369062	ABC transporters in lipid homeostasis	0.999999999993105	-6.89486361110306e-12	16	0	0	404	8202
R-HSA-202430	Translocation of ZAP-70 to Immunological synapse	0.999999999995407	-4.59296600507329e-12	18	0	0	404	8202
R-HSA-936964	Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon	0.999999999995407	-4.59296600507329e-12	18	0	0	404	8202
R-HSA-209776	Amine-derived hormones	0.999999999995407	-4.59296600507329e-12	18	0	0	404	8202
R-HSA-141430	Inactivation of APC/C via direct inhibition of the APC/C complex	0.999999999995407	-4.59296600507329e-12	18	0	0	404	8202
R-HSA-73780	RNA Polymerase III Chain Elongation	0.999999999995407	-4.59296600507329e-12	18	0	0	404	8202
R-HSA-5223345	Miscellaneous transport and binding events	0.999999999995407	-4.59296600507329e-12	18	0	0	404	8202
R-HSA-1234176	Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha	0.999999999995407	-4.59296600507329e-12	18	0	0	404	8202
R-HSA-141405	Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components	0.999999999995407	-4.59296600507329e-12	18	0	0	404	8202
R-HSA-5602358	Diseases associated with the TLR signaling cascade	0.999999999996305	-3.69514943520121e-12	24	0	0	404	8202
R-HSA-416572	Sema4D induced cell migration and growth-cone collapse	0.999999999996305	-3.69514943520121e-12	24	0	0	404	8202
R-HSA-1614635	Sulfur amino acid metabolism	0.999999999996305	-3.69514943520121e-12	24	0	0	404	8202
R-HSA-983170	Antigen Presentation: Folding, assembly and peptide loading of class I MHC	0.999999999996305	-3.69514943520121e-12	24	0	0	404	8202
R-HSA-70268	Pyruvate metabolism	0.999999999996305	-3.69514943520121e-12	24	0	0	404	8202
R-HSA-937041	IKK complex recruitment mediated by RIP1	0.999999999996305	-3.69514943520121e-12	24	0	0	404	8202
R-HSA-5260271	Diseases of Immune System	0.999999999996305	-3.69514943520121e-12	24	0	0	404	8202
R-HSA-933542	TRAF6 mediated NF-kB activation	0.999999999996305	-3.69514943520121e-12	24	0	0	404	8202
R-HSA-194002	Glucocorticoid biosynthesis	0.999999999997134	-2.86648326200338e-12	9	0	0	404	8202
R-HSA-2142816	Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)	0.999999999997134	-2.86648326200338e-12	9	0	0	404	8202
R-HSA-5666185	RHO GTPases Activate Rhotekin and Rhophilins	0.999999999997134	-2.86648326200338e-12	9	0	0	404	8202
R-HSA-425561	Sodium/Calcium exchangers	0.999999999997134	-2.86648326200338e-12	9	0	0	404	8202
R-HSA-156587	Amino Acid conjugation	0.999999999997134	-2.86648326200338e-12	9	0	0	404	8202
R-HSA-391908	Prostanoid ligand receptors	0.999999999997134	-2.86648326200338e-12	9	0	0	404	8202
R-HSA-162592	Integration of provirus	0.999999999997134	-2.86648326200338e-12	9	0	0	404	8202
R-HSA-196108	Pregnenolone biosynthesis	0.999999999997134	-2.86648326200338e-12	9	0	0	404	8202
R-HSA-389661	Glyoxylate metabolism and glycine degradation	0.999999999997134	-2.86648326200338e-12	9	0	0	404	8202
R-HSA-167590	Nef Mediated CD4 Down-regulation	0.999999999997134	-2.86648326200338e-12	9	0	0	404	8202
R-HSA-1247673	Erythrocytes take up oxygen and release carbon dioxide	0.999999999997134	-2.86648326200338e-12	9	0	0	404	8202
R-HSA-425381	Bicarbonate transporters	0.999999999997134	-2.86648326200338e-12	9	0	0	404	8202
R-HSA-428890	Role of Abl in Robo-Slit signaling	0.999999999997134	-2.86648326200338e-12	9	0	0	404	8202
R-HSA-426486	Small interfering RNA (siRNA) biogenesis	0.999999999997134	-2.86648326200338e-12	9	0	0	404	8202
R-HSA-1480926	O2/CO2 exchange in erythrocytes	0.999999999997134	-2.86648326200338e-12	9	0	0	404	8202
R-HSA-112411	MAPK1 (ERK2) activation	0.999999999997134	-2.86648326200338e-12	9	0	0	404	8202
R-HSA-2179392	EGFR Transactivation by Gastrin	0.999999999997134	-2.86648326200338e-12	9	0	0	404	8202
R-HSA-189085	Digestion of dietary carbohydrate	0.999999999997134	-2.86648326200338e-12	9	0	0	404	8202
R-HSA-390696	Adrenoceptors	0.999999999997134	-2.86648326200338e-12	9	0	0	404	8202
R-HSA-727802	Transport of nucleotide sugars	0.999999999997134	-2.86648326200338e-12	9	0	0	404	8202
R-HSA-629597	Highly calcium permeable nicotinic acetylcholine receptors	0.999999999997134	-2.86648326200338e-12	9	0	0	404	8202
R-HSA-159424	Conjugation of carboxylic acids	0.999999999997134	-2.86648326200338e-12	9	0	0	404	8202
R-HSA-196025	Formation of annular gap junctions	0.999999999997134	-2.86648326200338e-12	9	0	0	404	8202
R-HSA-1237044	Erythrocytes take up carbon dioxide and release oxygen	0.999999999997134	-2.86648326200338e-12	9	0	0	404	8202
R-HSA-139853	Elevation of cytosolic Ca2+ levels	0.999999999997134	-2.86648326200338e-12	9	0	0	404	8202
R-HSA-1296052	Ca2+ activated K+ channels	0.999999999997134	-2.86648326200338e-12	9	0	0	404	8202
R-HSA-201688	WNT mediated activation of DVL	0.999999999997134	-2.86648326200338e-12	9	0	0	404	8202
R-HSA-159740	Gamma-carboxylation of protein precursors	0.999999999997134	-2.86648326200338e-12	9	0	0	404	8202
R-HSA-159782	Removal of aminoterminal propeptides from gamma-carboxylated proteins	0.999999999997134	-2.86648326200338e-12	9	0	0	404	8202
R-HSA-390450	Folding of actin by CCT/TriC	0.999999999997134	-2.86648326200338e-12	9	0	0	404	8202
R-HSA-196071	Metabolism of steroid hormones and vitamin D	0.999999999997596	-2.40369439650732e-12	36	0	0	404	8202
R-HSA-5358565	Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha)	0.999999999997933	-2.06683397111224e-12	14	0	0	404	8202
R-HSA-162594	Early Phase of HIV Life Cycle	0.999999999997933	-2.06683397111224e-12	14	0	0	404	8202
R-HSA-162658	Golgi Cisternae Pericentriolar Stack Reorganization	0.999999999997933	-2.06683397111224e-12	14	0	0	404	8202
R-HSA-181431	Acetylcholine Binding And Downstream Events	0.999999999997933	-2.06683397111224e-12	14	0	0	404	8202
R-HSA-3371568	Attenuation phase	0.999999999997933	-2.06683397111224e-12	14	0	0	404	8202
R-HSA-5467340	AXIN missense mutants destabilize the destruction complex	0.999999999997933	-2.06683397111224e-12	14	0	0	404	8202
R-HSA-629602	Activation of Nicotinic Acetylcholine Receptors	0.999999999997933	-2.06683397111224e-12	14	0	0	404	8202
R-HSA-2024101	CS/DS degradation	0.999999999997933	-2.06683397111224e-12	14	0	0	404	8202
R-HSA-4839744	truncated APC mutants destabilize the destruction complex	0.999999999997933	-2.06683397111224e-12	14	0	0	404	8202
R-HSA-69166	Removal of the Flap Intermediate	0.999999999997933	-2.06683397111224e-12	14	0	0	404	8202
R-HSA-5358606	Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta)	0.999999999997933	-2.06683397111224e-12	14	0	0	404	8202
R-HSA-170670	Adenylate cyclase inhibitory pathway	0.999999999997933	-2.06683397111224e-12	14	0	0	404	8202
R-HSA-5467348	Truncations of AMER1 destabilize the destruction complex	0.999999999997933	-2.06683397111224e-12	14	0	0	404	8202
R-HSA-4839735	AXIN mutants destabilize the destruction complex, activating WNT signaling	0.999999999997933	-2.06683397111224e-12	14	0	0	404	8202
R-HSA-622327	Postsynaptic nicotinic acetylcholine receptors	0.999999999997933	-2.06683397111224e-12	14	0	0	404	8202
R-HSA-997269	Inhibition of adenylate cyclase pathway	0.999999999997933	-2.06683397111224e-12	14	0	0	404	8202
R-HSA-204174	Regulation of pyruvate dehydrogenase (PDH) complex	0.999999999997933	-2.06683397111224e-12	14	0	0	404	8202
R-HSA-5467337	APC truncation mutants have impaired AXIN binding	0.999999999997933	-2.06683397111224e-12	14	0	0	404	8202
R-HSA-918233	TRAF3-dependent IRF activation pathway	0.999999999997933	-2.06683397111224e-12	14	0	0	404	8202
R-HSA-5682910	LGI-ADAM interactions	0.999999999997933	-2.06683397111224e-12	14	0	0	404	8202
R-HSA-5675482	Regulation of necroptotic cell death	0.999999999997933	-2.06683397111224e-12	14	0	0	404	8202
R-HSA-4839748	AMER1 mutants destabilize the destruction complex	0.999999999997933	-2.06683397111224e-12	14	0	0	404	8202
R-HSA-877312	Regulation of IFNG signaling	0.999999999997933	-2.06683397111224e-12	14	0	0	404	8202
R-HSA-140837	Intrinsic Pathway of Fibrin Clot Formation	0.999999999999887	-1.1321834248713e-13	22	0	0	404	8202
R-HSA-3371571	HSF1-dependent transactivation	0.999999999999887	-1.1321834248713e-13	22	0	0	404	8202
R-HSA-140875	Common Pathway of Fibrin Clot Formation	0.999999999999887	-1.1321834248713e-13	22	0	0	404	8202
R-HSA-354192	Integrin alphaIIb beta3 signaling	1.00000000000094	9.41199856365673e-13	27	0	0	404	8202
R-HSA-76061	RNA Polymerase III Transcription Initiation From Type 1 Promoter	1.00000000000094	9.41199856365673e-13	27	0	0	404	8202
R-HSA-354194	GRB2:SOS provides linkage to MAPK signaling for Integrins	1.0000000000015	1.49674771409042e-12	15	0	0	404	8202
R-HSA-209952	Peptide hormone biosynthesis	1.0000000000015	1.49674771409042e-12	15	0	0	404	8202
R-HSA-5358751	S45 mutants of beta-catenin aren't phosphorylated	1.0000000000015	1.49674771409042e-12	15	0	0	404	8202
R-HSA-391903	Eicosanoid ligand-binding receptors	1.0000000000015	1.49674771409042e-12	15	0	0	404	8202
R-HSA-5358747	S33 mutants of beta-catenin aren't phosphorylated	1.0000000000015	1.49674771409042e-12	15	0	0	404	8202
R-HSA-111447	Activation of BAD and translocation to mitochondria	1.0000000000015	1.49674771409042e-12	15	0	0	404	8202
R-HSA-159418	Recycling of bile acids and salts	1.0000000000015	1.49674771409042e-12	15	0	0	404	8202
R-HSA-4839743	phosphorylation site mutants of CTNNB1 are not targeted to the proteasome by the destruction complex	1.0000000000015	1.49674771409042e-12	15	0	0	404	8202
R-HSA-5358752	T41 mutants of beta-catenin aren't phosphorylated	1.0000000000015	1.49674771409042e-12	15	0	0	404	8202
R-HSA-5358749	S37 mutants of beta-catenin aren't phosphorylated	1.0000000000015	1.49674771409042e-12	15	0	0	404	8202
R-HSA-69298	Association of licensing factors with the pre-replicative complex	1.0000000000015	1.49674771409042e-12	15	0	0	404	8202
R-HSA-372708	p130Cas linkage to MAPK signaling for integrins	1.0000000000015	1.49674771409042e-12	15	0	0	404	8202
R-HSA-5339716	Misspliced GSK3beta mutants stabilize beta-catenin	1.0000000000015	1.49674771409042e-12	15	0	0	404	8202
R-HSA-5358508	Mismatch Repair	1.0000000000015	1.49674771409042e-12	15	0	0	404	8202
R-HSA-879518	Transport of organic anions	1.00000000000206	2.0564730896766e-12	11	0	0	404	8202
R-HSA-71182	Phenylalanine and tyrosine catabolism	1.00000000000206	2.0564730896766e-12	11	0	0	404	8202
R-HSA-380320	Recruitment of NuMA to mitotic centrosomes	1.00000000000206	2.0564730896766e-12	11	0	0	404	8202
R-HSA-5625970	RHO GTPases activate KTN1	1.00000000000206	2.0564730896766e-12	11	0	0	404	8202
R-HSA-71288	Creatine metabolism	1.00000000000206	2.0564730896766e-12	11	0	0	404	8202
R-HSA-68689	CDC6 association with the ORC:origin complex	1.00000000000206	2.0564730896766e-12	11	0	0	404	8202
R-HSA-3371378	Regulation by c-FLIP	1.00000000000206	2.0564730896766e-12	11	0	0	404	8202
R-HSA-351906	Apoptotic cleavage of cell adhesion  proteins	1.00000000000206	2.0564730896766e-12	11	0	0	404	8202
R-HSA-5602498	MyD88 deficiency (TLR2/4)	1.00000000000206	2.0564730896766e-12	11	0	0	404	8202
R-HSA-5218900	CASP8 activity is inhibited	1.00000000000206	2.0564730896766e-12	11	0	0	404	8202
R-HSA-196757	Metabolism of folate and pterines	1.00000000000206	2.0564730896766e-12	11	0	0	404	8202
R-HSA-5603041	IRAK4 deficiency (TLR2/4)	1.00000000000206	2.0564730896766e-12	11	0	0	404	8202
R-HSA-375281	Hormone ligand-binding receptors	1.00000000000206	2.0564730896766e-12	11	0	0	404	8202
R-HSA-1059683	Interleukin-6 signaling	1.00000000000206	2.0564730896766e-12	11	0	0	404	8202
R-HSA-174490	Membrane binding and targetting of GAG proteins	1.00000000000206	2.0564730896766e-12	11	0	0	404	8202
R-HSA-1266695	Interleukin-7 signaling	1.00000000000206	2.0564730896766e-12	11	0	0	404	8202
R-HSA-3296469	Defects in cobalamin (B12) metabolism	1.00000000000206	2.0564730896766e-12	11	0	0	404	8202
R-HSA-211999	CYP2E1 reactions	1.00000000000206	2.0564730896766e-12	11	0	0	404	8202
R-HSA-174495	Synthesis And Processing Of GAG, GAGPOL Polyproteins	1.00000000000206	2.0564730896766e-12	11	0	0	404	8202
R-HSA-629594	Highly calcium permeable postsynaptic nicotinic acetylcholine receptors	1.00000000000206	2.0564730896766e-12	11	0	0	404	8202
R-HSA-1236977	Endosomal/Vacuolar pathway	1.00000000000206	2.0564730896766e-12	11	0	0	404	8202
R-HSA-193048	Androgen biosynthesis	1.00000000000206	2.0564730896766e-12	11	0	0	404	8202
R-HSA-71240	Tryptophan catabolism	1.00000000000206	2.0564730896766e-12	11	0	0	404	8202
R-HSA-5655291	Signaling by FGFR4 in disease	1.00000000000206	2.0564730896766e-12	11	0	0	404	8202
R-HSA-69416	Dimerization of procaspase-8	1.00000000000206	2.0564730896766e-12	11	0	0	404	8202
R-HSA-1855183	Synthesis of IP2, IP, and Ins in the cytosol	1.00000000000206	2.0564730896766e-12	11	0	0	404	8202
R-HSA-189451	Heme biosynthesis	1.00000000000206	2.0564730896766e-12	11	0	0	404	8202
R-HSA-5668599	RHO GTPases Activate NADPH Oxidases	1.00000000000206	2.0564730896766e-12	11	0	0	404	8202
R-HSA-159854	Gamma-carboxylation, transport, and amino-terminal cleavage of proteins	1.00000000000206	2.0564730896766e-12	11	0	0	404	8202
R-HSA-446652	Interleukin-1 signaling	1.00000000000395	3.94860513780281e-12	44	0	0	404	8202
R-HSA-167287	HIV elongation arrest and recovery	1.00000000000436	4.35916133997355e-12	31	0	0	404	8202
R-HSA-167290	Pausing and recovery of HIV elongation	1.00000000000436	4.35916133997355e-12	31	0	0	404	8202
R-HSA-168638	NOD1/2 Signaling Pathway	1.00000000000436	4.35916133997355e-12	31	0	0	404	8202
R-HSA-418990	Adherens junctions interactions	1.00000000000436	4.35916133997355e-12	31	0	0	404	8202
R-HSA-113510	E2F mediated regulation of DNA replication	1.00000000000492	4.92495012901456e-12	33	0	0	404	8202
R-HSA-1461957	Beta defensins	1.00000000000546	5.45921644285144e-12	42	0	0	404	8202
R-HSA-444473	Formyl peptide receptors bind formyl peptides and many other ligands	1.00000000000563	5.6297860850354e-12	8	0	0	404	8202
R-HSA-5340588	RNF mutants show enhanced WNT signaling and proliferation	1.00000000000563	5.6297860850354e-12	8	0	0	404	8202
R-HSA-196836	Vitamin C (ascorbate) metabolism	1.00000000000563	5.6297860850354e-12	8	0	0	404	8202
R-HSA-1253288	Downregulation of ERBB4 signaling	1.00000000000563	5.6297860850354e-12	8	0	0	404	8202
R-HSA-428643	Organic anion transporters	1.00000000000563	5.6297860850354e-12	8	0	0	404	8202
R-HSA-159763	Transport of gamma-carboxylated protein precursors from the endoplasmic reticulum to the Golgi apparatus	1.00000000000563	5.6297860850354e-12	8	0	0	404	8202
R-HSA-5619115	Disorders of transmembrane transporters	1.00000000000563	5.6297860850354e-12	8	0	0	404	8202
R-HSA-1483115	Hydrolysis of LPC	1.00000000000563	5.6297860850354e-12	8	0	0	404	8202
R-HSA-450520	HuR (ELAVL1) binds and stabilizes mRNA	1.00000000000563	5.6297860850354e-12	8	0	0	404	8202
R-HSA-5688849	Defective CSF2RB causes pulmonary surfactant metabolism dysfunction 5 (SMDP5)	1.00000000000563	5.6297860850354e-12	8	0	0	404	8202
R-HSA-804914	Transport of fatty acids	1.00000000000563	5.6297860850354e-12	8	0	0	404	8202
R-HSA-5688890	Defective CSF2RA causes pulmonary surfactant metabolism dysfunction 4 (SMDP4)	1.00000000000563	5.6297860850354e-12	8	0	0	404	8202
R-HSA-5603027	IKBKG deficiency causes anhidrotic ectodermal dysplasia with immunodeficiency (EDA-ID) (via TLR)	1.00000000000563	5.6297860850354e-12	8	0	0	404	8202
R-HSA-444821	Relaxin receptors	1.00000000000563	5.6297860850354e-12	8	0	0	404	8202
R-HSA-2142670	Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)	1.00000000000563	5.6297860850354e-12	8	0	0	404	8202
R-HSA-177128	Conjugation of salicylate with glycine	1.00000000000563	5.6297860850354e-12	8	0	0	404	8202
R-HSA-389397	Orexin and neuropeptides FF and QRFP bind to their respective receptors	1.00000000000563	5.6297860850354e-12	8	0	0	404	8202
R-HSA-5362798	Release of Hh-Np from the secreting cell	1.00000000000563	5.6297860850354e-12	8	0	0	404	8202
R-HSA-5632681	Ligand-receptor interactions	1.00000000000563	5.6297860850354e-12	8	0	0	404	8202
R-HSA-77286	mitochondrial fatty acid beta-oxidation of saturated fatty acids	1.00000000000563	5.6297860850354e-12	8	0	0	404	8202
R-HSA-1614558	Degradation of cysteine and homocysteine	1.00000000000563	5.6297860850354e-12	8	0	0	404	8202
R-HSA-210747	Regulation of gene expression in early pancreatic precursor cells	1.00000000000563	5.6297860850354e-12	8	0	0	404	8202
R-HSA-2046105	Linoleic acid (LA) metabolism	1.00000000000563	5.6297860850354e-12	8	0	0	404	8202
R-HSA-192456	Digestion of dietary lipid	1.00000000000563	5.6297860850354e-12	8	0	0	404	8202
R-HSA-1236973	Cross-presentation of particulate exogenous antigens (phagosomes)	1.00000000000563	5.6297860850354e-12	8	0	0	404	8202
R-HSA-446388	Regulation of cytoskeletal remodeling and cell spreading by IPP complex components	1.00000000000563	5.6297860850354e-12	8	0	0	404	8202
R-HSA-163765	ChREBP activates metabolic gene expression	1.00000000000563	5.6297860850354e-12	8	0	0	404	8202
R-HSA-389948	PD-1 signaling	1.00000000000606	6.05674061223394e-12	23	0	0	404	8202
R-HSA-179409	APC-Cdc20 mediated degradation of Nek2A	1.00000000000606	6.05674061223394e-12	23	0	0	404	8202
R-HSA-203927	MicroRNA (miRNA) biogenesis	1.00000000000606	6.05674061223394e-12	23	0	0	404	8202
R-HSA-211976	Endogenous sterols	1.00000000000606	6.05674061223394e-12	23	0	0	404	8202
R-HSA-191273	Cholesterol biosynthesis	1.00000000000606	6.05674061223394e-12	23	0	0	404	8202
R-HSA-201451	Signaling by BMP	1.00000000000606	6.05674061223394e-12	23	0	0	404	8202
R-HSA-186712	Regulation of beta-cell development	1.00000000000718	7.18454310031982e-12	32	0	0	404	8202
R-HSA-1660662	Glycosphingolipid metabolism	1.00000000000783	7.82693055211379e-12	40	0	0	404	8202
R-HSA-917729	Endosomal Sorting Complex Required For Transport (ESCRT)	1.0000000000089	8.90226480463109e-12	28	0	0	404	8202
R-HSA-190828	Gap junction trafficking	1.0000000000089	8.90226480463109e-12	28	0	0	404	8202
R-HSA-390648	Muscarinic acetylcholine receptors	1.00000000000908	9.08111752069916e-12	5	0	0	404	8202
R-HSA-77310	Beta oxidation of lauroyl-CoA to decanoyl-CoA-CoA	1.00000000000908	9.08111752069916e-12	5	0	0	404	8202
R-HSA-111932	CaMK IV-mediated phosphorylation of CREB	1.00000000000908	9.08111752069916e-12	5	0	0	404	8202
R-HSA-73943	Reversal of alkylation damage by DNA dioxygenases	1.00000000000908	9.08111752069916e-12	5	0	0	404	8202
R-HSA-140834	Extrinsic Pathway of Fibrin Clot Formation	1.00000000000908	9.08111752069916e-12	5	0	0	404	8202
R-HSA-75157	FasL/ CD95L signaling	1.00000000000908	9.08111752069916e-12	5	0	0	404	8202
R-HSA-5652084	Fructose metabolism	1.00000000000908	9.08111752069916e-12	5	0	0	404	8202
R-HSA-2161541	Abacavir metabolism	1.00000000000908	9.08111752069916e-12	5	0	0	404	8202
R-HSA-77346	Beta oxidation of decanoyl-CoA to octanoyl-CoA-CoA	1.00000000000908	9.08111752069916e-12	5	0	0	404	8202
R-HSA-446205	Synthesis of GDP-mannose	1.00000000000908	9.08111752069916e-12	5	0	0	404	8202
R-HSA-167827	The proton buffering model	1.00000000000908	9.08111752069916e-12	5	0	0	404	8202
R-HSA-1300652	Sperm:Oocyte Membrane Binding	1.00000000000908	9.08111752069916e-12	5	0	0	404	8202
R-HSA-2161517	Abacavir transmembrane transport	1.00000000000908	9.08111752069916e-12	5	0	0	404	8202
R-HSA-111464	SMAC-mediated dissociation of IAP:caspase complexes	1.00000000000908	9.08111752069916e-12	5	0	0	404	8202
R-HSA-163358	PKA-mediated phosphorylation of key metabolic factors	1.00000000000908	9.08111752069916e-12	5	0	0	404	8202
R-HSA-444209	Free fatty acid receptors	1.00000000000908	9.08111752069916e-12	5	0	0	404	8202
R-HSA-1614517	Sulfide oxidation to sulfate	1.00000000000908	9.08111752069916e-12	5	0	0	404	8202
R-HSA-5250981	Toxicity of botulinum toxin type F (BoNT/F)	1.00000000000908	9.08111752069916e-12	5	0	0	404	8202
R-HSA-77348	Beta oxidation of octanoyl-CoA to hexanoyl-CoA	1.00000000000908	9.08111752069916e-12	5	0	0	404	8202
R-HSA-210746	Regulation of gene expression in endocrine-committed (NEUROG3+) progenitor cells	1.00000000000908	9.08111752069916e-12	5	0	0	404	8202
R-HSA-70370	Galactose catabolism	1.00000000000908	9.08111752069916e-12	5	0	0	404	8202
R-HSA-197264	Nicotinamide salvaging	1.00000000000908	9.08111752069916e-12	5	0	0	404	8202
R-HSA-166187	Mitochondrial Uncoupling Proteins	1.00000000000908	9.08111752069916e-12	5	0	0	404	8202
R-HSA-114516	Disinhibition of SNARE formation	1.00000000000908	9.08111752069916e-12	5	0	0	404	8202
R-HSA-390651	Dopamine receptors	1.00000000000908	9.08111752069916e-12	5	0	0	404	8202
R-HSA-77350	Beta oxidation of hexanoyl-CoA to butanoyl-CoA	1.00000000000908	9.08111752069916e-12	5	0	0	404	8202
R-HSA-180689	APOBEC3G mediated resistance to HIV-1 infection	1.00000000000908	9.08111752069916e-12	5	0	0	404	8202
R-HSA-111461	Cytochrome c-mediated apoptotic response	1.00000000000908	9.08111752069916e-12	5	0	0	404	8202
R-HSA-5250955	Toxicity of botulinum toxin type D (BoNT/D)	1.00000000000908	9.08111752069916e-12	5	0	0	404	8202
R-HSA-964739	N-glycan trimming and elongation in the cis-Golgi	1.00000000000908	9.08111752069916e-12	5	0	0	404	8202
R-HSA-2855086	Ficolins bind to repetitive carbohydrate structures on the target cell surface	1.00000000000908	9.08111752069916e-12	5	0	0	404	8202
R-HSA-380095	Tachykinin receptors bind tachykinins	1.00000000000908	9.08111752069916e-12	5	0	0	404	8202
R-HSA-196843	Vitamin B2 (riboflavin) metabolism	1.00000000000908	9.08111752069916e-12	5	0	0	404	8202
R-HSA-2644607	Loss of Function of FBXW7 in Cancer and NOTCH1 Signaling	1.00000000000908	9.08111752069916e-12	5	0	0	404	8202
R-HSA-157881	Cyclin B2 mediated events	1.00000000000908	9.08111752069916e-12	5	0	0	404	8202
R-HSA-111463	SMAC binds to IAPs	1.00000000000908	9.08111752069916e-12	5	0	0	404	8202
R-HSA-112303	Electric Transmission Across Gap Junctions	1.00000000000908	9.08111752069916e-12	5	0	0	404	8202
R-HSA-561048	Organic anion transport	1.00000000000908	9.08111752069916e-12	5	0	0	404	8202
R-HSA-69478	G2/M DNA replication checkpoint	1.00000000000908	9.08111752069916e-12	5	0	0	404	8202
R-HSA-433137	Sodium-coupled sulphate, di- and tri-carboxylate transporters	1.00000000000908	9.08111752069916e-12	5	0	0	404	8202
R-HSA-111459	Activation of caspases through apoptosome-mediated cleavage	1.00000000000908	9.08111752069916e-12	5	0	0	404	8202
R-HSA-2644605	FBXW7 Mutants and NOTCH1 in Cancer	1.00000000000908	9.08111752069916e-12	5	0	0	404	8202
R-HSA-391906	Leukotriene receptors	1.00000000000908	9.08111752069916e-12	5	0	0	404	8202
R-HSA-68911	G2 Phase	1.00000000000908	9.08111752069916e-12	5	0	0	404	8202
R-HSA-5368598	Negative regulation of TCF-dependent signaling by DVL-interacting proteins	1.00000000000908	9.08111752069916e-12	5	0	0	404	8202
R-HSA-1169092	Activation of RAS in B cells	1.00000000000908	9.08111752069916e-12	5	0	0	404	8202
R-HSA-446199	Synthesis of Dolichyl-phosphate	1.00000000000908	9.08111752069916e-12	5	0	0	404	8202
R-HSA-112307	Transmission across Electrical Synapses	1.00000000000908	9.08111752069916e-12	5	0	0	404	8202
R-HSA-167826	The fatty acid cycling model	1.00000000000908	9.08111752069916e-12	5	0	0	404	8202
R-HSA-209931	Serotonin and melatonin biosynthesis	1.00000000000908	9.08111752069916e-12	5	0	0	404	8202
R-HSA-5661270	Catabolism of glucuronate to xylulose-5-phosphate	1.00000000000908	9.08111752069916e-12	5	0	0	404	8202
R-HSA-111469	SMAC-mediated apoptotic response	1.00000000000908	9.08111752069916e-12	5	0	0	404	8202
R-HSA-3065676	SUMO is conjugated to E1 (UBA2:SAE1)	1.00000000000908	9.08111752069916e-12	5	0	0	404	8202
R-HSA-446210	Synthesis of UDP-N-acetyl-glucosamine	1.00000000000908	9.08111752069916e-12	5	0	0	404	8202
R-HSA-1502540	Signaling by Activin	1.00000000000961	9.61268656360742e-12	13	0	0	404	8202
R-HSA-2046104	alpha-linolenic (omega3) and linoleic (omega6) acid metabolism	1.00000000000961	9.61268656360742e-12	13	0	0	404	8202
R-HSA-1679131	Trafficking and processing of endosomal TLR	1.00000000000961	9.61268656360742e-12	13	0	0	404	8202
R-HSA-209560	NF-kB is activated and signals survival	1.00000000000961	9.61268656360742e-12	13	0	0	404	8202
R-HSA-211227	Activation of DNA fragmentation factor	1.00000000000961	9.61268656360742e-12	13	0	0	404	8202
R-HSA-2046106	alpha-linolenic acid (ALA) metabolism	1.00000000000961	9.61268656360742e-12	13	0	0	404	8202
R-HSA-350054	Notch-HLH transcription pathway	1.00000000000961	9.61268656360742e-12	13	0	0	404	8202
R-HSA-5357786	TNFR1-induced proapoptotic signaling	1.00000000000961	9.61268656360742e-12	13	0	0	404	8202
R-HSA-428790	Facilitative Na+-independent glucose transporters	1.00000000000961	9.61268656360742e-12	13	0	0	404	8202
R-HSA-75205	Dissolution of Fibrin Clot	1.00000000000961	9.61268656360742e-12	13	0	0	404	8202
R-HSA-879415	Advanced glycosylation endproduct receptor signaling	1.00000000000961	9.61268656360742e-12	13	0	0	404	8202
R-HSA-174403	Glutathione synthesis and recycling	1.00000000000961	9.61268656360742e-12	13	0	0	404	8202
R-HSA-977441	GABA A receptor activation	1.00000000000961	9.61268656360742e-12	13	0	0	404	8202
R-HSA-198323	AKT phosphorylates targets in the cytosol	1.00000000000961	9.61268656360742e-12	13	0	0	404	8202
R-HSA-171007	p38MAPK events	1.00000000000961	9.61268656360742e-12	13	0	0	404	8202
R-HSA-74217	Purine salvage	1.00000000000961	9.61268656360742e-12	13	0	0	404	8202
R-HSA-140342	Apoptosis induced DNA fragmentation	1.00000000000961	9.61268656360742e-12	13	0	0	404	8202
R-HSA-209822	Glycoprotein hormones	1.00000000000961	9.61268656360742e-12	13	0	0	404	8202
R-HSA-5626467	RHO GTPases activate IQGAPs	1.00000000000961	9.61268656360742e-12	13	0	0	404	8202
R-HSA-2564830	Cytosolic iron-sulfur cluster assembly	1.00000000000961	9.61268656360742e-12	13	0	0	404	8202
R-HSA-1663150	The activation of arylsulfatases	1.00000000000961	9.61268656360742e-12	13	0	0	404	8202
R-HSA-175474	Assembly Of The HIV Virion	1.00000000000961	9.61268656360742e-12	13	0	0	404	8202
R-HSA-167238	Pausing and recovery of Tat-mediated HIV elongation	1.00000000000977	9.77213301956472e-12	30	0	0	404	8202
R-HSA-157858	Gap junction trafficking and regulation	1.00000000000977	9.77213301956472e-12	30	0	0	404	8202
R-HSA-167243	Tat-mediated HIV elongation arrest and recovery	1.00000000000977	9.77213301956472e-12	30	0	0	404	8202
R-HSA-5683826	Surfactant metabolism	1.00000000000977	9.77213301956472e-12	30	0	0	404	8202
R-HSA-5334118	DNA methylation	1.00000000001127	1.12661832647801e-11	62	0	0	404	8202
R-HSA-171306	Packaging Of Telomere Ends	1.00000000001161	1.16061247890832e-11	49	0	0	404	8202
R-HSA-445989	TAK1 activates NFkB by phosphorylation and activation of IKKs complex	1.0000000000122	1.22045720229296e-11	26	0	0	404	8202
R-HSA-912694	Regulation of IFNA signaling	1.0000000000122	1.22045720229296e-11	26	0	0	404	8202
R-HSA-983189	Kinesins	1.0000000000122	1.22045720229296e-11	26	0	0	404	8202
R-HSA-975298	Ligand-gated ion channel transport	1.0000000000122	1.22045720229296e-11	26	0	0	404	8202
R-HSA-3238698	WNT ligand biogenesis and trafficking	1.0000000000122	1.22045720229296e-11	26	0	0	404	8202
R-HSA-76066	RNA Polymerase III Transcription Initiation From Type 2 Promoter	1.0000000000122	1.22045720229296e-11	26	0	0	404	8202
R-HSA-72695	Formation of the ternary complex, and subsequently, the 43S complex	1.00000000001332	1.33181585260792e-11	48	0	0	404	8202
R-HSA-76009	Platelet Aggregation (Plug Formation)	1.00000000001344	1.34406026623379e-11	37	0	0	404	8202
R-HSA-156590	Glutathione conjugation	1.00000000001344	1.34406026623379e-11	37	0	0	404	8202
R-HSA-71406	Pyruvate metabolism and Citric Acid (TCA) cycle	1.00000000001422	1.42244495078734e-11	45	0	0	404	8202
R-HSA-5673000	RAF activation	1.0000000000145	1.45017813547426e-11	25	0	0	404	8202
R-HSA-5669034	TNFs bind their physiological receptors	1.0000000000145	1.45017813547426e-11	25	0	0	404	8202
R-HSA-162588	Budding and maturation of HIV virion	1.0000000000145	1.45017813547426e-11	25	0	0	404	8202
R-HSA-163125	Post-translational modification: synthesis of GPI-anchored proteins	1.0000000000145	1.45017813547426e-11	25	0	0	404	8202
R-HSA-75876	Synthesis of very long-chain fatty acyl-CoAs	1.0000000000145	1.45017813547426e-11	25	0	0	404	8202
R-HSA-176407	Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase	1.00000000001464	1.46410653982319e-11	17	0	0	404	8202
R-HSA-442729	CREB phosphorylation through the activation of CaMKII	1.00000000001464	1.46410653982319e-11	17	0	0	404	8202
R-HSA-438066	Unblocking of NMDA receptor, glutamate binding and activation	1.00000000001464	1.46410653982319e-11	17	0	0	404	8202
R-HSA-450302	activated TAK1 mediates p38 MAPK activation	1.00000000001464	1.46410653982319e-11	17	0	0	404	8202
R-HSA-176412	Phosphorylation of the APC/C	1.00000000001464	1.46410653982319e-11	17	0	0	404	8202
R-HSA-140534	Ligand-dependent caspase activation	1.00000000001464	1.46410653982319e-11	17	0	0	404	8202
R-HSA-5627117	RHO GTPases Activate ROCKs	1.00000000001464	1.46410653982319e-11	17	0	0	404	8202
R-HSA-422085	Synthesis, secretion, and deacylation of Ghrelin	1.00000000001464	1.46410653982319e-11	17	0	0	404	8202
R-HSA-196299	Beta-catenin phosphorylation cascade	1.00000000001464	1.46410653982319e-11	17	0	0	404	8202
R-HSA-450604	KSRP (KHSRP) binds and destabilizes mRNA	1.00000000001464	1.46410653982319e-11	17	0	0	404	8202
R-HSA-69205	G1/S-Specific Transcription	1.00000000001464	1.46410653982319e-11	17	0	0	404	8202
R-HSA-1482925	Acyl chain remodelling of PG	1.00000000001464	1.46410653982319e-11	17	0	0	404	8202
R-HSA-1482801	Acyl chain remodelling of PS	1.00000000001464	1.46410653982319e-11	17	0	0	404	8202
R-HSA-189445	Metabolism of porphyrins	1.00000000001464	1.46410653982319e-11	17	0	0	404	8202
R-HSA-5676594	TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway	1.00000000001464	1.46410653982319e-11	17	0	0	404	8202
R-HSA-432142	Platelet sensitization by LDL	1.00000000001464	1.46410653982319e-11	17	0	0	404	8202
R-HSA-2559586	DNA Damage/Telomere Stress Induced Senescence	1.0000000000161	1.60975466163469e-11	77	0	0	404	8202
R-HSA-111465	Apoptotic cleavage of cellular proteins	1.00000000001668	1.6681978903355e-11	38	0	0	404	8202
R-HSA-390471	Association of TriC/CCT with target proteins during biosynthesis	1.00000000001765	1.76527217913365e-11	29	0	0	404	8202
R-HSA-5601884	PIWI-interacting RNA (piRNA) biogenesis	1.00000000001765	1.76527217913365e-11	29	0	0	404	8202
R-HSA-73728	RNA Polymerase I Promoter Opening	1.00000000001796	1.79594350801553e-11	60	0	0	404	8202
R-HSA-75105	Fatty Acyl-CoA Biosynthesis	1.00000000001821	1.8210161154796e-11	46	0	0	404	8202
R-HSA-442720	CREB phosphorylation through the activation of Adenylate Cyclase	1.00000000001821	1.82136701690316e-11	7	0	0	404	8202
R-HSA-182218	Nef Mediated CD8 Down-regulation	1.00000000001821	1.82136701690316e-11	7	0	0	404	8202
R-HSA-174577	Activation of C3 and C5	1.00000000001821	1.82136701690316e-11	7	0	0	404	8202
R-HSA-2993913	Clearance of Nuclear Envelope Membranes from Chromatin	1.00000000001821	1.82136701690316e-11	7	0	0	404	8202
R-HSA-3656225	Defective CHST6 causes MCDC1	1.00000000001821	1.82136701690316e-11	7	0	0	404	8202
R-HSA-435368	Zinc efflux and compartmentalization by the SLC30 family	1.00000000001821	1.82136701690316e-11	7	0	0	404	8202
R-HSA-83936	Transport of nucleosides and free purine and pyrimidine bases across the plasma membrane	1.00000000001821	1.82136701690316e-11	7	0	0	404	8202
R-HSA-111471	Apoptotic factor-mediated response	1.00000000001821	1.82136701690316e-11	7	0	0	404	8202
R-HSA-75158	TRAIL  signaling	1.00000000001821	1.82136701690316e-11	7	0	0	404	8202
R-HSA-196791	Vitamin D (calciferol) metabolism	1.00000000001821	1.82136701690316e-11	7	0	0	404	8202
R-HSA-629587	Highly sodium permeable acetylcholine nicotinic receptors	1.00000000001821	1.82136701690316e-11	7	0	0	404	8202
R-HSA-3595177	Defective CHSY1 causes TPBS	1.00000000001821	1.82136701690316e-11	7	0	0	404	8202
R-HSA-110362	POLB-Dependent Long Patch Base Excision Repair	1.00000000001821	1.82136701690316e-11	7	0	0	404	8202
R-HSA-162791	Attachment of GPI anchor to uPAR	1.00000000001821	1.82136701690316e-11	7	0	0	404	8202
R-HSA-426117	Cation-coupled Chloride cotransporters	1.00000000001821	1.82136701690316e-11	7	0	0	404	8202
R-HSA-166665	Terminal pathway of complement	1.00000000001821	1.82136701690316e-11	7	0	0	404	8202
R-HSA-190371	FGFR3b ligand binding and activation	1.00000000001821	1.82136701690316e-11	7	0	0	404	8202
R-HSA-210744	Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells	1.00000000001821	1.82136701690316e-11	7	0	0	404	8202
R-HSA-3656244	Defective B4GALT1 causes B4GALT1-CDG (CDG-2d)	1.00000000001821	1.82136701690316e-11	7	0	0	404	8202
R-HSA-429593	Inositol transporters	1.00000000001821	1.82136701690316e-11	7	0	0	404	8202
R-HSA-3595174	Defective CHST14 causes EDS, musculocontractural type	1.00000000001821	1.82136701690316e-11	7	0	0	404	8202
R-HSA-163767	PP2A-mediated dephosphorylation of key metabolic factors	1.00000000001821	1.82136701690316e-11	7	0	0	404	8202
R-HSA-5619102	SLC transporter disorders	1.00000000001821	1.82136701690316e-11	7	0	0	404	8202
R-HSA-420597	Nectin/Necl  trans heterodimerization	1.00000000001821	1.82136701690316e-11	7	0	0	404	8202
R-HSA-2187335	The retinoid cycle in cones (daylight vision)	1.00000000001821	1.82136701690316e-11	7	0	0	404	8202
R-HSA-5603029	IkBA variant leads to EDA-ID	1.00000000001821	1.82136701690316e-11	7	0	0	404	8202
R-HSA-5649702	APEX1-Independent Resolution of AP Sites via the Single Nucleotide Replacement Pathway	1.00000000001821	1.82136701690316e-11	7	0	0	404	8202
R-HSA-3595172	Defective CHST3 causes SEDCJD	1.00000000001821	1.82136701690316e-11	7	0	0	404	8202
R-HSA-427601	Multifunctional anion exchangers	1.00000000001821	1.82136701690316e-11	7	0	0	404	8202
R-HSA-3656243	Defective ST3GAL3 causes MCT12 and EIEE15	1.00000000001821	1.82136701690316e-11	7	0	0	404	8202
R-HSA-71336	Pentose phosphate pathway (hexose monophosphate shunt)	1.00000000001821	1.82136701690316e-11	7	0	0	404	8202
R-HSA-2980767	Activation of NIMA Kinases NEK9, NEK6, NEK7	1.00000000001821	1.82136701690316e-11	7	0	0	404	8202
R-HSA-164843	2-LTR circle formation	1.00000000001821	1.82136701690316e-11	7	0	0	404	8202
R-HSA-426496	Post-transcriptional silencing by small RNAs	1.00000000001821	1.82136701690316e-11	7	0	0	404	8202
R-HSA-2142789	Ubiquinol biosynthesis	1.00000000001821	1.82136701690316e-11	7	0	0	404	8202
R-HSA-4411364	Binding of TCF/LEF:CTNNB1 to target gene promoters	1.00000000001821	1.82136701690316e-11	7	0	0	404	8202
R-HSA-1475029	Reversible hydration of carbon dioxide	1.00000000001914	1.91353936161631e-11	12	0	0	404	8202
R-HSA-264870	Caspase-mediated cleavage of cytoskeletal proteins	1.00000000001914	1.91353936161631e-11	12	0	0	404	8202
R-HSA-2160916	Hyaluronan uptake and degradation	1.00000000001914	1.91353936161631e-11	12	0	0	404	8202
R-HSA-75035	Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex	1.00000000001914	1.91353936161631e-11	12	0	0	404	8202
R-HSA-3371511	HSF1 activation	1.00000000001914	1.91353936161631e-11	12	0	0	404	8202
R-HSA-2022857	Keratan sulfate degradation	1.00000000001914	1.91353936161631e-11	12	0	0	404	8202
R-HSA-933543	NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10	1.00000000001914	1.91353936161631e-11	12	0	0	404	8202
R-HSA-2197563	NOTCH2 intracellular domain regulates transcription	1.00000000001914	1.91353936161631e-11	12	0	0	404	8202
R-HSA-2168880	Scavenging of heme from plasma	1.00000000001914	1.91353936161631e-11	12	0	0	404	8202
R-HSA-174414	Processive synthesis on the C-strand of the telomere	1.00000000001914	1.91353936161631e-11	12	0	0	404	8202
R-HSA-1296346	Tandem pore domain potassium channels	1.00000000001914	1.91353936161631e-11	12	0	0	404	8202
R-HSA-429958	mRNA decay by 3' to 5' exoribonuclease	1.00000000001914	1.91353936161631e-11	12	0	0	404	8202
R-HSA-417957	P2Y receptors	1.00000000001914	1.91353936161631e-11	12	0	0	404	8202
R-HSA-202670	ERKs are inactivated	1.00000000001914	1.91353936161631e-11	12	0	0	404	8202
R-HSA-166786	Creation of C4 and C2 activators	1.00000000001914	1.91353936161631e-11	12	0	0	404	8202
R-HSA-622323	Presynaptic nicotinic acetylcholine receptors	1.00000000001914	1.91353936161631e-11	12	0	0	404	8202
R-HSA-113501	Inhibition of replication initiation of damaged DNA by RB1/E2F1	1.00000000001914	1.91353936161631e-11	12	0	0	404	8202
R-HSA-432047	Passive transport by Aquaporins	1.00000000001914	1.91353936161631e-11	12	0	0	404	8202
R-HSA-432720	Lysosome Vesicle Biogenesis	1.0000000000196	1.95994128198856e-11	35	0	0	404	8202
R-HSA-912446	Meiotic recombination	1.00000000002038	2.03822417998488e-11	84	0	0	404	8202
R-HSA-140877	Formation of Fibrin Clot (Clotting Cascade)	1.00000000002096	2.09592413181022e-11	39	0	0	404	8202
R-HSA-6782315	tRNA modification in the nucleus and cytosol	1.00000000002096	2.09592413181022e-11	39	0	0	404	8202
R-HSA-202427	Phosphorylation of CD3 and TCR zeta chains	1.00000000002161	2.16103228046537e-11	21	0	0	404	8202
R-HSA-211981	Xenobiotics	1.00000000002161	2.16103228046537e-11	21	0	0	404	8202
R-HSA-164938	Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters	1.00000000002161	2.16103228046537e-11	21	0	0	404	8202
R-HSA-2022870	Chondroitin sulfate biosynthesis	1.00000000002161	2.16103228046537e-11	21	0	0	404	8202
R-HSA-1810476	RIP-mediated NFkB activation via ZBP1	1.00000000002161	2.16103228046537e-11	21	0	0	404	8202
R-HSA-381426	Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)	1.00000000002161	2.16103228046537e-11	21	0	0	404	8202
R-HSA-156588	Glucuronidation	1.00000000002161	2.16103228046537e-11	21	0	0	404	8202
R-HSA-174048	APC/C:Cdc20 mediated degradation of Cyclin B	1.00000000002161	2.16103228046537e-11	21	0	0	404	8202
R-HSA-427359	SIRT1 negatively regulates rRNA Expression	1.00000000002318	2.31785010119281e-11	65	0	0	404	8202
R-HSA-212300	PRC2 methylates histones and DNA	1.00000000002424	2.42444305138736e-11	70	0	0	404	8202
R-HSA-877300	Interferon gamma signaling	1.00000000003016	3.01595471875607e-11	92	0	0	404	8202
